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Abbreviations, symbols and units
Abbreviations
AFM atomic force microscopy
ABL Ableson leukemia virus
BCR break point cluster region
BCR/ABL fusion protein due to gene fusion of BCR and ABL
BMSC bone marrow stromal cells
BDM butandione-2-monoxime
BSA bovine serum albumin
CAM cell adhesion molecule
CAM-DR cell adhesion-mediated drug resistance
CHO chinese hamster ovary
CML chronic myeloid leukemia
Col collagen type I matrix used in this work
DAB 3.3´-diaminobenzidine
DDR discoidin domain receptor
DFS dynamic force spectroscopy
DMEM Dulbeccos modified eagle medium
DNA deoxyribonucleic acid
ECM extracellular matrix
EDTA ethylenediaminetetraacetic acid
EGTA ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid
EM electron microscopy
FAK focal adhesion kinase
FCS fetal calf serum
F-D force-distance
FITC fluorescein isothiocyanate
FN fibronectin
GFOGER glycine-phenylalanine-hydroxyproline- glycine-glutamate-arginine
HRP horse radish peroxidase
ICAM intercellular adhesion molecule
Abbreviations, symbols and units -2-
IL-3 interleukin-3
IM imatinib mesylate
Itgb1 gene encoding b1-integrin
JAM junctional adhesion molecule
LFA lymphocyte function-associated molecule
mAB monoclonal antibody
MEM minimal essential medium
MIDAS metal ion dependent adhesion site
MMP matrix metallo-protease
MSC mesenchymal stem cell
pAB polyclonal antibody
PBS phosphate buffered solution
pdCol partially denatured collagen type I matrix used in this work
PFA paraformaldehyde
RGD arginine-glycine-aspartic acid
RNA ribonucleic acid
RPMI Roswell Park Memorial Institute
RT room temperature
SCFS single-cell force spectroscopy
SD standard deviation
SMFS single-molecule force spectroscopy
TRITC tetramethylrhodamine isothiocyanate
VCAM vascular cell adhesion molecule
VLA very late antigen
Symbols
aeff effective cantilever area [mm
2]
A area [mm2][m2]
E elasticity [Pa]
f, F force [N][pN][nN]
f* mean or most probable rupture force [pN]
FD detachment force [pN][nN]
heff  effective cantilever height [mm]
Abbreviations, symbols and units -3-
j single rupture event
kB Boltzman constant (1.3806504*10
-23 J/K)
keff effective spring constant [pN/nm]
koff rate of bond dissociation [sec
-1]
kon rate of bond formation [M
-1*sec-1)]
L ligand
h viscosity [Pa*s]
NL,R number of ligands, receptors
p pressure [Pa]
P probability
reff effective loading rate [pN/sec]
rpm rotations per minute [min-1]
R receptor
t lifetime [sec]
t membrane nanotube unbinding event
v velocity [mm/sec]
WD detachment work [J]
Units
Å Angstrom (10-10 m)
°C degree Celsius
K Kelvin
M Molar (mol/l)
m meter
mm mikrometer (10-6!m)
N Newton (kg*m/s2)
nm nanometer (10-9!!m)
nN nanonewton (10-9 N)
pN piconewton (10-12 N)
Pa Pascal [N/m2]
sec seconds
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Summary
Interactions of cells with their environment regulate important cellular functions
and are required for the organization of cells into tissues and complex organisms. These
interactions involve different types of adhesion receptors. Interactions with extracellular
matrix (ECM) proteins are mainly mediated by the integrin family of adhesion molecules.
Situations in which integrin-ECM interactions are deregulated cause diseases and play a
crucial role in cancer cell invasion. Thus, the mechanisms underlying integrin-binding
and regulation are of high interest, particularly at the molecular level.
How can cell-ECM interactions be studied? While there are several methods to
analyze cell adhesion, few provide quantitative data on adhesion forces. One group,
single-cell force spectroscopy (SCFS), quantifies adhesion at the single-cell level and can
therefore differentiate the adhesive properties of individual cells. One implementation of
SCFS is based on atomic force microscopy (AFM); this technique has been employed in
the presented work. Advantageously AFM-SCFS combines high temporal and spatial cell
manipulation, the ability to measure a large range of adhesion forces and sufficiently
high-force resolution to allow the study of single-molecule binding events in the context
of a living cell. Since individual adhesion receptors can be analyzed within their
physiological environment, AFM-SCFS is a powerful tool to study the mechanisms
underlying integrin-regulation.
The presented work is split into six chapters. Chapter one gives background information
about cell-ECM interactions. In chapter two, different adhesion assays are compared and
contrasted. The theoretical Bell-Evans model which is used to interpret integrin-mediated
cell adhesion is discussed in chapter three. Thereafter, the three projects that form the
core of the thesis are detailed in chapters four through six.
In the first project (chapter 4), a2b1-integrin mediated cell adhesion to collagen type I, the
most abundant structural protein in vertebrates, was quantified using CHO cells. Firstly,
a2b1-collagen interactions were investigated at the single-molecule level. Dynamic force
spectroscopy permitted calculation of bond specific parameters, such as the bond
dissociation rate koff (1.3 ± 1.3 sec
-1) and the barrier width xu (2.3 ± 0.3 Å). Next, a2b1-
integrin mediated cell adhesion to collagen type I was monitored over contact times
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between 0 and 600 sec. Thereby the kinetics of a2b1-integrin mediated interactions was
explored and insights into the underlying binding mechanisms were gained.
In the second project (chapter five), effects of cryptic integrin binding sites within
collagen type I exerted on pre-osteoblasts were investigated. Collagen type I matrices
were thermally denatured which lead to exposure of cryptic RGD (Arg-Gly-Asp)-motifs.
As a consequence pre-osteoblasts enhanced their adhesion to denatured collagen.
Compared to native collagen type I, adhesion to denatured collagen was mediated by a
different set of integrins, including av- and a5b1-integrins. Cells grown on denatured
collagen showed enhanced spreading and motility, which correlated with increased focal
adhesion kinase phosphorylation levels. Moreover, osteogenic differentiation kinetics and
differentiation potential were increased on denatured collagen. The findings of this
project open new perspectives for optimization of tissue engineering substrates.
In the third part (chapter six), the effect of the fusion protein BCR/ABL, a hallmark of
chronic myeloid leukemia, on adhesion of myeloid progenitor cells was studied.
Adhesion between BCR/ABL transformed progenitor cells to bone marrow derived
stromal cells and to different ECM proteins was quantitatively compared to that of
control cells. The tyrosine kinase activity of BCR/ABL enhanced cell adhesion, which
was blocked by imatinib mesylate, a drug interfering with BCR/ABL activity.
BCR/ABL-enhanced adhesion correlated with increased b1-integrin cell surface
concentrations. Since adhesion of leukemic cells to the bone marrow compartment is
critical for the development of drug resistance, the reported results may provide a basis
for optimized target therapies.
In the three described projects AFM-based SCFS was applied to investigate early steps of
integrin-mediated adhesion at the molecular level. Taken together, the results
demonstrate that AFM-SCFS is a versatile tool that permits monitoring of cell adhesion
from single-molecule interactions to the formation of more complex adhesion sites at the
force level.
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Zusammenfassung (german)
Interaktionen zwischen Zellen und ihrer Umgebung sind maßgeblich an der
Regulierung zellulärer Funktionen beteiligt und daher notwendig für die Organisation
von Zellen in Geweben und komplexen Organismen. Zellinteraktionen mit der
extrazellulären Matrix (EZM) werden hauptsächlich durch Integrine vermittelt.
Situationen, in denen Integrin- EZM Interaktionen verändert sind, können Krankheiten
verursachen und spielen zudem eine wichtige Rolle bei der Invasion von Krebszellen.
Daher besteht ein großes Interesse darin, die molekularen Mechanismen, die Integrin-
EZM Interaktionen regulieren, besser zu verstehen.
Wie können Zell-EZM Interaktionen untersucht werden? Obwohl es mehrere
Methoden gibt, mit denen Zelladhäsion untersucht werden kann, sind die wenigsten dazu
geeignet, Zelladhäsionskräfte zu quantifizieren. Einzelzellspektroskopie erfasst die
Adhäsionskräfte einzelner Zellen quantitativ und ermöglicht dadurch eine differenzierte
Betrachtung der Adhäsion individueller Zellen. Eine Variante der
Einzelzellspektroskopie basiert auf der Rasterkraftmikroskopie (AFM); diese Technik
wurde in der vorliegenden Arbeit verwendet. Ein Vorteil von AFM-
Einzelzellspektroskopie besteht darin, dass Zellen mit hoher zeitlicher und räumlicher
Präzision manipuliert werden können. Zelladhäsionskräfte können zudem über einen
großen Kraftbereich hinweg untersucht werden. Dabei ermöglicht es die hohe
Kraftauflösung, einzelne Integrin-Ligandenbindungen in lebenden Zellen zu untersuchen.
Die vorliegende Arbeit gliedert sich in sechs Kapitel. Kapitel eins gibt
Hintergrundinformationen über Zell-EZM Wechselwirkungen. In Kapitel zwei werden
verschiedene Adhäsionsassays einander gegenüber gestellt. Das theoretische Bell-Evans
Modell, mit dessen Hilfe die gewonnenen Daten interpretiert wurden, wird in Kapitel drei
diskutiert. Im Anschluss werden drei Projekte, welche das Herzstück dieser Doktorarbeit
bilden, in Kapiteln vier bis sechs näher ausgeführt.
Im ersten Projekt (Kapitel vier) wurde die Adhäsion von a 2b1-Integrin
exprimierenden CHO Zellen zu Kollagen I, dem häufigsten strukturellen Protein in
Wirbeltieren, quantitativ untersucht. Zunächst wurden a2b1-Kollagen-Interaktionen auf
Einzelmolekülebene analysiert. Mithilfe der dynamischen Kraftspektroskopie wurden für
diese Bindung Dissoziationsrate koff (1.3 ± 1.3 sec
-1) und Potentialbarrierenbreite xu
(2.3 ± 0.3 Å) bestimmt. Daraufhin wurde die a2b1-vermittelte Adhäsion über einen
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Zeitraum von zehn Minuten untersucht. Dadurch konnten Einblicke in die Kinetik von
a2b1-integrin vermittelter Zelladhäsion sowie in die zugrunde liegenden
Regulationsmechanismen gewonnen werden.
Im zweiten Projekt (Kapitel fünf) wurde die Rolle von kryptischen Integrin-
Bindungsstellen in Kollagen I untersucht. Die zuvor verwendeten Kollagenoberflächen
wurden thermisch denaturiert, wodurch versteckte RGD (Arg-Gly-Asp)-Sequenzen
freigelegt wurden. Die partielle Denaturierung hatte- verglichen mit nativem Kollagen I-
eine erhöhte Adhäsion von Präosteoblasten (MC3T3-E1) zur Folge, was auf das Binden
zusätzlicher Integrine zurückgeführt wurde. Im Unterschied zu nativem Kollagen wurde
die Zelladhäsion zu denaturiertem Kollagen I u.a. durch av- and a 5b1-Integrine
vermittelt. Präosteoblasten zeigten verstärktes Zellspreiten sowie höhere Motilität auf
denaturiertem Kollagen I; zudem wurde ein erhöhtes Differenzierungpotential der
Präosteoblasten festgestellt. Die in diesem Projekt erhaltenen Einblicke bilden eine
hilfreiche Basis für die Entwicklung optimierter Oberflächen für diverse Zell- und
Gewebekulturanwendungen.
Im dritten Projekt (Kapitel sechs) wurde der Einfluss des Fusionproteins
BCR/ABL, charakteristisch für chronische myeloische Leukämie, auf die Adhäsion von
myeloischen Vorläuferzellen untersucht. Dazu wurde die Adhäsion von BCR/ABL
transformierten Vorläuferzellen (32D Zellen) bzw. Kontrollzellen zu Stromazellen (M2-
10B4) sowie verschiedenen EZM Proteinen untersucht. BCR/ABL erhöhte die
Zelladhäsion der myeloischen Vorläuferzellen signifikant. Dieser Effekt wurde durch die
Zugabe von Imatinib, welches die Tyrosinkinaseaktivität von BCR/ABL inhibiert,
aufgehoben. Die BCR/ABL-verstärkte Zelladhäsion korrelierte mit erhöhten b1-Integrin-
konzentrationen. Da die Adhäsion von Leukämiezellen im Knockenmark
bekanntermaßen kritisch für die Entwicklung von Resistenzen gegenüber verschiedenen
Wirkstoffen ist, könnten die Ergebnisse dieser Studie eine Grundlage für die Entwicklung
optimierter Target-Therapien sein.
In den drei beschriebenen Projekten wurde AFM Einzelzellspektroskopie
verwendet, um Integrin- vermittelte Adhäsion auf molekularer Ebene zu untersuchen. Die
Ergebnisse zeigen, dass AFM-Einzelzellspektroskopie ein vielseitiges Werkzeug
darstellt, das überaus geeignet dazu ist, Zelladhäsion- ausgehend von
Einzelmolekülinteraktionen bis hin zur Entstehung komplexerer Adhäsionsstellen- auf
der Kraftebene zu verfolgen.
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Chapter 1. Background
Interactions between cells and extracellular matrix
1.1 The extracellular matrix (ECM)
1.1.1 Composition
The extracellular matrix (ECM) represents the authentic substrate for most cells in
living organisms1. It is a three-dimensional and complex structure composed of
collagens, adhesive glycoproteins, proteoglycans and glycosaminoglycans (Table 1).
These macromolecules are secreted by cells and locally assembled into an organized
network providing a scaffold to embedded cells (Fig. 1)1-4. To further increase the
complexity of the ECM microenvironment, soluble factors such as growth factors,
cytokines, matrix metalloproteinases and other enzymes are present in the ECM.
Fig. 1. Chicken fibroblast in the connective tissue of the skin. The cell is surrounded by
an ECM composed of thick bundles of collagen type I fibrils (some fibrils are seen as
cross-section) (figure taken from5).
Composition and density of ECM macromolecules vary significantly in different
tissues and organs (Table 1)6. For instance, the bone matrix is a composite material
consisting of mainly collagen type I fibrils and an inorganic component, hydroxyapatite.
Whereas collagen fibrils confer tensile strength, hydroxyapatite makes the bone structure
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rigid7, 8. Collagen type I also significantly contributes to the extremely high tensile
strength of tendons9. The basal lamina in blood vessels, mainly consisting of laminin and
collagen type IV, represents a physical barrier to soluble molecules and a scaffold for
aligning cells. Moreover, the ability of the cornea to transmit light while being
mechanically resilient can be attributed to an ECM consisting of orthogonal sheets of
highly organized collagen fibrils10. The given examples show that collagens play an
essential role in shaping and strengthening of the ECM in different tissues and organs.
Indeed, collagens are the most abundant proteins in vertebrates, contributing to
approximately 25 % of their whole protein mass. Apart of fulfilling mechanical functions,
collagens further provide a scaffold for the attachment of numerous other proteins, such
as adhesive glycoproteins11. Subsequently structural features explaining the exceptional
mechanical properties of collagens are detailed.
Table 1. Overview about ECM macromolecules. (modified from6).
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Collagens
There are at least 28 different types of collagen molecules in vertebrates12. The
basic building block of all collagens is a right-handed triple-helix, formed by three
individual polypeptide strands, the so-called a-chains. The polypeptide strains contain
approximately 1000 residues and have a length of about 300 nm. The alpha-chains
display the repeating structure G-X-Y, in which every third amino acid is glycine, the
amino acids X and Y are often proline and hydroxyproline13. The polypeptide chains
form a left-handed helix that intertwines with two other helices into a right-handed triple-
helical structure. This triple-helix can be homotrimeric or heterotrimeric, which is
dependent on the collagen type14. For instance, Collagen type I is composed of different
types of a-chains, two a1(I)- and one a2(I)-chain.
Several collagen types are organized into fibrils (type I, II, III, V, XI). Such
collagen fibrils are the most important element providing tensile strength within the ECM
in most animal tissues12, 15. Other collagens build up networks, such as collagen IV,
forming an interlaced network in basement membranes, or are organized to anchoring
fibrils (e.g. type VII) or beaded-filaments (e.g. type VI). Further collagen types are
classified as transmembrane collagens, endostatin-producing collagens (type XV) or
fibril-associated collagens with interrupted helices (FACITs)12.
There are 11 genes encoding for fibrillar collagens in mammals. In fibrillar
collagens the triple-helices assemble into larger units, microfibrils and fibrils16, 17. Five
triple-helices are believed to form the microfibril, the building block for higher organized
fibrils15, 16. EM images of negatively stained fibrils and AFM topographs of native fibrils
reveal the characteristic, multi-banded structure of the collagen fibrils, which regularly
repeats at 67nm18. This so-called D-periodicity is explained by the regular staggering of
the triple-helices that are laterally aligned (Fig. 2)15, 19. This arrangement results in gap
and overlap regions and thereby alternating regions of protein density within the fibril10,
15, 20, 21. The length of collagen fibrils is undetermined and depends on the tissue type as
well as the developmental stage of the tissue; fibrils lengths from mm to mm, and
diameters from 12 to >500 nm were found12. For example, adult bovine cornea contains
uniform collagen fibrils with diameters between 30 and 35 nm and a mean length of
900 mm. In contrast, adult tendon fibrils have diameters of up to 300 nm, their length can
reach up to several millimeters14, 22.
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Fig. 2. Axial structure of D-periodic collagen type I fibrils. A. Schematic representation
of the axial arrangement of triple-helical collagen molecules within a microfibril. Triple-
helices are staggered by D=67nm. B. EM image of negatively stained collagen type I
fibrils purified from calfskin (taken from15).
Fibril forming collagens are synthesized as procollagens having N- and C-
propeptides at both ends of the triple-helical domains. These propeptides are
enzymatically cleaved by proteases. The cleaved triple-helices expose telopeptides at
their ends, short non-helical extensions. Intact telopeptides are required for collagen
fibrillogenesis. Whereas collagen fibrillogenesis can occur in vitro as an entropy-driven
self-assembly process upon cleavage of the propeptides or from solubilized collagen23-25,
fibrillogenesis in vivo is much more complex26. It has been proposed that many different
proteins participate in this process, for instance fibronectins, integrins and minor
collagens serving as organizers and nucleators26. However, the exact mechanisms are still
not fully understood. Weak noncovalent interactions between the collagen triple-helices
assist in fibrillogenesis, but provide only low tensile strength to fibrils6. The high tensile
strength of collagen fibrils is owed to intra- and inter-molecular covalent crosslinks.
These crosslinks are found at residues within the triple-helix and the telopeptides. For
most collagens, lysyl oxidases catalyse this crosslinking reaction by activating lysine and
hydroxylysine residues12, 14.
Chapter 1 -12-
Collagen type I is the most abundant collagen type and the most frequent
structural protein in vertebrates. It resides in many tissues and organs, predominantly in
skin, bone, tendon and cornea. Aberrant collagen type I synthesis result in a wide
spectrum of diseases including Ehlers Danlos Syndrome or osteogenesis imperfecta12. Its
predominant occurrence in body tissues together with its excellent biocompatibility and
biodegradability make collagen type I the polymer of choice for biomedical and tissue-
engineering matrices27-29. During the last years, collagen type I has gained the acceptance
as a safe material28. Common collagen type I sources are collagen rich tissues, such as
porcine or cow skin, alternatively recombinant collagen can be used. Collagen type I can
be prepared in various formats, as reconstituted soluble collagen or shaped into
membrane films, sponges and hydrogels30. Medical applications include for instance
scaffolds for ligament repair, collagen grafts for scar and burn repair and artificial heart
valves. Solubilized collagen or alternatively collagen-like peptides can be used for
coating and patterning of non-biological materials to enhance their biocompatibility27.
1.1.2 Effects of the ECM on cellular functions
Apart of shaping tissues and fulfilling important mechanical functions, the ECM
is vital to manifold physiological processes. Cellular interactions with the ECM regulate
important cellular processes including cell migration, gene expression, cell survival,
tissue organization and differentiation1, 31-36. For instance, it is known for a long time that
ECM proteins influence the differentiated phenotype of cells34, 35,37. It has been
demonstrated, for instance, that chondrocytes grown on the ECM protein fibronectin (FN,
table 1) adopted a fibroblastic phenotype; this effect could be reversed in absence of
FN37. Another early study demonstrated that tissue fibroblasts grown in vivo in contact
with bone powder transformed into osteoblasts38. Furthermore, perturbing ECM-cell
interactions during embryonic development leads to severe mutations35, 39-42. The role of
cell-ECM interactions on cell survival is further demonstrated by the fact that cells that
loose contact to their ECM usually undergo apoptosis43-45. This mechanism, called
anoikis, is crucial for the establishment and maintenance of tissue architecture46. There
exists also a close interplay between ECM-Cell interactions and growth factor signalling.
Growth factors act in concert with ECM molecules and their receptors to promote cell
proliferation47-49. Growth factor signalling can further activate intracellular signalling
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pathways that regulate expression of genes encoding for ECM proteins and their
receptors48, 50-53. In opposite direction cellular interactions with ECM proteins can alter
the synthesis of growth factors and respective receptors48. Additionally, growth factors
can bind directly to ECM proteins and are thereby presented at high local concentration
to cells. Some ECM proteins themselves possess mitogenic activity, for instance laminin,
tenascin and thrombospondin-135.
The mentioned examples show that cells receive specific signals from
surrounding ECM proteins that have an influence on essential intracellular signalling
pathways. The transfer of signals from the ECM into the cell requires an interface, such
as provided by transmembrane ECM binding adhesion molecules.
1.1.3 ECM receptors
By affinity chromatography and experiments using adhesion-blocking antibodies
specific membrane glycoproteins that are ECM receptors have been identified54, 55. Most
of the discovered molecules are part of the integrin family of cell adhesion molecules
(CAMs). CAMs are classified into different families, with the main families being
cadherins, integrins, selectins and adhesion molecules of the immunoglobulin family. All
CAMs are transmembrane proteins, with an ectodomain engaging the ligand, a
transmembrane domain and a cytoplasmic domain, which interacts with manifold
cytoplasmic proteins. CAM ectodomains are usually large multi-domain structure (20 -
50 nm) projecting out from the lipid bilayer. Since the cell surface is relatively rough, this
“spacer” distance enables CAMs to bind their ligands56. Whereas some CAMs mediate
homotypic interactions between cells (e.g. cadherins), others mediate heterotypic
interactions with either other cells (selectins, integrins) or ECM proteins (mainly
integrins). Other ECM-binding molecules are a diverse group of cell surface
proteoglycans. They include among others different lectins, cd44, syndecans, cd3657 and
discoidin domain receptors (DDR)58. Some of these bind to collagens (e.g. cd44, cd36,
DDR) 58, but also other binding partners within the ECM have been reported35. Whereas
some of them directly mediate adhesion to ECM proteins, others play a regulatory role in
cell adhesion, for instance syndecans59, 60 and galectins61, 62. Due to the dominant role
they play in cell-ECM interactions, integrins are introduced subsequently.
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1.2 Integrins
1.2.1 General aspects
Integrins are heterodimeric transmembrane glycoproteins found in all metazoans.
They are built up by two non-covalently associated a- and b-subunits63. So far, 18 a- and
8 b-subunits have been described that can assemble into 24 different heterodimers
(Fig. 3). Alternative splicing further enhances the diversity of integrin isoforms. Integrins
represent the major adhesion receptors for ECM proteins, few of them also participate in
cell-cell adhesion (e.g. a4b1, aLb2).
Fig. 3. Overview of integrin heterodimers. (A) Sketch of an integrin heterodimer
composed of transmembrane a- and b-subunits. (B) 18 a- and 8 b- subunits can
assemble to 24 different types of integrin heterodimers (adapted from 63).
Integrin-ECM interactions appear to be redundant: several integrin heterodimers
can bind to a particular ECM protein (e.g. FN), and most integrins can interact with
different ECM proteins (Fig. 4).
Fig. 4. Combinations of integrin-
ECM interactions. Colour-
marked circles present different
ECM proteins. Binding integrins
are inserted. The apparent redun-
dance  o f  in tegr in -ECM
interactions is illustrated by the
overlapping circles and the
multiple receptors within each
circle. Note that the shown ECM
proteins are only few examples.
The figure was created on the
basis of integrin ligands reported
in. 64.
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1.2.2 Integrin structure
The overall shape of the integrin ectodomain is well known from EM images65, 66.
Integrins have an extracellular globular head (diameter approximately 70 Å), consisting
of the N-terminal domains of the a- and b-subunits. The head domain is linked via a long
(ª100 Å) rigid stalk to a pair of membrane-spanning helices and short cytoplasmic
tails*67, 68. X-ray crystallography data of integrin ectodomains have predominantly
contributed to the understanding of the architecture of integrins. The first integrin crystal
structure -the one of integrin avb3- was obtained in 2001 without bound ligand
67 and later
in presence of bound ligand69. The N-terminal domains of all a-subunits form a seven-
bladed b-propeller that assembles together with the N-terminal domain of the b-subunit
(bI-domain) to form the globular head structure (Fig. 5). Glycosylations within the b-
propeller further contribute to stabilize the heterodimer70.
Fig. 5. Molecular model of
integrin a2b1 ectodomain in
its extended conformation.
On the left, the a2-subunit is
shown with its domains in
pink/yellow/red. On the
right, the (blue/green/
turquoise colour- marked)
b1-subunit domains are
depicted. Divalent metal ions
are illustrated as spheres in
the a I and bI domains.
Collagen binding occurs at
the I-domain of the a -
subunit (taken from 71).
                                                 
*  b4-integrin subunit is an exception, it has a long cytoplasmic tail
70.
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Two major groups of a-integrins can be distinguished that either contain or lack
the so-called “aI-domain” or “von Willebrand factor type A”-domain. aI-domain
comprising integrins include all collagen-binding integrins (a1b1, a2b1, a10b1, a11b1) and
furthermore integrins aDb2, a Eb2, a Lb2, a Mb2, aXb2. Crystal and NMR structures of
several integrin aI-domains are available, for instance of a2I
68, a1I
72, aMI
73, aLI
74, 75. a2I-
domain structures have been resolved in presence and absence of their ligands68, 76. The
aI-domains are inserted in the b-propeller of the a-subunit, looping out of between
blades 2 and 368, 70, 71 (Fig. 5). They comprise about 200 amino acids and adopt a so-
called Rossmann-fold with a central b-sheet surrounded by a-helices68(Fig. 6).
Fig. 6. Structure of the a2I-domain in complex with a collagen like peptide. (A) The
shown structure was derived from crystallization experiments using a recombinant a2I-
domain and a triple-helical collagen peptide (here green/blue/yellow) comprising the a2-
integrin  high-affinity binding motif GFOGER 
68. I-domain helices are drawn as
cylinders, b-strands as arrows. (B) Blow-up of (A) revealing details of the interactions
between side-chains at the I-domain-ligand interface. Selected side-chains are
represented as ball-and–stick. The metal ion (blue ball) is labeled with “M”.GFOGER
motifs of two collagen strands are involved in binding (middle and trailing strand, yellow
and blue). Interactions include Van der Waals interactions, hydrogen bonds (dotted
lines) and ionic interactions. (C) MIDAS motif of the I-domain (metal ion blue ball).
Coordinating side-chains are shown as ball-and-stick, water molecules w, the collagen
glutamate is in gold. In grey-blue the three loops coordinating the metal are shown.
(Figure taken from 68).
The aI-domains contain a conserved site at which metal ions are bound, the so-
called MIDAS site (metal ion dependent adhesion site). It has been shown by
mutagenesis studies that the MIDAS motif and surrounding side chains form the contact
site with the ligand (Fig. 6)68. In the ligand bound state, side-chains forming the MIDAS
motif and a negatively charged side residue in the ligand (glutamate in case of collagen
a2b1), coordinate a central metal ion
76, 77 (Fig. 6).
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In integrins that do not possess an I-domain, e.g. avb3, the ligand binds at the
interface of the a-subunit b-propeller and the bI-domain67, 68, 73. Many integrins of this
group bind to RGD (arginine-glycine-aspartic acid) motifs within their ligands. It was
shown that the aspartic acid of the RGD motif coordinates a metal ion-occupied MIDAS
within the bI-domain by a similar mechanism as shown for aI-domains69, 70.
1.2.3 Integrin regulation
In most biological situations cell adhesion is mediated by multiple adhesive
interactions of same or different types of CAMs. The requirements on these adhesive
interactions can be quite diverse: in some situations adhesive contacts must be quickly
assembled and disassembled (e.g. during cell migration). Other adhesive contacts need to
be strong to resist mechanical stress (e.g. in contracting muscle). Thus, adhesive
interactions have to be precisely regulated not only quantitatively, but also locally and
temporally.
. 
Fig. 7. Different mechanisms to regulate cell surface concentrations of integrins. 1.
Altering the binding affinity of individual receptors by inside-out signalling78. 2.
Controlling cooperative receptor binding63, 77, 79. 3. Regulating de novo protein synthesis,
for instance at transcriptional and translational level. 4. Transport of CAMs to the cell
surface, 4. Receptor endocytosis and recycling or degradation80, 81. Taken with
modifications from 81.
Chapter 1 -18-
Fig. 7 summarizes different strategies that can be used by cells to regulate
adhesion, the focus is thereby on integrin-mediated adhesion. Firstly, avidity of integrin
binding, the overall adhesion, can be modulated. Avidity regulation includes both,
regulation of the affinity of individual integrins for their ligands (activation) (Fig. 7-1),
but also cooperative integrin binding at sites of clustered integrins (Fig. 7-2). Moreover,
total integrin concentrations can be altered by controlling integrin de novo synthesis and
maturation, degradation and recycling of integrins. Last, cell surface concentrations can
be tuned by controlled endocytosis and exocytosis81.
In the following mechanisms underlying integrin activation and integrin
clustering will be further explained.
Integrin activation- inside out signalling
Two principal quaternary conformations have been described for integrins, an
extended and a bent one71, 77 (Fig. 8). These have been attributed to the active/high-
affinity and the inactive/low affinity states of the integrin82. The conversion of the bent
into the extended integrin conformation and increase in ligand-binding affinity (here also
called integrin activation) is regulated by intracellular signals, in a process called inside-
out signalling. In the last years, important insights into the mechanisms underlying
integrin activation have been obtained. Mutagenesis studies showed that the membrane-
proximal regions of the cytoplasmic tails play a pivotal role in integrin activation83. The
integrin is kept in its low-affinity state when the cytoplasmic tails are bound together71, 84
85. This association is stabilized by a salt bridge between the membrane-proximal regions
of the cytoplasmic integrin a- and b-tail (Fig. 8). Upon inside-out signalling the salt
bridge between a/b-tails is disrupted and the tails are separated. This leads to major
conformational changes, resulting in an extended integrin conformation84, 86. Since the
membrane proximal regions are well conserved within a- and b-subunits, similar
mechanisms might be responsible for the activation of different integrin heterodimers.
It has been shown that inside-out activation of b1- and b3-integrins requires talin
binding to regions far from the membrane-proximal region83, 87, 88. In addition, binding of
cytohesin-189 and b3-endonexin90 were shown to result in b2- and b3-integrin activation
88.
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Fig. 8. Integrin structural changes during activation. Integrin in its inactive, low-
affinity (A) and active, high-affinity conformation (B).
Many different mechanisms were proposed by which talin-binding to integrin tails
might be regulated. These include integrin phosphorylation, talin proteolysis, talin
activation by phosphatidylinositol (4,5)-bisphosphate and competition between integrin
tail-binding proteins83. Recently it has been shown that kindlin-2 is required for talin-
induced integrin activation91. However, so far the exact mechanisms have not been
elucidated. Whereas the integrin b-tail is involved in regulating integrin activation upon
binding to signalling proteins, the a-tail appears to contribute to the cell-type specificity
of integrin activation92.
Since the initial events leading to integrin activation occur at the membrane-
proximal regions of the cytoplasmic integrin tails, long-range conformational
rearrangements must propagate through the transmembrane and stalk regions up to the
ligand-binding site77, 93. Crystal structure data of I-domains revealed structural variations
between ligated and unligated states which were attributed to high-affinity/closed and
low-affinity/open conformations76, 94. The interpretation of these structural data has been
highly controversial in the integrin field77. The critical question was if the conformational
changes within the I-domain were physiologically relevant for affinity-regulation of the I-
domain, or if they resulted from induced fit upon ligand binding77. The so-called
switchblade model postulates that integrin leg separation and extension are directly
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coupled to conformational changes within the ligand binding site. Thus, integrin
extension switches the ligand-binding site from its low-affinity to its high-affinity state95.
In accordance with the switchblade model, there are two effects of integrin extension that
contribute to high-affinity binding: in the bent integrin conformation, the ligand-binding
head domains are in proximity to the membrane and sterically hinder ligand binding.
Integrin leg extension lifts the ligand-binding site that is faced toward the membrane in
the low-affinity state up and orients it pointing away from the cell membrane towards a
potential ligand. Thereby the ligand-binding domain within the head is exposed to the
ECM and better accessible for ligands71, 82. Secondly, the conformational changes within
the I domain occurring as a consequence of leg extension additionally increase its affinity
for its ligand. Thus, following the switchblade model, extended integrins represent the
high-affinity, bent integrins the low-affinity conformation 71, 77, 82.
Another model, the so-called deadbolt  model provides an alternative
interpretation. According to this model, also integrins in bent conformation may bind
their ligands, which as a consequence leads to integrin extension. The deadbolt model
was supported by EM images that found soluble avb3 bound to FN fragments in its bent
conformation. However, these findings might be explained by fact that truncated and
soluble integrins were used for analysis and the use of small fragments instead of the
entire FN molecule. Recent experiments clearly favour the switchblade model82.
Outside-in signalling
Integrins that are not bound to their ECM ligands are supposed to be diffusely
distributed over the cell surface and not linked to the actin cytoskeleton96. Binding to an
ECM ligand stabilizes the integrin in its extended, high-affinity conformation77. In the
high-affinity conformation the cytoplasmic integrin tails are separated and cytoplasmic
components can bind71, 77, 82, 85. Thus, ligand binding facilitates association of integrin
tails with the cytoskeleton97, 98.
Cytoskeleton-associated integrins can form clusters that contribute to enhanced
cell adhesion by increasing integrin avidity for its ligands 96 99, 100. It has been speculated
that integrin clustering is initiated by the multivalent nature of ECM proteins: ligand
binding stabilizes integrins in a certain spatial arrangement that supports cluster
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formation77, 101. Controversially, it has been proposed that integrin clustering occurs upon
signals from inside the cells. Rho A activation and increased acto-myosin contractility
have been implicated in this process102-104. Possibly these mechanisms are not mutually
exclusive. Integrin-clustering does not only contribute to enhanced mechanical anchorage
of cells to ECM proteins, but also has an important role in regulating important cellular
functions. Upon integrin-clustering signalling proteins and cytoskeletal proteins are
recruited to the cytoplasmic sites and thereby intracellular signalling pathways
controlling cell differentiation81, 105, 106, proliferation107 and survival108, 109 are triggered
(Fig. 9). Since these pathways are initiated by an extracellular stimulus (=ligand binding)
this process is referred to as outside-in signalling.
Fig. 9. Integrin-cytoskeleton interactions. Integrin clusters associate with multiple
intracellular proteins and thereby trigger signalling pathway regulating important
cellular processes.
In Fig. 10 the mechanisms of inside-out and outside-in signalling are summarized.
It is underlined that the shown events are not sequentially following mechanisms, but that
there is a dynamic change between the different states (bend, extended, cytoskeleton-
associated, clustered). The equilibrium between the respective states can be shifted upon
binding of intracellular or extracellular binding partners.
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Fig. 10. Integrin inside-out and outside-in signalling. In the inactive integrin
conformation (bent) interactions between cytoplasmic tails are stabilized by a salt bridge
(black bar). Talin binding induces integrin activation (extended conformation) (inside-
out signalling). In the active conformation integrins can bind to extracellular ligands.
Ligand binding stabilizes the active conformation with separated cytoplasmic tails and
intracellular ligands can bind to tails. Integrin clustering is regulated by multivalent
extracellular ligand binding and/or intracellular events involving acto-myosin
contractility. Association with intracellular signalling proteins activates intracellular
signalling pathways (outside-in signalling).
Higher order adhesion sites
Above mentioned integrin clusters can be visualized by fluorescence microscopy
as dynamic, dot-like structures at the edges of lamellipodia110-113. They are called focal
complexes. Focal complexes are believed to be precursors of focal adhesions* (also
termed focal contacts) at which strong cell-matrix adhesion occurs (Fig. 11)115. Focal
adhesions are sites of high protein density that were identified long ago using
interference-reflections microscopy and electron microscopy 116, 117. In focal adhesions, a
tight contact exists between membrane and substrate, leaving a gap of only 10-15 nm117,
118. Maturation of focal complexes into focal adhesions is generally accepted to be a
consequence of Rho activation or external force application102, 104, 110, 112, 119.
                                                 
* Beside focal adhesions, there exist also other types of matrix adhesions, such as
fibrillar adhesions and podosomes, but these will not be discussed here114, 115.
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The major transmembrane ECM receptors within adhesion sites are integrins, but
also others, such as preoteoglycans120, glycosaminoglycan receptors such as syndecans121
and signalling proteins are present122-124. Moreover, >50 cytoplasmic proteins localize to
focal adhesions, e.g. cytoskeletal proteins (e.g. vinculin, a-actinin, talin), tyrosine kinases
(e.g. Src, FAK), serine /threonine kinases (e.g. ILK, PAK), modulators of small GTPases
(ASAP1, Graf), tyrosine phosphatases (e.g. SHP-2) and other enzymes (e.g. PI3K,
calpain II). Some of these components bind to actin filaments and/or to the cytoplasmic
tails of integrins. It has been suggested that the list of focal contact molecules is far from
being complete118.
Fig. 11. Focal adhesions visualized by
fluorescence microscopy. Mef cells seeded
on glass coverslips were fixed,
permeabilized and stained for the focal
adhesion protein paxillin. Arrows point to
two exemplary focal adhesions.
1.2.4 Biological function of integrins
Characterization of integrin knockout mice have revealed important physiological
roles of integrins. Although the binding specificities of several integrins are redundant,
loss of almost any a- or b-subunits results in biological defects in respective knockout-
mice. Such defects range from small imperfections (e.g. a1-knockout mice
125) to severe
malfunctions that are lethal at certain embryonic stages or shortly after birth (e.g. b1-
integrin126-128). Integrins are involved in many physiological processes, for instance in the
immune system during inflammations, during wound healing, blood clot formation,
during fertilization or embryonic development129. Consequently several human diseases
correlate with defects of certain integrin encoding genes, for instance:
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- Defects in platelet integrins (aIIb- or b3-subunits) cause the bleeding
disorder Glanzmann´s thrombasthenia130.
- Defects in the collagen binding integrin a1-integrin can lead to fibrosis
125.
- Mutations of b2-integrins can result in LAD  (leukocyte adhesion
deficiency)130.
- Due to their role in cell signalling, angiogenesis and migration and
interactions with urokinase receptor, integrins have been also implicated
in tumour progression131, 132.
- Some integrins are targets of viruses (Hantavirus, Papillomavirus,
Echovirus and other pathogens, such as Borrelia burgdorferi, Bordetella
pertussis and Yersinia spp.129, 133, 134.
- Agents that are secreted by leeches and disintegrins inherent to toxins e.g.
snake venom jararhagin133 are integrin ligands and act as inhibitors of
platelet aggregation129.
Consequently, integrins have been recognized as important targets for drug
development. It has been proven in independent studies that antagonists against integrin
aIIbb3, such as monoclonal antibodies or cyclic peptides, can be used to counteract blood
clot formation79. Abciximab, a monoclonal antibody, is already admitted for use and
indicated for application during and after coronary artery procedures, for instance.
1.3 Conclusions
In the previous sections the importance of integrin-ECM interactions has been
discussed. Since these interactions play an essential role in many physiological, but also
pathological situations, the basic mechanisms underlying integrin binding and regulation
are of great interest. For instance, a better understanding of integrin-ECM may bring
benefits to pharmaceutics, since it may aid the development of specific drugs. Moreover,
understanding cell-ECM interactions is of particular importance for the design of implant
materials that promote cell attachment and growth. How can these interactions be
investigated? In the following different techniques that were developed to analyse cell
adhesion are compared and contrasted.
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Chapter 2 
Cell adhesion assays- Overview 
 
There exist many cell adhesion assays that have been developed to qualitatively or 
quantitatively study cell adhesion. These techniques have in common that cells are 
allowed to attach for a certain period to an adhesive substrate, for instance a surface 
coated with purified proteins. Thereafter, cell detachment is induced by a certain method. 
Common assays employ centrifugal forces, hydrodynamic shear forces or locally applied 
pulling forces to cause cell detachment. Adhesion assays can be classified by many ways, 
one is by the number of cells that is analysed in each experiment, either many (bulk) or 
only single cells (single-cell assays). Subsequently respective examples are presented. In 
Table 2 a systematic overview is provided, and main characteristics, advantages and 
disadvantages of the techniques are given. 
 
2.1 Bulk assays 
2.1.1 Techniques using hydrodynamic shear flow 
In hydrodynamic flow assays, a flow of physiological buffer is generated on a 
surface with attached cells. The cells are thereby subjected to shear forces that eventually 
cause cell detachment. Depending on the apparatus and the flow configuration, constant 
flow rates (e.g. parallel plate) or gradients can be applied (e.g. spinning disc). In 
difference to other adhesion assays, detachment forces generated in hydrodynamic flow 
systems peel off the cells, since forces act approximately parallel to the substrate (table 
2). Disadvantageously, these hydrodynamic shear forces depend on cell geometry and are 
not uniformly distributed along the cell surface. Therefore, to get an estimate of the 
applied detachment forces, simplified assumptions have to be used 135.  
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Washing assays 
The simplest and most commonly applied adhesion assays are so-called washing 
assays. Cells are allowed to attach for a certain time to a substrate of interest, being either 
a protein-coated surface or to a monolayer of cells. Then the substrate is rinsed several 
times with physiological buffers and thereby non-attached or weakly attached cells are 
dislodged from the substrate136. For quantification the number of cells that remained 
attached to the substrate is determined. Cell numbers are either counted, otherwise more 
convenient methods such as radiolabelling, staining with colorimetric or fluorescent 
reagents or enzymatic techniques may be used137. A major advantage of the washing 
assays is their simplicity, and the fact that only routine laboratory equipment is needed. It 
is remarkable that these washing assays could identify adhesion molecules and regulatory 
mechanisms135. The same simplicity, however, carries severe disadvantages as low 
reproducibility and poor sensitivity of the measurements. First of all, no quantitative data 
on adhesion forces are obtained. Moreover, the applied shear forces are unknown, 
unevenly distributed and furthermore difficult to control. Sensitivity is low, consequently 
small differences in adhesion among different experimental groups that might be of 
biological relevance are difficult to detect. Whereas short contact times (< 30 min) are 
difficult to control, the applied forces may not be sufficiently high to detach cells after 
prolonged contact times, especially when cell are spread on the substrate; this effect can 
mask eventual adhesion differences of distinct cell populations. Taken together, these 
limitations might explain the inconsistent results that are frequently obtained among 
different research groups. However, despite their limitations, washing assays can be a 
useful tool for certain biological and medical questions, being economic and fast tests to 
perform. Washing assays were also carried out in the projects presented in chapters five 
and six. 
 
Spinning disc device 
Better-controlled flow conditions are generated using spinning disc devices. 
Adhesive substrates with attached cells are mounted onto a rotating device and spun in a 
fluid-filled chamber. Upon rotation of the disc, fluid from the surrounding is axially 
drawn to the disc center and displaced radially.135. At laminar flow conditions thickness 
and radial velocity of the fluid layer carried with the disc are constant. By the liquid flow, 
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well-characterized hydrodynamic forces are applied to the cells; these tangentially acting 
forces increase linearly with the disc radius, such that negligible hydrodynamic forces act 
at disc center and maximal forces at the periphery. After spinning, numbers of attached 
cells per radial position are evaluated. This can be done by staining fixed cells with a 
DNA-binding fluorescent dye, followed by automated analysis of the fluorescence 
intensity per radial position135. Commonly the shear force, at which 50 % of cells 
remained attached, is calculated and defined as mean adhesive force. However, the actual 
force acting on the cells cannot be precisely assessed. Moreover, obtained results 
critically depend on the cell shape (e.g. spreading morphology) and size. The method is 
not suitable to perform cell-cell adhesion measurements. Furthermore, initial cell 
adhesion cannot be investigated, because cell attachment periods < 30 min are difficult to 
control. Positive aspects of spinning discs devices are that the experiments are well 
reproducible and a large number of cells can be easily analysed.  
 
Parallel plate chamber 
Parallel plate chambers can be used to study both static and dynamic cell 
adhesion. To perform a static adhesion assay, an adhesive substrate with attached cells is 
mounted into the flow chamber. Then a well controlled, laminar flow of physiological 
buffer is pumped through the chamber. Depending on the flow rate, cells may become 
dislodged. For analysis the fraction of cells that remained attached to the substrate is 
detected as a function of the applied flow rate. Since a constant flow is produced in this 
system, several experiments must be conducted at different flow rates to characterize the 
dependence of attached cell number on the applied shear force.  
In dynamic adhesion tests cell attachment to an adhesive substrate is studied in a 
well defined shear field. Therefore a cell suspension is perfused through the flow 
chamber that carries an adhesive substrate at its bottom. Since the chamber is mounted on 
a light microscope equipped with a camera, the movement of single cells can be 
monitored and recorded. Transient adhesive interactions between cell and substrate cause 
cell rolling, similar as occurring in vivo for blood cells in the blood vessels138. Thus, flow 
chambers are of particular interest to study adhesion events that occur in vivo under such 
flow conditions. Typically frequency and duration of cell arrest on the adhesive substrate 
are analysed and by applying varying flow rates, bond dissociation rates can be 
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determined139-142. However, the effective force acting on the established bonds is 
unknown. Usually it is assumed that the generated forces are too low (5-10 pN) to alter 
the natural bond lifetimes. This may be the case if flow chambers are operated at very 
low shear rates (1 - 10 s-1)140, 143. However, such shear rates are approximately an order of 
magnitude lower than shear rates found in the blood stream, and therefore not comparable 
to physiological conditions. Advantageously, flow chambers provide relatively simple 
and inexpensive systems. Moreover, there are commercially available systems. 
 
2.1.2 Centrifugation assay 
In centrifugation assays cells attached to an adhesive substrate experience 
centrifugal forces that act- in difference to above described hydrodynamic flow assays- 
vertical to the adhesive substrate (Table 2). Typically microtiter wells are coated with 
purified proteins of interest. Then, cells are added to the wells and by mounting another 
microtiter plate on the first one, small chambers of two opposed wells are created. By 
short centrifugation the cells are gently brought in contact with the coated surface. Then, 
cells are allowed to attach for a certain time to the wells, until wells are inverted and 
another centrifugation step is performed. Thereby weakly attached and non-attached cells 
are released and transferred into the opposite well. Quantification of cells that remained 
attached to the substrate can be done automatically, e.g. by radio-labelling, staining with 
a colorimetric or fluorescent reagent or enzymatic techniques. Since only a single force is 
exerted in each experiment, the experiment has to be repeated at different centrifugation 
speeds to obtain information about the involved adhesion forces144, 145.  
 
2.1.3 Further methods 
There are also functional assays, as migration or spreading assays that are 
employed to indirectly study cell adhesion146. However, cell spreading or migration do 
not always directly correlate with adhesion. Although cell adhesion is required for cell 
spreading, the mechanisms regulating cell spreading are far more complex. Similarly, cell 
migration is a tightly regulated process. For instance, it was shown for epithelial cells on 
FN-coated surfaces that there is not a simple linear correlation between adhesion and 
migration speed147. Thus, no reliable information on cell adhesion forces can be provided 
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by such assays. In another approach, focal adhesions are quantified in terms of size of 
numbers to get insights into the adhesion strength of cells148-150. However, no information 
about adhesion forces can be obtained. 
 
2.2 Single-cell force spectroscopy (SCFS) techniques  
In above described bulk assays a larger number of cells is tested in each 
experiment. This has the advantage that easily statistically relevant data can be obtained. 
However, as discussed above, bulk assays cannot give exact quantitative data on adhesion 
forces. Moreover, since the average behaviour of a large cell population is analysed, 
potential differences in the adhesion of individual cells cannot be detected. Such adhesive 
subpopulations might appear due to different functional states of individual cells. Thus, 
valuable information might get lost in bulk assays. 
For a more quantitative approach, techniques are needed that quantify the 
adhesion of single cells. Such techniques have been developed within the last years; they 
are termed single-cell force spectroscopy (SCFS) techniques. SCFS experiments are 
usually more time-consuming compared to bulk assays, because only one cell is analysed 
in each experiment. Since adhesive properties of individual cells can vary considerably, 
even for cells of the same cell line, the experiment has to be repeated many times.  
Some SCFS techniques allow cell adhesion to be characterised at the single-
molecule level. Respective examples are given below. SCFS experiments with single-
molecule resolution permit to identify a certain set of adhesion receptors contributing to 
overall cell adhesion. Furthermore, single-molecule studies can give detailed insights into 
regulation mechanisms of adhesion receptors. This is of particular interest for the 
presented work, in which integrin-mediated adhesion is studied. As discussed in the 
previous chapter, integrin regulation can involve multiple mechanisms (1.2.3) that might 
be distinguished by SCFS.  
SCFS single-molecule experiments can be further employed to determine 
biophysically relevant parameters, such as bond dissociation rates (see 3.3). Traditionally 
binding rates of adhesion receptors are studied using in vitro bulk assays with purified 
molecules, e.g. solid phase assays151 or batch experiments with radio-labeled ligands152. 
Since in such assays many molecules are examined in parallel, the results reflect the 
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ensemble average of the behaviour of individual molecules. Thus, they are not suitable to 
reveal different functional states of individual adhesion receptors. Further limitations of 
traditional binding assays arise from the use of purified adhesion receptors. Separated 
from their native environment, the membranes of living cells, receptor-binding 
characteristics might be significantly altered 143, 153. For instance, the purification process 
might affect the functionality of the adhesion receptor. Moreover, the spatial orientation 
of adhesion receptors inserted in the cell membrane is optimized for ligand binding. In 
contrast, ligand binding affinities of isolated receptors are possibly altered. Moreover, in 
vitro assays are usually restricted to the study of receptor ectodomains or even smaller 
fragments; their binding characteristics might not be comparable to intact adhesion 
receptors. A further important issue is, that multiple different intracellular and 
transmembrane binding partners regulate adhesion receptor binding in vivo. Since these 
are absent in in vitro assays, mechanisms that regulate adhesion receptor binding cannot 
be studied. The given arguments underline that a far better approach consists in analyzing 
adhesion receptor-ligand interactions in the context of a living cell. In the following 
several techniques that can be used for SCFS are briefly described. 
 
2.2.1 Micropipettes 
A cell is aspirated into a micropipette and allowed to interact with an adhesive 
substrate. Thereafter, the micropipette is retracted, which leads- depending on the suction 
pressure- either to cell-substrate or cell-pipette detachment. In case of cell-pipette 
detachment, the suction pressure in the micropipette- and thereby the force holding the 
cell (F=p/A)- is stepwise increased, until the cell detaches from the substrate. By 
averaging the forces applied in the steps prior and at cell-substrate detachment, the 
adhesion of the cell to the substrate can be approximated. In the described setup, the force 
resolution is limited to large forces of several 100´s of pN´s and single-molecule binding 
cannot be assessed.  
Micropipettes can also be used in a modified setup to perform single-molecule 
experiments at a high force resolution (<0.1 pN); this technique is referred to as 
biomembrane force probe (BFP)154. Beside single-molecule interactions with isolated 
adhesion molecules, this system can also be used to detect cell-protein or cell-cell 
interactions155. To study cell-ECM interactions, a microsphere with immobilized ligand 
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molecules is coupled to the force sensor. This sensor is typically a swollen red blood cell 
or a phospholipid vesicle, aspirated by a micropipette. Then a cell, held by another 
pipette, is brought into contact with the ligand-coated microsphere and thereafter 
separated again. Implemented piezoelements permit precise relative movements of the 
pipettes. The position of the microsphere attached to the force sensor is monitored via a 
camera. Its displacement is proportional to the force acting on the microsphere154, 156, 157. 
Since the range of detectable forces is limited to <1 nN158, BFP is confined to the 
detection of lower adhesion forces.  
 
2.2.2 Optical tweezers 
An object, for instance a microsphere modified with a molecule of interest, is 
trapped within the focal point of a strongly focused laser beam. The force holding the 
object in focus of the laser depends on the dielectric properties of the object and the 
gradient intensity159. To measure adhesive forces between the trapped object and a living 
cell, for instance, the object is brought in contact with the cell and withdrawn. If the 
object adheres to the cell, the object is displaced from the focal point of the trap. This 
displacement, detected for instance by differential interference contrast (DIC), can be 
correlated to the acting force159. In such experiments forces within a limited range of 0.1 -
 100 pN can be generated and detected160. Consequently only single molecule binding can 
be assessed. Apart of the limited force range, optical tweezers have further limitations: 
Optical tweezers are very sensitive to optical perturbations. Moreover, the selectivity is 
limited, since many other dielectric particles near the focus of the lasers will be trapped.  
Also entire cells can be trapped and manipulated, for instance bacteria161 or 
mammalian cells159, 162. Thereby interactions between trapped cells and a substrate can be 
analysed. However, the possible range of detachment forces is even more limited for 
trapped cells. The maximal forces that could be measured between mammalian cells and 
substrates were lower than 50 pN, which is not sufficient to break multiple adhesive 
bonds159. Moreover, the high intensity at the focus of the trapping laser beam results in 
local heating, which may cause damage to living cells160. Although there are 
commercially available systems, these are often not fully suitable to perform high-
resolution measurements, therefore adapting such a system might still be challenging 
regarding technical knowledge and time. 
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2.2.3 Magnetic tweezers 
The principle of magnetic tweezers consists in the application of a force on a 
magnetic microsphere within a magnetic field. This technique can be used to investigate 
cell-protein interactions. Therefore a microsphere is decorated with ligand molecules and 
brought into contact with a living cell. Thereafter a force is applied onto the bead by 
generating a magnetic field. In systems with implemented feedback controlled forces up 
to several nN can be applied, which allows also to study the rupture of more complex cell 
adhesion sites163. However, the actual force acting on the cell cannot be precisely 
measured. Thus, precise single-molecules measurements are not possible. Furthermore, 
the position at which the microsphere is in contact with the cell cannot be controlled. The 
mentioned experimental setup is not suitable to investigate adhesion events at early time-
points. Therefore an alternative setup can be used: a magnetic bead is linked to a cell, and 
the bead-cell-couple is brought in contact with a flat substrate. After a certain contact 
time, the bead-cell-couple is detached by pulling on the microsphere164. Advantageously, 
the setups can be combined with fluorescence microscopy, and thereby interesting 
biological questions can be addressed. As an example, magnetic tweezers were 
successfully used to study the remodeling of focal adhesions under applied mechanical 
stress165.  
 
2.2.4 Conclusion 
It has been shown that quite a few different techniques exist that study cell 
adhesion. These techniques differ significantly in their principles and abilities, as 
summarized in Table 2. Which of the technique is applied for a certain task, clearly 
depends on the context. First aim of the presented work is the analysis of α2β1-integrin 
collagen type I interactions at the molecular level (chapter four). This requires a 
technique with single-molecules resolution, which reduces the presented techniques to 
BFP and optical tweezers. Furthermore, the kinetics of integrin-mediated adhesion is 
going to be studied over a time range of 10 min. Since after several minutes cells may 
establish strong contact to the substrate, a large force range of several nN must be 
assessable to detach the cell. Thus, BFP and optical tweezers were not suitable for such 
task. Furthermore the time for which the cell is kept in contact with the adhesive 
substrates must be precisely controlled to study kinetics. Thus, a technique is needed that 
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combines the mentioned aspects of covering a large force range, detecting adhesion at 
high force resolution and permitting high temporal and spatial precision of cell 
manipulation. This can be done by a SCFS technique based on atomic force microscopy 
(AFM) that is introduced in the following. 
 
Table 2. Overview about different cell adhesion assays. 
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2.3 Atomic force microscopy- based SCFS 
2.3.1 Principle – force spectroscopy mode 
Atomic force microscopy (AFM)166 has been developed as a tool to analyse the 
topography of flat samples at sub-nanometer resolution*. Its basic principle consists in the 
detection of ultrasmall forces166. The so-called AFM cantilever, a highly flexible spring, 
represents the key component of the AFM (Fig. 12 A). Forces acting on the cantilever 
cause it to bend. This bending is - within a limited range- directly proportional to the 
applied force, according to Hook´s law (
! 
F = k " x ). Most commonly cantilever bending is 
detected via an optical lever method (Fig. 12 B). A laser beam is reflected by the back of 
the cantilever onto a segmented photodiode†170-172. When the cantilever bends, the 
position at which the laser beam hits the photodiode changes and different voltage signals 
are detected in the individual segments of the photodiode. To convert the detected voltage 
change into a force, the system has to be calibrated prior to experiments (see B1.1).  
 
Fig. 12. AFM cantilever and principle of force detection. A. EM image of a chip with 
five AFM cantilevers. Scale bar corresponds to ∼2 µm (taken from www.veeco.com). B. 
The cantilever bends proportional to the force acting on it. Cantilever bending causes 
laser beam deflections and as consequence altered voltage signals are detected in the 
segmented photodiode. 
 
Whereas AFM has been applied as an imaging tool for the last decades, it has 
been increasingly used during the last years to measure molecular forces. This technique 
is referred to as force spectroscopy. At normal conditions and in liquid environment, 
AFM force spectroscopy allows the detection of forces down to 10 pN. This permits the 
                                                
* Since AFM imaging is not scope of this thesis, it will not be expanded here. 
† There exist also alternative detection methods for the cantilever deflection, for instance, 
interferometric detection167, 168 or piezo-resistive detection169. 
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detection of weak non-covalent ligand-receptor interactions which break in the pN 
range158, 173. Since AFM force spectroscopy experiments can be conducted under 
physiological conditions, functional biological samples can be studied.  
In AFM force spectroscopy experiments the X-Y-position of the AFM cantilever 
is maintained constant, whereas its Z-position is changed in a controlled fashion by 
piezoelectric elements. During cantilever movement, forces acting on the cantilever are 
monitored over the covered distance. Thereby a force-distance (F-D) curve is generated. 
There are several possible variants of force spectroscopy experiments. To specifically test 
ligand-receptor interactions, the AFM tip is decorated with certain receptor molecules 
and brought in contact with a ligand-coated surface (Fig. 13 B). When the cantilever is 
withdrawn again, potential interactions established between tip and substrate bend the 
cantilever towards the surface (Fig. 13 C) until the tip is released (Fig. 13 D). From the F-
D retraction curve the interaction force between tip and substrate is measured (Fig. 13). 
 
Fig. 13. AFM force 
spectroscopy. (A) The 
cantilever tip is brought in 
contact with a substrate. (B) 
During contact the tip interacts 
with the substrate. (C) When 
the cantilever is withdrawn, the 
cantilever bends down due to 
established interactions until 
(D) the tip is released. By using 
a cantilever functionalized with 
a certain receptor and a 
surface coated with the 
respective ligand, ligand- 
receptor inter-actions can be 
analysed.  
 
 
First AFM force spectroscopy experiments were conducted with the classical 
ligand-receptor system Streptavidin-Biotin174-176, further forces between complementary 
DNA strands177, Lectin-lactose178, antibody-antigen interactions179-181 interactions. Also 
cell adhesion receptor interactions have been studied by AFM force spectroscopy, for 
instance selectin-sialyl Lewis X182-184, P-selectin-PSGL-1185-187, Concanavalin A-
mannose188, Cadherin-Cadherin interactions189, 190 and Integrin-ligand interactions191. In 
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the latter examples purified adhesion receptors were analysed. However, as discussed 
above, a far better approach consists in studying adhesion receptors-ligands interactions 
in the context of a living cell. This can be easily done with a modified AFM setup. 
Firstly, AFM needs to be combined with optical microscopy, to ensure well-controlled 
measurements. Moreover, a temperature-controlled chamber has to be implemented, 
filled with a sufficiently high volume of cell culture medium to create an appropriate 
environment for the cells. For certain cell adhesion measurements (especially cell-cell 
adhesion) an enhanced Z-range of up to 100 µm is further needed. These modifications 
allow the conduction of AFM-SCFS experiments as detailed below. 
 
2.3.2 AFM- SCFS –experimental setup 
In AFM-SCFS experiments adhesion between a living cell and an adhesive 
substrate, being either another cell or a surface coated with a protein of interest 
(Fig. 14 A-C) is studied. In cell-surface interaction experiments, the cell is typically 
attached to an AFM cantilever and interactions with a protein-coated surface are 
quantified192-194(Fig. 14 A). Alternatively, the tip can be modified with a protein of 
interest and probed on a single cell (Fig. 14 A)195. The majority of cell-surface interaction 
studies have applied the aforementioned setup (Fig. 14 A) since it has the advantage of 
being more versatile with respect to ligand immobilization techniques. Therefore the 
setup shown in Fig. 14 A will be detailed below.  
Fig. 14. Possible SCFS experimental setups to measure cell interactions with adhesive 
substrates. (A) A single cell is immobilized on the AFM cantilever and probed on an 
adhesive substrate. (B) The cell is sitting on a surface and the ligand-coated cantilever is 
probed onto it. (C) To quantify cell-cell adhesion, one cell is attached to the cantilever 
and probed on a cell sitting on the surface. 
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Cell immobilization on the cantilever 
To enable attachment of a living cell to the cantilever, the cantilever surface has 
to be modified accordingly. Commonly, for eukaryotic cells Concanavalin A (Con A) is 
used, a lectin that binds carbohydrate groups on the cell surface196. There have also been 
reported alternative methods; for instance wheat germ agglutinin (WGA) has been used 
to immobilize different cell types197. In other studies cells were biotinylated and then 
bound to a streptavidin-modified cantilever198 or cells were grown on the cantilever192. 
Furthermore cells can be immobilized via ECM proteins (FN, collagen), RGD peptides or 
antibodies to AFM cantilevers.  
To attach a cell onto the functionalized cantilever, suspended cells are added into 
the fluid chamber. After the cells settled down, the cantilever is gently brought in contact 
with a single cell and withdrawn to capture the cell (Fig. 15). 
Fig 15. Attaching a living cell onto the AFM cantilever. (A) The functionalized 
cantilever is positioned above a cell sitting on the substrate and gently pressed onto it 
(B). During contact, adhesive interactions are established between cell and cantilever 
coating. (C) Thereafter, the cell-cantilever couple is separated from the surface. During 
the next minutes firm attachment is established. (D) Green-fluorescent fibroblast 
(vinculin-GFP) immobilized on a AFM cantilever. The picture is an overlay of images 
recorded by phase contrast and epi-fluorescence microscopy. The scale bar corresponds 
to a length of 50 µm. 
 
Recording a F-D curve 
Once the cell is stably bound to the cantilever, the cantilever is approached to the 
surface until a certain force set-point is reached. Thereby the cell is brought into contact 
with the adhesive substrate. After a given contact period the cantilever is retracted and 
the cell is pulled away from the substrate (Fig. 16). If adhesive interactions were 
established between cell and substrate the cantilever bends downwards during retraction 
until the cell is fully separated from the surface. During the described procedure- the so-
called F-D cycle- the force acting on the cantilever is monitored (Fig. 16) (appendix, 
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supplementary videos 1 and 2). Parameters significantly influencing the experiment, such 
as contact force and period, contact condition (contant height, constant force) and pulling 
speed can be precisely controlled.  
Fig. 16. Monitoring the force signal during a F-D cycle. Piezo movement (above) and 
force signal (below) versus time during a F-D cycle. The piezo extends until a certain 
force set-point is reached (black). In constant height-mode the piezo position is 
maintained constant during contact (green). Due to its viscous properties, the cell relaxes 
and the force on the cantilever decays during the first seconds of contact. In the 
retraction curve (grey) the cantilever bends down due to the established adhesion 
between cell and substrate. The baseline force level is reached when all linkages between 
cell and substrate are broken. 
 
Plotting the detected force versus the distance separating cell and substrate generates a F-
D curve (Fig. 17). 
 
Fig. 17. F-D curve and extracted information. (A) Schematic representation of the F-D 
cycle. (B) Information that can be obtained from the F-D curve. FD maximal force 
required to detach the cell, E elastic properties, WD adhesion work, d distance required 
for separation, discrete force steps (jumps and tethers).  
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2.3.3 Interpretation of SCFS F-D curves 
F-D retraction curves (Fig. 17, grey) usually show a characteristic and complex 
force pattern. How can this force pattern be interpreted? Fig. 18 illustrates different 
phases of the cell detachment process and correlates these to an example F-D curve.  
 
Fig. 18. Schematic 
representation of the 
cell detachment 
process. The cell 
detachment process is 
separated into 
different phases. (A) 
The cell is in contact 
with the substrate. In 
the contact zone 
adhesive interactions 
occur. (B,C) During 
cell detachment 
established bonds are 
ruptured and the 
formed contact zone 
shrinks. When the cell 
body is separated from 
the surface, solely 
membrane nanotubes 
link cell and substrate 
until the cell is fully 
detached from the 
substrate (D). 
 
F-D curves do not only contain useful information about the established 
interactions between cell and substrate, but also give information about the mechanical 
properties of the cell, for instance. Subsequently parameters that can be extracted from F-
D curves are discussed. Thereby overall adhesion is defined as the sum of adhesive 
interactions occurring between cell and substrate. 
 
Detachment force FD:  
The detachment force is defined as the maximal force that is required to separate 
the cell from the substrate. How can the detachment force be interpreted? By light 
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microscopy it can be observed that the apparent* contact zone established between cell 
and substrate is approximated by a circular area (see Fig. 39 and 46). During the initial 
detachment phase, bonds established in the outer zone of the contact zone are stressed 
first. Depending on the established adhesion, the cell is stretched until a maximal force is 
reached. Upon bond failure, the contact zone shrinks. Assuming a homogenous 
distribution of receptors over the contact zone, more bonds per radial section will have 
formed at the periphery of the contact zone than in the inner region (Fig. 18A). 
Consequently a maximal force is detected initially before the bonds at the periphery 
begin to fail. After the maximal force is overcome, the force decreases quickly because 
the applied force load is shared by fewer receptors in the inner contact zone and the 
probability that these bonds resist rupture decreases199. Since the total number of 
receptors and their binding strengths contribute to FD, it is most commonly used to 
quantify overall cell adhesion. 
 
Jumps (j)/tethers (t).  
F-D curves usually display small discrete force steps. These can be distinguished 
into jumps (j) and tethers (t) (Fig. 17). Whereas j events are typically preceded by a non-
linear force loading, a force plateau is detected prior to t (Fig. 19). Both, force gradient 
prior rupture (>0: j, ∼0: t) and the distance at which the force jumps occur (dependent on 
the context) can be used to distinguish j and t. Distinguishing j and t events is necessary, 
since they are contributed to different detachment scenarios (Fig. 19):  
j events. j events can be interpreted as the rupture of single or a few ligand-
receptor bonds. Unbound receptors are supposed to be linked to the cytoskeleton 
(Fig. 19)200. For instance, integrins often localize to specialized complexes involving 
assemblies of cytoskeletal linker and signalling proteins. Stretching of these membrane-
cytoskeleton linkers leads to a non-linear force increase prior bond rupture200. The 
magnitude of the force step reflects the stochastic survival of this ligand-receptor bond 
under an increasing force load199, 200. The ensemble of many j events can provide 
information on the binding strength (discussed in 3.3).  
                                                
* Unequal to the molecular contact area in which cell and substrate are in sufficiently 
close proximity to enable receptor-ligand interactions. 
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t events are often found in F-D curves at pulling distances of several µm. The 
force plateau preceding the force step (t) appears when membrane nanotubes (often also 
called membrane tethers) are pulled out of the cell membrane (Fig. 19, 20). Membrane 
nanotubes may form in two different processes: either one or few receptors that are not 
linked to the cytoskeleton bound their ligands and are pulled –together with a membrane 
nanotube- from the cell. Alternatively receptor/receptors are pulled from the cell after the 
molecular link coupling them to the cytoskeleton has been disrupted200 (Fig. 19).  
 
Fig. 19. Sketch illustrating the different events causing j and t events. A. “j”-like events 
(left). A receptor anchored to the cytoskeleton binds to a ligand in the ECM (here 
collagen). Upon pulling on the cell during cantilever retraction, the receptor-membrane-
cytoskeleton linker is stretched and the force on the cantilever increases. Upon bond 
rupture the force on the cantilever rapidly decreases. B. “t”-like event (left). A receptor 
that is not anchored to the cytoskeleton (alternatively anchorage is disrupted during 
pulling) is extracted with a membrane nanotube from the cell body. The force on the 
cantilever remains constant during tether extraction. When the receptor-ligand bond is 
released, the force on the cantilever decreases staircase-like (upper sketch). 
Alternatively, the nanotube might fail (sketch below) or the receptor might be pulled out 
of the membrane. 
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In case of a receptor sustaining the nanotube, the nanotube may be released upon 
receptor-ligand dissociation. In such case the length of the nanotube can be used to 
calculate the lifetime of the receptor-ligand interaction at a certain force201. Thereby the 
bond lifetime- approximately equal to the tether survival time- is calculated by dividing 
nanotube length through the pulling speed. During tether formation the plasma membrane 
is deformed, thus the magnitude of t events reflects the mechanical characteristics of the 
probed membrane. These include surface tension and binding rigidity202-205. The 
biophysical aspects of membrane nanotube pulling have been characterized in 
phospholipid vesicles and different cell types204-206. Membrane nanotubes can also be 
found in vivo. They are suggested to facilitate the transfer of vesicles and small molecules 
from one cell to another207. Thus, there exists certain interest in studying the biophysical 
behaviour of membrane nanotubes. Different to some tethers formed in vivo that contain 
actin filaments or microtubuli, artificially created tethers usually exhibit no cytoskeleton 
compounds.  
 
 
 
 
Fig. 20. Image of a membrane nanotube pulled from an 
embryonic zebrafish cell. A ConA-coated cantilever was 
brought into contact with a cell having fluorescent labelled 
membrane (cell b). Upon separating the cantilever from the 
cell, a membrane nanotube (red arrow) is formed between 
cantilever and cell (the cantilever cannot be seen here). 
Membrane nanotubes usually exhibit a radius of 
approximately 100 nm and can have a length of several tens 
of µm. Scale bar corresponds to 10 µm. 
 
 
Separation distance d,  
The separation distance is the distance at which all linkages between cell and substrate 
between cell and substrate have been ruptured. This length is highly influenced by 
membrane nanotubes. 
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Elastic properties of the cell E.  
The slope of the force increase in the approach curve during contact formation 
(Fig. 17) is influenced by the elastic properties of the cell. The elastic properties of most 
cell types are substantially influenced by organized actin filaments of the cell cortex. 
Fig. 21 shows F-D curves (approach) recorded in the presence of increasing 
concentrations of Cytochalasin D that destabilizes actin filaments. The cell becomes 
softer with increasing Cytochalasin D concentration in the medium, as indicated by the 
increasing cell deformation (0.25 µm - 0.5 µm – 1 µm). Moreover, during contact with 
the substrate, a decay of the force can be observed in constant height mode (Fig. 16). This 
decay is explained by the viscous properties of the cell. Approach F-D curves can be used 
in appropriate experimental setups to analyse the viscous properties of cells208, 209 (see 
below). 
 
 
 
 
 
 
 
 
 
 
Fig. 21. F-D curves recorded in presence of cytochalasin D. Only approach curves are 
shown. F-D curves were recorded after adding increasing concentrations of 
Cytochalasin D to the medium. The circle illustrates the region in which contact is 
established between cell and surface. Trend fits describe the non-linear force increase 
during indentation. 
 
 
Detachment work WD 
The detachment work corresponds to the work that has to be done to detach the 
cell from the substrate. WD is found by measuring the area enclosed by retraction curve 
and baseline (hatching in Fig. 17). WD relates to the overall adhesion established between 
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cell and substrate, but is also substantially influenced by the elastic properties of the cell 
(see covariance data, Appendix A1). Due to their length, often ten´s of µm, membrane 
nanotubes significantly contribute to the WD.  
 
2.3.4 SCFS –state of the art 
With the described setups various experiments can be designed. Advantageously 
AFM based SCFS allows forces within a large range from a few pN up to several 
hundreds of nN to be measured. Thus, interactions mediated by single CAMs 153, 193, 198, 
210, 211 up to adhesive interactions established by larger adhesive complexes can be 
detected197, 212. This versatility makes it possible to address a broad range of biological 
questions.  
Pioneering SCFS experiments with living mammalian cells were carried out by H. 
Gaub´s group192, quantifying cell-cell adhesion between trophoblasts and uterine 
epithelial cells, to model interactions occurring during embryo implantation. In another 
early study, Lehenkari et al. analysed adhesion between osteoblasts/osteoclasts and 
different RGD-containing ligands195.  
Numerous SCFS experiments were performed by V. Moy´s group, for instance 
characterizing α5β1-integrin-FN interactions at the single-molecule level193. Furthermore, 
overall endothelial cell-leukocyte adhesion213, 214 was investigated and the contribution of 
integrin- and selectin-mediated interactions in overall adhesion was demonstrated by 
using respective blocking antibodies. These experiments could provide insights into the 
mechanisms underlying adhesive interactions between leukocytes and endothelium that 
are crucial to initiate the process of transmigration during inflammatory response. 
Adhesive interactions between endothelial cells and leukocytes interactions involve LFA 
(lymphocyte function-associated molecule)-1-ICAM (intercellular adhesion molecule)196, 
215 and α4β1-integrin-VCAM (vascular cell adhesion molecule)216 interactions; these were 
further explored at the single molecule level. Thereby bond specific parameters, such as 
bond dissociation rates could be determined. Recently homophilic JAM-A (junctional 
adhesion molecule) interactions were characterized and a role of LFA-1 in their 
regulation was shown217.   
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For several years, the group of D. Müller has established AFM-SCFS as a tool to 
quantify cell adhesion. An important improvement of experimental setup was the 
implementation of an enhanced piezo range that enables to perform sensitive cell-cell 
adhesion measurements218. This optimized setup further allowed probing adhesion over a 
broad range of detachment forces, starting with single-molecule interactions up to high 
forces exerted by more complex adhesive sites219. Moreover, by using a system 
combining SCFS with advanced optical microscopy techniques, a better control of the 
experiment was provided. In first projects adhesion of gastrulating zebrafish cells to FN 
coated surfaces has been quantified. Thereby the role of Wnt11 in modulating integrin-
mediated adhesion was investigated. Wnt11 -deficient mutants showed decreased 
adhesion to FN, which was attributed to decreased integrin binding194. In a similar setup 
the impact of Wnt11 on intercellular adhesion of gastrulating zebrafish cells was studied. 
Thereby Wnt11 was found to modulate E-cadherin mediated adhesion via a Rab5-
dependent mechanism220. Furthermore adhesion between gastrulating zebrafish cells 
raised from different germ layers221 was compared. Thereby mechanisms underlying 
cellular movements during gastrulation could be investigated and the contribution of 
differential cell adhesion and cell cortex tension in germ layer organization could be 
deciphered. In two further studies the role of galectin-3 in adhesion to laminin-111 and 
collagen type I has been quantified. Thereby galectin-3 was demonstrated to inhibit 
cooperative α2β1-integrin binding on collagen type I222, 223. In another study the role of 
the integrin activator TPA in strengthening integrin-cytoskeleton interactions and 
increasing α2β1-integrin avidity could be demonstrated224. For all these projects 
principally the same SCFS setup could be used, only with slight modifications (appendix 
B1.1, table S2). 
In D. Wirtz´s group homophilic and heterophilic N-, E- and VE-cadherin 
interactions were further characterized at the single-molecule level198, 225. In further 
experiments the role of alpha-catenin in strengthening cadherin-mediated interactions 
was examined226. Other groups analysed interactions between isolated P-selectins and 
their ligands on the surface of polymorphonuclear leukocytes and colon carcinoma cells  
at the single-molecule level227. Furthermore, adhesive interactions of cell surface 
integrins with nanopatterned RGD-peptide coated substrates were quantified. Thereby 
insights into the optimal spatial organization of RGD ligands for integrin binding could 
be gained212. 
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Alternative SCFS setups 
SCFS can also be used in alternative experimental setups to address different 
biological problems. SCFS can probe mechanical properties of cells, for instance 
(Fig. 22 A): Thereby the AFM tip or a bead attached to the cantilever is used to indent a 
cell in a controlled manner. The indentation resulting from a given force or the force 
required to reach a certain indentation depth can be measured and compared among 
different cell types/conditions. In a more quantitative approach the relationship between 
force and indentation is used to determine the cell´s young modulus according to Hertz 
model208, 209, 228-230 or alternatively the liquid droplet model228. By combining imaging 
and elasticity measurements, local elastic properties of a cell can be analysed and an 
elastic map of the cell can be created. Such experiments were used to assess local or 
temporal changes in elastic properties of a cell upon certain treatment, for instance anti-
cytoskeletal drugs, chemotherapeutic drugs or radiation231-234. The described experiments 
can give valuable insights into altered elastic properties of cells, which is relevant to 
several diseases, for instance in osteoarthritis and in cancerous diseases, e.g. leukemia 228. 
Several independent studies have for instance reported that malignant cancer cells are 
more compliant compared to non-malignant cells228, 235-237. 
Fig. 22. Alternative SCFS experimental setups. (A) Studying mechanical properties of 
cells. (B) Manipulating cells at high temporal and spatial precision. (C) Creating an 
interaction map of living cells using a receptor/ligand- functionalized AFM tip. 
 
Moreover, AFM cantilevers may be used to specifically manipulate cells in 
multiple ways (Fig. 22). This allows investigating the behaviour of cells when these are 
subjected to mechanical stress. In a previous work, for instance, osteoblasts were 
indented by a bead attached to an AFM cantilever; by using an colorimetric assay in 
parallel, the mechanical stimulus was directly shown to cause an increase of intracellular 
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calcium concentrations 238. Furthermore forces generated by cells can be quantified, for 
instance during cell migration239, 240 or during mitotic cell rounding.  
Other applications include affinity imaging (Fig. 22 C), in which an array of F-D 
curves is recorded on a surface, for instance the surface of a cell. By using a cantilever tip 
decorated with specific bio-molecules (e.g. an antibody, specific ligand/receptor) an 
interaction map of this surface can be generated241-244 181, 244, 245. 
 
 
2.4 Conclusions 
As shown by the given examples, AFM-SCFS is a versatile tool that allows the 
performance of sensitive cell-ECM and cell-cell adhesion measurements at a high 
temporal precision. Advantageously a large range of adhesion forces can be detected. The 
high force resolution further allows the analysis of single-molecule interactions. How can 
the measured forces be interpreted? To extract biophysically relevant data, e.g. 
information about bond dissociation rates, a model is needed that allows to relate 
measured forces to binding rates. In the following chapter, chapter three, the Bell-Evans 
model that was used in the presented work to interpret force spectroscopy data is 
introduced.  
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Chapter 3 
The Bell-Evans model 
 
3.1 Basic reaction equations & bond kinetics for receptor-ligand interactions 
About thirty years ago a seminal model was proposed by George Bell to describe 
the kinetics of receptor-mediated adhesion occurring between two cells or between a cell 
and a ligand-coated surface246. Expanded by Evan Evans, this model deals with the effect 
of an externally applied force on the lifetime of biomolecular bonds. Thus, it provides an 
appropriate framework to interpret data obtained in above described AFM-SCFS 
experiments at the molecular level.  
In AFM-SCFS experiments such as conducted in the presented work, a single cell 
bound to the AFM cantilever is brought into contact with a surface coated with ligand 
molecules (Fig. 23). Upon reaching contact with the surface, the cell deforms and contact 
is established over a certain contact zone. Then the cell is held in contact for a certain 
period. Within the contact zone interactions between the cell and the surface can occur, 
these include unspecific and specific interactions. Thereby unspecific interactions are 
defined as interactions that occur between all cells, for instance ionic interactions*, steric 
repulsion and van der Waals forces246. In contrast, specific interactions are by definition 
mediated by receptors (CAMs) that bind to their ligands on the surface. The binding 
reaction in the contact zone can be written as: 
! 
R + L
koff
" # # # 
kon
# $ # # 
RL          Eq. 1 
where R are the free receptors, L the free ligands, kon and koff are the rate 
constants for formation and dissociation of the bound state RL respectively 246. 
                                                
* The lipid bilayer of cells has net negative charge, thus repelling forces act among cells. 
In physiological medium this force is mostly reduced by surrounding counter- ions, thereby the 
Debye length has been estimated to be in the order of 1nm in physiological media. Furthermore, 
ionic interactions occur among charged sidegroups of cell- surface proteins246.  
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These receptor-ligand interactions can occur between binding partners that are in 
close proximity with each other. Since the CAMs are inserted in the cell membrane, the 
distance between cell membrane and the plane in which the ligand is immobilized has to 
be small enough, such that a ligand and a receptor can bind. The proximity in vertical 
direction is established by approaching the cell by the cantilever movement and further 
by cellular fitting to the surface during contact. Both processes also reduce steric 
repulsion mediated by large extracellular molecules of the glycocalyx247. For simplicity it 
is assumed that the receptors are initially uniformly distributed throughout the contact 
area246.  
 
Fig. 23. Sketch illustrating the 
contact zone established between a 
cell and a ligand-coated surface 
during AFM-SCFS. The initially 
applied force establishes contact 
and brings receptors and ligands 
together. Bonds can form if 
receptors and ligands are in close 
proximity to each other. Receptors 
can diffuse in the membrane (see 
arrows). 
 
Once contact is established, receptors and ligands encounter each other because 
the receptors are motile and diffuse in the plane of the cell membrane. Diffusion 
constants of CAMs have been measured by various techniques, for instance by 
fluorescence recovery after photo-bleaching (FRAP), fluorescence correlation 
spectroscopy (FCS) or by single-particle tracking (SPT)248-250. Depending on the analysed 
system, diffusion constants between 
! 
10
"11
"10
"9
m
2
/sec  have been found250, 251; they are 
influenced by the motility of the proteins and interactions with other proteins or linkage 
to the cytoskeleton. For instance, for integrin α4β1 a diffusion constant of 
! 
D = 3 "10
#10
m
2
/sec  has been measured when not cytoskeleton-associated, and 
! 
D = 5 "10
#11
m
2
/sec  when linked to the cytoskeleton249. Differently to CAMs, ligand 
molecules immobilized on the surface are not free to move. Since the diffusion constants 
are approximately four orders of magnitude smaller for membrane-inserted proteins than 
for proteins free in solution, the bond formation rate kon will be near the diffusion limit246. 
The small diffusion rates further imply that dissociated receptor and ligand can 
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recombine before diffusing apart246. Thus, the following kinetic equations can be 
formulated to describe the time-dependent change of the number of ligand-receptor 
interactions per unit area NRL (unit: 
! 
1/µm2): 
! 
d NRL[ ]
dt
= kon " NRf " NLf # koff " NRL       Eq. 2 
with NRf and NLf being the number of free receptors and ligands, respectively, per unit 
area. With NR and NL being the total number of receptor/ligands per unit area, it can be 
written: 
NR=NRL+NRf         Eq. 3 
and 
NL=NRL+NLf         Eq. 4 
Thus, Eq. 2 can be rewritten as follows246: 
! 
d NRL[ ]
dt
= kon " (NR # NRL ) " (NL # NRL ) # koff " NRL     Eq. 5 
Formulating Eq. 5 it was assumed by G. Bell that the overall receptor density within the 
contact area remains constant†. In AFM-SCFS experiments the cantilever is withdrawn 
after a certain time period. During separation the force is recorded for each distance 
separating cell and surface. If the cell remains attached to the substrate, a linearly 
increasing force is exerted onto the ligand-receptor bonds 
! 
F = k " x . How does this force 
affect the unbinding rate of receptor-ligand bonds? 
 
3.2 Dissociation kinetics near and far from equilibrium 
Interactions between CAMs and their ligands are governed by weak non-covalent 
interactions such as van der Waals, electrostatic, hydrophobic/hydrophilic and hydrogen 
bond interactions. Dissociation kinetics is determined by the energy landscape of barriers, 
being the free energy profile along a preferential pathway (there are more possible 
pathways, which might be traversed, but these might be energetically less favorable)253. 
                                                
† A possible change of receptor density might occur due to inward-diffusion of membrane 
bound receptors outside the contact area252 or by transport of new receptors from the cytoplasm 
to the cell surface. 
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This energy landscape is described by a minimum (bound state) that is separated by one 
or several energy barriers from the unbound state (Fig. 24). These potential barriers 
influence the kinetics of bond dissociation in a way that the bond lifetime τ increases 
exponentially with the barrier height: 
! 
" = " 0 # exp
E
b
k
B
#T
$ 
% 
& 
' 
( 
)         Eq. 6 
where τ is the bond lifetime (
! 
" =1/koff ), τ0 is the reciprocal of a natural frequency 
of oscillations, Eb the height of the energy barrier, kB the Boltzmann constant and T the 
absolute temperature254. 
 
 
Fig. 24. Schematic representation of 
receptor-ligand bond dissociation.  A 
potential barrier (height Eb, width xu) has 
to be overcome to dissociate a ligand-
receptor bond. . For simplicity, a model 
with a single-barrier is shown. The energy 
landscapes of biomolecular bonds is 
expected to be much more complex, since 
many interaction sites are involved255. 
Figure modified from255. 
 
 
How does an externally applied force affect bond lifetime? Adhesive bonds often 
function under mechanical stress246, 256, 257. Good example are leukocytes that experience 
shear stress while they are attached to blood vessels. Furthermore, pulling forces are 
exerted on adhesion sites anchoring fibroblasts during wound contractions and muscle 
cells during muscle contraction256. Also cells within static tissues can transiently be 
subjected to high mechanical stress. Such forces determine substantially bond 
lifetimes246. In his model describing cell-cell adhesion, G. Bell proposed the following 
relationship between bond lifetime τ and force246:  
! 
"( f ) = " (0) # exp
$xu # f
kB #T
% 
& 
' 
( 
) 
*        Eq. 7 
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or analogously, substituting τ by 
! 
1/koff  and τ(0) by 
! 
1/koff (0)  
! 
koff ( f ) = koff (0) " exp
xu " f
kB "T
# 
$ 
% 
& 
' 
(        Eq. 8 
where τ(0) is the lifetime under zero force; koff(0) the dissociation rate under zero force, 
kB the Boltzman constant and T the absolute temperature, f is the applied force and xu is 
the width of the energy barrier.  
According to Eq. 7 a force f applied to the ligand-receptor interaction lowers the 
energy barrier by 
! 
xu " f  (Fig. 25), and shortens the bond lifetime by the factor of 
! 
exp
xu " f
kB "T
# 
$ 
% 
& 
' 
( . Since the lifetime is the reciprocal of the bond dissociation rate koff, it 
follows that koff increases exponentially with the applied force (Eq. 8). Thus, a single 
bond resists to a force for a time period that is smaller than the time needed for its 
spontaneous dissociation under thermal activation τ(0)256. The relationship in Eq. 7 was 
taken over by Bell from solid-materials theory. A similar relationship was found 
experimentally in fraction tests with various solid materials, ranging from metals to 
polymers258. By applying this relationship between force and lifetime to the case of the 
interaction of two adhering cells, G. Bell postulated that the dissociation of biological 
bonds had similarity to the rupture of solid materials. The predictions of G. Bell were 
later experimentally and theoretically confirmed by E. Evans and corrected to describe 
the force-induced rupture of ligand-receptor interactions254.  
 
 
 
 
 
Fig. 25. Influence of an external force on 
a single energy barrier separating the 
bond and the unbound state. Along the 
reaction coordinate x, an external force 
adds a mechanical potential –fx that tilts 
the energy landscape and lowers the 
barrier to dissociation (figure modified 
from 256). 
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As illustrated in Fig.  25, a force that is applied via a structural element with an 
effective spring constant keff on a molecular bond creates a spring-like potential that alters 
the chemical energy of interaction.  
Substituting the dissociation rate from Eq. 8 into Eq. 5, the kinetics of bond 
formation under force can be newly formulated as246: 
! 
d N
RL[ ]
dt
= k+ " NR # NRL )(NL # NRL( ) # NRL " k# " exp
x
u
" F /C
k
B
"T
$ 
% 
& 
' 
( 
)   Eq. 9 
where 
! 
F /C  is the force applied to a single bond. Above a certain critical force rebinding 
events (=first term) can be neglected. Thus, dissociation under sufficiently high force 
represents kinetics far from equilibrium246, 254. 
According to Eq. 9 an ideal situation is considered, in which the applied pulling 
force is equally distributed among all receptor-ligand interactions. This formula could 
theoretically allow calculating the kinetics of failure of multiple bonds as occurring in our 
SCFS experiments. In most physiological situations multiple bonds are formed between 
cells and their environment. These include either multiple interactions by the same type 
of receptor, or interactions mediated by different receptors. However, the unbinding of 
multiple receptors is non-trivial: even given the (improbable) situation that only multiple 
interactions of a single type of receptor, for instance a certain integrin heterodimer, are 
analysed, the situation could become very complex: some heterodimers might not be 
linked to the cytoskeleton, others are bound to cytoskeletal proteins, others might be 
located in dense adhesion receptor clusters. Consequently local elasticity varies and 
therefore the individual bonds do not evenly share the applied force. The mentioned 
aspects might have as a consequence that a broadened distribution of rupture forces is 
detected, furthermore multiple distributions could appear.  
This implies that single molecule interactions have to be analysed. Therefore the 
number of occurring interactions has to be reduced. In AFM-SCFS experiments, this can 
be achieved by reducing both, contact time and contact force to minimize the established 
contact area. Under such conditions, F-D curves with only one single-rupture event can 
be obtained (Fig. 26). To test that single-rupture events are due to specific receptor-ligand 
unbinding, respective control experiments have to be conducted, for instance by using 
specific blocking antibodies or by comparing different mutants (see chapter four). From a 
set of F-D curves a distribution of rupture forces is obtained. This distribution contains 
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information on the binding strength of the probed ligand-receptor interaction as discussed 
below. 
 
 
Fig. 26. Representative F-D curve 
recorded in AFM-SCFS experiments. To 
reduce integrin binding to single-
molecules, short contact time and low 
contact force was chosen. From the F-D 
curve the rupture force (f) and the spring 
constant of the linker keff can be extracted. 
 
 
3.3 Binding strength 
The binding strength 
! 
f
* is defined as the most probable254 or mean259 force that 
produces bond failure in repeated detachment tests. For a single receptor- ligand bond 
subjected to a force f(t), the probability P(t) that it survives in its bound state is given 
by254:   
! 
dP(t)
dt
= "k( f (t)) # P(t)        Eq. 10 
Since bond rupture is a stochastic event, 
! 
f
* is dependent on the rate by which 
force is applied to the receptor-ligand interaction (the loading rate 
! 
reff ). It was 
theoretically derived and experimentally shown by Evans and Ritchie254 that 
! 
f
* increases 
linearly with the logarithm of the loading rate (Fig. 27): 
! 
f
*
=
kBT
xu
" ln(
reff " xu
kBT " koff
) =
kBT
xu
" ln(
xu
kBT " koff
) +
kBT
xu
" ln(reff )    Eq. 11 
Eq. 11 predicts
! 
f
* to increase linearly with the logarithm of the applied force 
loading rate 
! 
reff . In force spectroscopy experiments the force loading rates are varied by 
applying different pulling speeds (see B1.3). 
! 
f
* is determined for each dataset recorded 
at a certain pulling speed (corresponding to an average 
! 
reff ) and plotted versus 
! 
ln(reff ) 
(Fig. 27 A, right and 4.3.2). By fitting data with Eq.11, 
! 
x
u
 and 
! 
koff  can be calculated. 
 Chapter 3 -55- 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27. Schematic presentation showing the effects of force on average bond lifetime 
and binding strength of slip and catch bonds. (A) Slip bond. The exponential decrease 
of the bond lifetime- as predicted by the Bell model- with increasing force is shown (left). 
(right) Linear increase of the binding strength with the logarithm of the loading rate. The 
solid line shows the behaviour for a single-potential barrier overcome during unbinding, 
as illustrated in Fig. 24. The dashed line corresponds to the force increase for two 
potential barriers. (B) Catch bonds. In the low loading rate regime, the average lifetime 
increases with applied force until a maximum is reached. Thereafter the average lifetime 
decays (left). (right) Effect of increasing force loading rate on the binding strength. The 
binding strength of a catch bond is switched at a fast loading rate. Modified from 
256and260. 
 
In previous experiments several integrin-ligand interactions have been 
characterized in AFM-SCFS experiments, for instance α5β1-FN261, α4β1- VCAM-1262 and 
αLβ2- ICAM-1 and αLβ2- ICAM-2 interactions263. In addition different cadherin 
interactions were analysed by SCFS, e.g. VE-cadherin264 and N-cadherin interactions265. 
In all these mentioned cases the Bell-Evans model could be used to interpret the 
relationship between binding strength and force load and to determine koff and xu.  
However, there are some examples of ligand-receptor bonds in which the Bell 
model cannot be used for interpretation. In fact, it has been found that the effect of force 
on bond lifetimes can be very different. Some ligand-receptor systems show quick 
unbinding in the low-loading rate regime and strengthen their binding -within a certain 
range- with augmenting force loading. Bonds showing such behaviour are termed “catch 
bonds”257 (Fig. 27 B). Catch bonds have been reported for certain types of adhesion 
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receptors, for instance p-selectin PSGL257, 266-268 269 and the most common E. coli 
adhesin, FimH270, 271.  
In the case of p-selectin, the catch bond behaviour has been proposed to be 
adapted to the physiological environment of leukocytes expressing those molecules. In 
the blood stream, leukocytes are exposed to varying shear rates. Leukocytes show a 
shear-threshold behaviour; they move freely below a certain shear stress, at increased 
shear rate they start rolling on blood vessels due to transient binding events260. Thus, 
catch bonds can modulate cell adhesion under varying mechanical stress257.  
 
3.4 Conclusions 
Experiments conducted far from equilibrium are of particular interest for the 
study of ligand-receptor bonds that experience forces in vivo, as basically all CAM-ligand 
bonds do. Since the behaviour of adhesion receptors under external forces can be such 
diverse as described, the relationship between bond lifetime and external force has to be 
experimentally tested for each ligand-receptor system. As seen in the previous section, 
AFM-SCFS represents an optimal tool for that purpose, since adhesion bonds are probed 
in their native environment over a large range of loading ranges. Thereby energy barriers 
that are essential to the dynamic functions of adhesion molecules may be detected253.  
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Chapter 4
Quantifying early steps of a2b1-integrin mediated cell adhesion
to collagen type I
4.1 Abstract
In this first project early steps of a2b1-integrin mediated cell adhesion to two-
dimensional collagen type I matrices (Col) were quantified by AFM-SCFS. CHO cells
that had been transfected with a2-integrin subunits (CHO-A2) were chosen for the
analysis. a2-integrin negative CHO-WT served as controls. For all tested contact times,
detachment forces were significantly higher for CHO-A2 cells compared to CHO-WT,
suggesting that adhesive interactions between CHO-A2 cells and Col were dominated by
a2b1-integrin-collagen bonds. Using CHO-A2 cells, a2b1-collagen interactions were
subsequently analysed at the single-molecule level. Dynamic force spectroscopy
permitted calculation of bond specific parameters, such as the bond dissociation rate koff
(1.3±1.3 sec-1) and the barrier width xu (2.3±0.3 Å). Next, the time-dependent build-up of
CHO-A2 cell adhesion was monitored over 600 sec. Detachment forces increased slowly
during the first 60 sec and the single rupture forces were consistent with the unbinding of
individual integrin-collagen bonds. When contact between cell and Col was sustained for
> 60 sec, a fraction of cells suddenly reinforced adhesion and detachment forces
increased up to tenfold. Interestingly, adhesion reinforcement coincided with a rise of the
individual rupture events above the values measured for individual a2b1-integrin-collagen
bonds. This suggested that integrin clusters had formed which allowed cooperative
integrin binding. When adhesion was quantified in the presence of inhibitors of acto-
myosin contractility less cells reinforced adhesion. This indicated that acto-myosin
contractility was required for the establishment of cooperative integrin binding. In
conclusion, the kinetics of a2b1-integrin mediated adhesion was investigated and insights
into the underlying binding mechanisms were obtained.
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4.2 Introduction
Within the integrin family, collagen binding integrins present a structurally and
functionally distinct subgroup comprising four integrin heterodimers, a1b1, a2b1, a10b1
and a11b1
272, 273. These collagen receptors share a common b1-integrin subunit that can
associate with the four structurally related a-integrin subunits a1, a2, a10 or a11
1. The
expression of collagen binding integrins varies among different cell types. a1b1- and
a2b1-integrins are widely expressed collagen receptors. For instance, a1b1-integrin is
present on smooth muscle cells and in many mesenchymal cell types276. a 2b1-integrin
was first identified in 1987 in the human fibrosarcoma cell line HT-1080274 and later
found to be abundant on epithelial cells, platelets and mesenchymal cells277, 278. a10b1-
and a11b1-integrins are more recently discovered integrin heterodimers and compared to
a1b1 and a2b1, their expression is more limited. Whereas a10b1 is specifically expressed
in cartilage279. a11b1 is expressed in fibroblasts
280 and in many mesenchymal tissues
during development273, 281.
a1b1- and a2b1-integrins transmit different signals into the cell and thereby fulfill
different biological functions. Specific signalling pathways were revealed in experiments
using a1- and a2 knockout mice and by using a1- and/or a2-negative cell types that were
transfected with the respective integrin subunit273. Surprisingly the phenotypes of a1b1
and a2b1 knockout mice are mild, suggesting that their function can be compensated by
other collagen binding integrins282. a1b1-integrin promotes cell proliferation
283 and is a
negative feedback regulator of collagen synthesis in vitro and in vivo282, 284. It has a
further functional role in inflammatory cells273. In contrast, a 2b1-integrin activates
collagen synthesis and induces expression of matrix metalloproteinases285. In fibroblasts
and osteogenic cell lines, a2b1 can mediate cell migration on collagen and reorganization
of collagen fibrils. When cells are enclosed in three-dimensional collagen gels, a2b1-
dependent gel contraction can be observed. In contrast, the effects of a10b1 and a11b1 on
intracellular signalling pathways are not as well known so far. a11b1-integrin has been
                                                 
1 Whereas initially a3b1 had been initially also described as a collagen
binding integrin274, it has been later found that it might have a more indirect role as
an assisting rather than primary collagen receptor275.
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associated with cell migration286, 287 and collagen fibril assembly288. In some cell types,
such as fibroblasts, chondrocytes, osteoblasts, endothelial cells and lymphocytes, a1b1
and a2b1 can be expressed at the same time
289, 290. Since a1b1 and a2b1 can activate
opposing signalling pathways, their binding is inversely regulated, as recently observed
in renal cells. There are also cell types, for instance KHOS-240 osteosarcoma cells, in
which all four collagen binding integrins are expressed at the same time290.
All collagen binding integrins contain I-Domains in their a-subunits which are
used for ligand binding (see 1.2.2). I-domain crystal structures of a1- and a2-integrins
have been solved; they share many similarities. The binding preferences of different
collagen binding integrins were elucidated by cell attachment assays using transfected
cells or by binding assays performed with purified integrin I-domains. For instance CHO
cells which lack endogenous collagen binding integrins were transfected to express either
a1- or a2-integrin and attachment and spreading of these cells was analysed on collagen
coated surfaces289. It became evident that a1b1 and a2b1 have different preferences
regarding the collagen subtype. a1b1-integrin expressing CHO cells could spread on
collagen types I, III, IV and V, but not on collagen type II289. a2b1-integrins mediated
spreading on collagen types I-VI289. Although a1b1 could mediate cell adhesion and
spreading to collagen type I285, 291, binding affinities were significantly lower than for
a2b1
289, 292. This is in agreement with several studies showing that a1b1 is a high affinity
receptor for collagen type IV293, 294, whereas a2b1-integrin was proposed as main integrin
receptor for fibrillar collagen type I292. Cell attachment experiments with cells expressing
a1/a2 chimeric heterodimers suggested that the different binding preferences of a1- and
a2-integrins towards collagen type I are determined by their integrin I-domains
295. This
was confirmed by binding assays with isolated aI-domains showing that a2I exhibited
higher binding affinity towards collagen type I compared to a1I
296. Binding affinities of
a10- and a11-integrins have also been studied. These studies suggest that a10b1 resembles
more a1b1 regarding its binding preferences and that a11b1 has similar binding behaviour
as a 2b1
291, 296. However, results obtained with isolated I-domains are not always
consistent with cell binding assays289. This suggests that integrin-binding experiments
should be analysed in living cells (see 2.2).
Different types of integrin-binding sites in collagens have been proposed. First,
there are specific motifs inside the triple-helical areas that can be recognized by collagen
Chapter 4 -60-
receptors. Second, there are cryptic binding sites which will be discussed in the next
chapter. Last, there are also binding sites for integrins in the non-collagenous domains273.
Studying attachment of different a1b1- and/or a2b1-integrin expressing cells to collagen
type I fragments indicated the presence of distinct binding sites within collagen type I for
these integrins275. Knight et al. identified GFOGER within the triple-helical domains of
collagen type I as a high-affinity binding motif for a1b1 and a2b1-integrins
297. The crystal
structure of a triple-helical peptide comprising the GFOGER motif in complex with the
a2I-domain has been resolved and provided insights into the a2b1-collagen binding
mechanisms298 (See 2.1.1). However, it is not known how many different recognition
sites for integrins exist in total in collagen type I273. In the case of a2b1, various low-
affinity binding sites have been suggested apart from the high-affinity binding motif
GFOGER273. Single molecule experiments detecting the binding strength to collagen type
I may give insights into different binding sites. So far, only few studies have analysed
quantitatively integrin- ligand binding at the single molecule level. There has been only
one study addressing a 2b1-integrin-collagen type I interactions. Adhesion of
keratinocytes to collagen I was studied in a flow chamber and a bond dissociation rate
(koff) of 0.06s
-1 was determined299.
In adherent cells, integrins are usually arranged into highly-organized structures,
such as focal complexes or focal adhesions300 (see 1.2.3). Whereas the molecular
composition of adhesion sites and signalling pathways controlling their macroscopic
assembly or disassembly have been analysed in detail, less is known about the early
molecular events leading to their formation. Thus, the precise sequence of these events
and their relative contribution to the transition from weak initial binding to strong, mature
cell-substrate adhesion is still poorly understood. This might be due to the fact that the
experimental setup to address these questions has not been available. The aim of the
present study was it to study single a2b1-integrin-collagen interactions and to follow the
time-dependent build up of more complex adhesive sites containing a2b1-integrin. In a
first step, an appropriate experimental set-up was chosen based on preliminary
experiments.
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4.3 Preparations
Characterisation of two-dimensional collagen type I matrices (Col)
Col matrices developed in the group of Prof. D. Müller were chosen as substrate
for SCFS experiments301-303. In agreement with previous work, AFM topographs of Col
revealed parallel arrays of collagen fibrils that completely coated the underlying mica
surface (Fig. 28A). In AFM topographs recorded at higher resolution (Fig. 28B) Col and
pdCol fibrils display the 67 nm D-band characteristic for collagen type I fibrils304. This
indicated that fibrils of Col/pdCol matrices share structural similarities with fibrils
assembled in vivo305, 306. Most cell attachment studies in the past have been performed
with monomeric collagen type I coatings. However, different binding affinities have been
reported for a2b1-integrin interactions with monomeric and fibrillar collagen type I
292.
Since in vivo collagen type I assembles into fibrils, it is preferable to study integrin
mediated adhesion to fibrillar coatings. In previous studies cell adhesion to collagen
fibrils that were randomly adsorbed to flat surfaces was non-quantitatively analysed292.
However, such substrates are not structurally homogenous enough to allow precise SCFS
with minimal non-specific interactions. In contrast, the collagen type I matrices shown in
Fig. 28 represent a suitable substrate to specifically investigate integrin-mediated
adhesion.
Fig. 28. AFM topographs of two-dimensional collagen I matrices. (A) AFM topographs
of a self-assembled collagen matrix. (B) Topograph recorded at higher resolution.
Contact-mode AFM topographs were recorded in buffer solution and exhibit vertical
scales of 6 nm. Scalebars correspond to 1µm.
Chapter 4 -62-
a2b1-integrin expression in Saos-2 and CHO cells
In previous studies binding of a2b1-integrin to collagen type I has been
investigated in human osteosarcoma (Saos) and in Chinese hamster ovary (CHO) cells289.
Both cell lines lack endogenous integrin a2-subunits. To study the role of a2b1 in
mediating adhesion, these cell lines were transfected with human a2-integrin subunits.
Integrin a2-subunits combine with endogenously expressed b1-integrin subunits to form
functional a2b1-integrin heterodimers
289. Before these cells were analysed by SCFS in the
presented project, a2-integrin expression levels was confirmed in western blots for both,
Saos-2 and CHO cells (Fig. 29).
Fig. 29. Integrin a2 expression in Saos-WT/-A2 and CHO-WT/-A2 cells. Cell lysates of
equal protein concentrations were loaded on 7.5 % SDS-polyacrylamide gels and a2-
integrin was detected by western blotting. Vinculin served as a loading controls.
Analyzing the effect of trypsin treatment on cell surface associated a2b1
For SCFS experiments adherent growing Saos-2 and CHO cells had to be
detached from the tissue culture dishes. For that purpose trypsin-EDTA solution was
used. Trypsin functions by degrading proteins that mediate cell attachment, for instance
secreted ECM proteins adsorbing to the surface of tissue culture surfaces and cell
adhesion molecules. Furthermore, trypsin-treatment may also degrade adhesion
molecules on the cell surface that are later to be analysed in SCFS experiments. To test
whether a2b1-integrin cell surface representation was affected by trypsin treatment,
CHO-A2 cells were treated for 0 or 10 min with trypsin-EDTA. An extended incubation
period was chosen to enhance the eventual degradation effect although prior to SCFS,
cells were treated for only 3 min with trypsin. After trypsin-EDTA treatment, total a2b1-
integrin concentrations and biotinylated cell surface proteins were compared by western
blotting (appendix B13). Western blot analysis did not indicate any effect of typsin
treatment, since comparable protein levels (both total and cell surface associated) were
found for trypsin-treated and non-trypsin-treated cells. Furthermore, no integrin
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fragments of lower molecular weight were detected. Moreover, when cell adhesion was
quantified by SCFS immediately after trypsin treatment or after a recovery time of 1 h, no
differences in adhesion were detected (not shown). Thus, it was concluded that trypsin
treatment preceeding SCFS did not affect a2b1-integrin levels.
Fig. 30. Effect of trypsin
treatment on a2- and b1-
integrins. CHO-A2 cells were
incubated with trypsin-EDTA
for 10 min. Lysates of equal
protein concentrations were
loaded on 7.5 % SDS-PAA gels
and a2- and b1-integrins were
detected in western blots. Cell
surface proteins  were
separated using the EZ-link
Sulfo-NHS Biotinylation kit
from Pierce.
a2b1-integrin mediated cell attachment and spreading on Col matrices
To compare their spreading morphology, Saos-WT and -A2 cells were seeded on
Col. Both cell types could attach and spread on Col, but showed different morphologies
after spreading. Whereas Saos-A2 cells were found to spread uni-axially, Saos-WT cells
spread multi-axially (Fig. 31 A, B). Apparently a2b1-integrins were responsible for the
uni-axial spreading of cells. Previous work of the group showed that a2b1-integrin
expressing cells, including Saos-A2 cells, aligned in the fibril direction307. It was further
demonstrated that cell alignment depended on the ability of cells to exert traction forces
onto the collagen fibrils308. This was in accordance with studies showing that cells require
a2b1 to exert high traction forces
290. The finding that Saos-WT cells could also attach and
spread on Col, suggested that other integrins than a2b1 were involved. Previous studies
have identified a1b1-, a10b1- and a11b1-integrins in Saos-WT cells
292. Whereas addition
of 4 mM EDTA caused rounding of spread cells, addition of 4 mM EGTA had no effect
(not shown). EDTA has similar binding affinities for Mg2+ and Ca2+ ions, whereas EGTA
preferentially sequesters Ca2+ ions. Thus, spreading of both Saos-WT and -A2 cells was
dependent on Mg2+ ions in the medium (Fig. 31 C). This is in line with previous studies
showing that Mg2+ ions are required for collagen binding of integrins309,275.
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Fig. 31. Spreading of Saos-WT and –A2 cells on Col matrices. Saos-WT (A) and Saos-
A2 cells in the absence (B) or presence (C) of 4 mM EDTA. Phase contrast images were
taken 1 h after cell seeding.
CHO-WT and -A2 cells seeded onto Col matrices displayed clear differences in
attachment and spreading. CHO-A2 cells attached rapidly to Col and spread within
30 min (Fig. 32 B). In contrast, CHO-WT cells did not spread and remained rounded
even after prolonged contact (>3 h) with Col (Fig. 32 A). This further indicated that
CHO-WT cells lacked endogenous collagen receptors. Fluorescence staining for the a2-
subunit in fully spread CHO-A2 cells showed that a2-integrin co-localize with classical,
elongated focal adhesion contacts (not shown). In absence of Mg2+ ions, CHO-A2 cells
failed to spread on Col (Fig. 32 C), whereas Ca2+-ion removal had no influence (not
shown), similar as observed for Saos-A2 cells. The binding of collagen binding integrins
is Mg2+-dependent. In contrast, other collagen receptors, such as discoidin domain
receptors 1 and 2 (DDR-1 or –2) that bind in a Ca2+-dependent manner. Consequently, it
was concluded that attachment and spreading of CHO-A2 cells on Col was dominated by
a2b1-integrins.
Fig. 32. Spreading of CHO-WT and –A2 cells on Col matrices. CHO-WT (A) and CHO-
A2 cells in presence (B) or absence (C) of Mg2+. Phase contrast images were taken 1 h
after cell seeding.
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Adhesion forces of a2b1-integrin expressing cells measured by SCFS
Next, preliminary SCFS experiments were conducted with Saos-WT and -A2 cells
on Col. Individual Saos-WT and -A2 cells were attached to the AFM cantilever and
brought for 5 sec in contact with Col matrices. From F-D curves (examples given in
Fig. 33 A) cell detachment forces were quantified (2.3.3 and supplementary info B1.2).
Fig. 33. Quantifying adhesion of Saos-A2 and -WT cells to Col. (A) Representative F-D
curves (retrace) recorded for Saos-A2, -WT and -A2 in absence of of Mg2+ after 5 sec
contact on Col. (B) Distribution of detach-ment forces for Saos-A2 and -WT after 5 sec
contact. (C) Mean detachment forces (+/-SEM), recorded for 5 sec contact at different
blocking conditions
Significantly increased detachment forces were found for Saos-A2 compared to -
WT cells (means: 263 pN versus 147 pN) (Fig. 33 B, C). Detachment forces of Saos-A2
cells were reduced to WT-level in presence of blocking peptide l229, an effective
inhibitor of a2-integrin-collagen type I interactions (mean: 155 pN). The sequence of the
l229 blocking peptide is deduced from jararhagin, a venom from a pit viper (Bothrops
jararaca)310.
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Addition of 4 mM EDTA significantly reduced adhesion of Saos-A2 (Fig. 33 C)
and -WT cells (not shown). Taken together, these results indicated that enhanced
adhesion Saos-A2 cells was due to a2b1-integrin binding. These results were consistent
with the different spreading behaviour of cells (above). SCFS revealed that Saos-WT
cells still could attach to Col matrices, thus, other collagen binding integrins such as a1b1,
a10b1 or a11b1 or other collagen receptors were involved in cell attachment.
SCFS with CHO cells
Next, SCFS was employed to quantitatively measure adhesion of CHO-WT and -
A2 cells to Col. F-D curves recorded with CHO-A2 cells (Fig. 34 A) exhibited multiple
discrete rupture events, whereas these were rare in CHO-WT F-D curves. In Mg2+-free
medium, adhesion of CHO-A2 cells was blocked (Fig. 34 A), but could be restored when
Mg2+ (0.8 mM) was added to the medium (not shown).
Fig. 34. Quantifying cell adhesion of CHO-WT and -A2 cells to Col. (A) Representative
F-D curves (retrace) for CHO-A2 and -WT and -A2 cells in absence of Mg2+ after 5 sec
contact. (B) Distribution of detachment forces for CHO-A2 and -WT after a contact time
of 5 sec. (C) Comparison of mean detachment forces (±SEM) for CHO-WT and -A2 cells
with and without Mg2+.
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A wide distribution of detachment forces was found for CHO-A2 cell after 5 sec
contact; detachment forces between ~10 and 580 pN were detected (Fig. 34 B). In
contrast, detachment forces of CHO-WT cells showed less deviations, detachment forces
ranged between ~10 and 140 pN. Detachment forces of CHO-A2 cells were significantly
higher, 3-fold increased mean detachment forces were found for CHO-A2 (155 pN)
compared to CHO-WT cells (49 pN) after 5 sec contact. In the absence of Mg2+ CHO-A2
detachment forces were significantly reduced, values were even lower than for CHO-WT
cells (Fig. 34 C).
Moreover, cell diameters (Fig. 35 A) of CHO-WT and -A2 cells were compared.
Larger cell diameter might increase the contact area that forms between cell and substrate
during the measurement and thereby the total number of established integrin-collagen
bonds. Similar cell diameters (mean: ~10 µm) were found for CHO-WT and -A2 cells.
Furthermore elastic properties of cells were compared by AFM and no differences were
found (see 2.3.4, not shown). Thus, it was concluded that increased adhesion of CHO-A2
was not due to different cell size or different mechanical properties of the cells. It was
rather assumed that adhesion of CHO-A2 cells to Col was predominantly mediated by a2-
integrins. This was also in agreement with recently performed SCFS experiments in
presence of a2-integrin blocking antibody which reduced adhesion to CHO-WT levels
(not shown)311. Residual adhesion detected for CHO-WT might be attributed to
unspecific interactions or indicate background binding of other non-integrin collagen
receptors. Apart from integrins, there are also other collagen binding cell surface
proteins, so called non-integrin collagen receptors, for instance DDR-1 and DDR-2312.
Other collagen receptors include GPVI, cd36, LAIR-1, annexin A5, cd44 and
syndecans273. However, most of these receptors may predominantly mediate collagen-
induced signalling in the cells rather than playing a significant role in mechanically
anchoring cells to collagen273, 312.
The broad distribution of detachment forces detected for CHO-A2 cells, might be
attributed to the varying a2b1-integrin expression levels within the analysed CHO-A2 cell
population. FACS analysis of CHO-A2 cells fluorescently stained for a2-integrin
revealed a single, log-normal distribution of intensity values (Fig. 35 C, D). This
suggested that all CHO-A2 cells exposed a2-integrins on their cell surfaces. In contrast,
the fluorescence signal of CHO-WT cells was comparable to CHO-A2 negative controls,
incubated with secondary antibodies only (Fig. 35 C).
Chapter 4 -68-
Comparing the SCFS results obtained for Saos and CHO cells, it could be
concluded that CHO-A2 cells present the better cellular system to specifically analyse
a2b1 mediated adhesion, since the background of other collagen binding-receptors was
minimal. Thus, all further experiments were conducted with CHO-A2 cells.
Fig. 35. Analysis of CHO cell diameters and a2-integrin expression (A) Cell diameter
distributions for CHO-A2 and -WT cells. (B) Comparing a2-integrin levels in CHO-A2,
CHO-WT and a431 cells. Cell lysates of equal protein concentrations were loaded on
7.5% SDS-polyacrylamide gels. a2- and b1-integrins were detected by western blotting.
(C)(D) Flow-cytometry of CHO-WT and -A2 cells incubated with antibodies raised
against the human a2- integrin subunit (grey). Negative controls (Black) were only
treated with FITC-conjugated secondary antibodies.
Overexpression of an exogenous protein might negatively affect normal cell
behaviour. Therefore a2-integrin protein concentrations of CHO-A2 were compared to
A431 cells that endogenously express a2-integrin
313. Since a2-integrin levels were similar
in CHO-A2 and A431 cells (Fig. 35 B), it was concluded that a2-integrin expression was
regulated to levels normally found in cells of epithelial origin.
In the next part, a2b1-integrin mediated adhesion was analysed in CHO-A2 cells
at the single molecule level.
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4.4 Results & Discussion
4.4.1 Investigating single a2b1-integrin mediated adhesion events
To investigate a2b1-collagen binding in CHO-A2 cells at the single-molecule
level, the SCFS setup was adjusted accordingly (see supplementary info B1.3). The
contact area between cells and Col was reduced by minimizing the force by which the
cell was brought in contact with the substrate (100-200 pN). Thereby the cell-collagen
contact zone was reduced to a minimum. Moreover, a short contact time (50-200msec)
was chosen to further reduce the number of interactions between cell and Col. Typically
two different types of rupture events can be observed in F-D curves, either rupture events
are preceded by a nonlinear force increase (“j”, Fig. 36 A) or by a force plateau, “t”. j
events were interpreted as force-induced unbinding of integrins that were anchored to the
cytoskeleton. In contrast, t events were interpreted as the extraction of membrane
nanotube (2.3.3, Fig. 20).
Fig. 36. Detecting single a2b1- integrin Col interactions. (A) F-D curve displaying one
single rupture event (f, rupture force; keff, effective spring constant). (B) The specificity of
the a2b1-mediated interaction was confirmed by analyzing the frequency with which
interactions occurred in experiments with CHO-A2 cells and controls (i.e. CHO-WT and
CHO-A2 cells without Mg2+).
Under the applied conditions approximately 7 % of all CHO-A2 F-D curves
displayed j events (Fig. 36 B). j were usually found at pulling distances between 0 and
500 nm. In most F-D curves displaying j, a single rupture event appeared (Fig. 36 A).
According to Poisson probability, at a binding frequency of 7 % the probability that a
single bond is unbound is 96% (appendix B1.3, Eq. S2). In absence of Mg2+ the binding
frequency of CHO-A2 cells was decreased to 0.8 % (Fig. 36 B). Moreover, under
identical contact conditions, the binding frequency of CHO-WT cells was only 0.1 %
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(Fig. 36 B). These controls show that j events in CHO-A2 F-D curves corresponded to
the unbinding of single a2b1-heterodimers from Col.
Next, dynamic force spectroscopy (DFS) was performed to determine bond-
specific parameters, such as the dissociation constant koff, bond lifetime (1/koff) and
potential barrier width xu (see 3.3, Fig. 24)
314. Therefore, single-molecule adhesion
measurements were performed at different pulling velocities (Fig. 37 A, B). Pulling
velocities between 0.9 to 22 µm/s were chosen, corresponding to effective loading rates
in the range of ~200 to 8000 pN/s (appendix B1.3). Rupture forces were mainly normally
distributed (normality test, p-value > 0.1) (Fig. 37 A).
Fig. 37. Analyzing a2b1-integrin-collagen interactions by dynamic forces spectroscopy.
(A) Distribution of rupture forces measured for different loading rates (n>50 adhesion
events). (B) Dependence of rupture forces (mean±SD) on loading rates (mean±SD).
Mean rupture forces were fitted by a line (r2=0.9) and from the obtained fit parameters
(slope, y-intercept), bond parameters koff and barrier width xu were calculated.
With increasing loading rates the mean rupture forces f* (here interpreted as
binding strength2) increased from 38 to 90 pN. Plotting fm versus the logarithm of the
respective loading rates revealed a linear relationship, as predicted by theory (see 3.3)314.
The constant slope of the binding strength increase suggested the existence of a single
energy barrier that was overcome during unbinding. In contrast, the existence of several
energy barriers would have been manifested in different regimes, in which the binding
                                                 
2 Since datasets were normally-distributed, there was no significant difference between
plotting median, mean or modal.
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strength increases at different slopes (e.g. as shown in Fig. 27, 3.3). Applying Eq. 11 to
fit the data points, a dissociation rate koff=1.3 ± 1.3 sec
-1, corresponding to a lifetime of
0.8 ± 0.7 sec, and a barrier width of 2.3 ± 0.3 Å were determined for the a2b1-integrin-
collagen type I bond.
SCFS measurements can only detect the unbinding of established integrin-
collagen bonds. The switchblade model proposes that integrins can either adopt an active,
high-affinity or an inactive, low-affinity conformation (see 1.2.3). Accordingly, a ligand
can be only bound in the high-affinity conformation of the integrin. Therefore, the probed
integrin-collagen bonds represent high-affinity binding. Alternatively it has been
suggested that ligand binding can also occur in an integrin low-affinity conformation
(deadbold-model, 1.2.3)315. However, this would imply that both low-affinity and high-
affinity binding might occur and be detected in parallel. The presented rupture force data
exhibit a single force distribution for all analysed loading rates. This suggests the
presence of only one (high-affinity) integrin conformation if it may be assumed that force
and temporal resolution of the measurements was sufficiently high to detect potential
low-affinity conformations.
Moreover, the existence of several high-affinity binding sites within collagen type
I was proposed based on solid-phase assays with isolated I-domains316. Based on the
obtained SCFS data it is hypothesized that there exists either only one single high-affinity
binding site for a2b1-integrin or several binding sites with integrin binding strength. In a
previous study similar affinities of a 2I-domains towards peptides containing
GLOGERGRO and GFOGERGVQ motifs were shown which were assigned as high-
affinity binding sites within collagen type I. Binding to both binding sites might result in
similar unbinding forces and may therefore not be distinguishable. In the same study
another collagen motif (GASGERGPO) was proposed to bind to a2I, albeit with much
lower affinity316. If such a third binding site exists, it is possible that this low-affinity
binding site could not be detected by the used experimental setup.
The measured binding strength values (fm=47 pN at 500 pN/sec) are in good
agreement with values measured for other integrin-ligand interactions at similar loading
rates with AFM. For instance, for a5b1-integrin-FN interactions a binding strength of
55 pN317, for a4b1-VCAM ~50 pN
318 and for aLb2-ICAM-1/-2 ~50 pN
319 were found.
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The calculated dissociation rate of 1.3 s-1 compares well with values previously
found in AFM-SCFS experiments for a4b1-VCAM-1 interactions (1.1 s
-1)320, whereas for
a5b1-integrin-FN interactions a smaller dissociation rate was found (0.13 s
-1)317. So far,
there has been only one study in which a2b1-integrin-collagen I interactions were
analysed performing flow chamber experiments. The authors report a dissociation rate of
0.06 s-1, being about half the value found in the presented AFM data299. One possible
explanation for the observed differences might be that the binding rates are influenced by
the cell type and species in which the respective integrins are analysed. The different
results obtained by AFM and flow chambers might be further attributed to the different
experimental setups used. Inconsistent results have been reported, for instance, when the
lifetime of E-cadherin interactions was analysed by different techniques (flow chambers,
BFP and AFM)321. Apart from systematic differences that emerge from different analysis
methods, the most relevant aspect might be the fact that lifetime is calculated from a
dataset recorded at relatively high loading rates. koff is then determined by extrapolating
force data detected at high loading rates (see 3.3). The range of loading rates at which
data are recorded usually varies among different techniques. Compared to BFP and flow
chambers AFM force spectroscopy is limited to relatively high loading rates321.
Consequently large errors are expected. Moreover, measurements performed at lower
loading rates, as in flow chamber experiments, might detect different energy barriers and
thereby different values of koff. Another difference between flow chamber and AFM
experiments consists in the direction in which bonds are stressed. It has been shown
before that the pulling direction can influence the binding strength322. This shows that the
obtained koff rates must always be discussed in the context of the applied experimental
conditions, the technique used and the way bonds are loaded.
Other SCFS experiments conducted with AFM have revealed further activation
energy barriers for different integrin-ligand interactions317, 319, 320, 323 In these studies
higher loading rates (> 10000 pN/sec) were applied than in this work although
comparable pulling speeds were used. This is explained by differences of the spring
constants keff of the system (membrane, bond, cell cortex, cantilever) (see 3.3). Since
cantilever spring constants were similar to the ones used in this work, the differences in
keff might be due to different elastic properties of the cell types used: CHO cells used in
this study might be softer compared to small lymphoid cells in previous studies. Since no
loading rates >10000 pN/sec could be applied, possible additional activation barriers may
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not have been detected. Alternatively, the existence of a single energy barrier might
reflect differences in the binding mechanism between different integrins and their
ligands.
Until now, only j events were discussed. In the F-D curves, occasionally t events
were detected (~5 %) which were discriminated from j by the slope preceeding the force
step (~0 pN/nm) and the larger distance (> 500 nm) from the surface at which such events
occurred. Comparing the magnitude of j and t, major differences were found. Firstly, the
forces detected for j at same pulling speeds were significantly higher than those for t
events.
Fig. 38. j- and t- events at different pulling velocities. Mean unbinding force±SD are
presented. On the left example F-D retraction curves are shown.
Moreover, compared with j events (5.90 pNsec/µm), the rupture forces increased
slowly with increasing pulling speed (0.83 pNsec/µm) (Fig. 38). During tether formation
the underlaying membrane is deformed, thus tether formation depends on the mechanical
characteristics of the probed membrane including surface tension and binding rigidity324-
328. The values for t events that were found in this work (27 pN) are in good agreement
with other force spectroscopy studies in which tethers that were pulled out from CHO
cells with comparable pulling speeds (28 pN).
The increase of tether forces with increasing pulling speed can be explained by
membrane viscosity and friction between membrane and cytoskeleton327. The relationship
between tether force increase and pulling speed permits the calculation of the effective
viscosity (supplementary info B1.3, Eq. S2). From the determined slope of
0.83 pNsec/µm, an effective viscosity of 0.13 pNsec/µm was calculated. This value was
smaller compared to a recently reported effective viscosity of 0.33 pNsec/µm determined
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for tethers pulled by AFM on CHO cells, but very similar to values measured for
neutrophil tethers (0.14 pN pNsec/µm)329.
If tether formation is due to a bond established between a specific receptor and
substrate, membrane tethers can also be used to directly calculate bond lifetime330.
However, in the presented data, no clear differences in the frequency of tether formation
between CHO-WT and CHO-A2 cells were seen. Thus, it might be concluded, that most
of the formed tethers are contributed to unspecific adhesion events. Indeed, also previous
studies performed with living cells concluded that it is not easy and maybe even
impossible to distinguish between membrane nanotubes that have formed through
specific and unspecific interactions331, 332.
The results described above show the unbinding of single a2b1-integrin-collagen
type I bonds. When a cell is in longer contact with a substrate, the number of interactions
is expected to increase with time. In a next step, the time-dependent increase of a2b1-
integrin mediated adhesion of CHO-A2 cells to collagen I was therefore investigated.
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4.4.2 Dependence of a2b1-mediated adhesion on contact time
Investigating overall cell adhesion
For that purpose, CHO-WT and -A2 cell detachment forces were quantified after
contact times between 5 and 600 sec. For all time points detachment forces of CHO-A2
cells were higher compared to CHO-WT cells. This indicated that adhesion of CHO-A2
cells was dominated by a2b1-integrins. During prolonged contact with Col, cells usually
maintained their rounded shape on the cantilever. Hence the contact area established
between cell and Col did not vary significantly (Fig. 39).
Fig. 39. Monitoring cell shape during contact. (A) Phase contrast images of a CHO-A2
cell on the AFM cantilever during contact with Col. (B) The area of the cell-Col contact
zone was measured from the images (A).
Between 0 and 10 sec detachment forces of CHO-WT and -A2 cells continuously
increased with time, while no further increase was detected between 10 and 30 sec. The
progression of detachment forces in the first 30 sec was well described by an exponential
curve (formula given in Fig. 40). Thus, it could be concluded that in the initial attachment
period (here 0- 10 sec) an increasing number of a2b1-integrin collagen bond had formed,
similar as predicted by Eq. 5 (see 3.1).
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Fig. 40. Detachment forces of CHO-A2 and -WT cells for 0 - 30 sec contact. Data are
presented as mean±SEM. Data were fitted by an exponential fit function (given in figure).
Recording cell detachment forces over a time course of ten minutes revealed a
non-linear build-up of adhesion force. Whereas initially mean CHO-A2 detachment
forces grew slowly, they rose quickly after ~60 sec, and reached ~ 5 nN after 180 sec
(closed circles, Fig. 41 A). Between 180 and 300 sec, detachment forces did not change
significantly. A further increase of detachment forces occurred between 300  and 600 sec.
Fig. 41. Dependence of detachment forces on contact time. (A) CHO-A2 cell
detachment forces for 5 and 600 sec contact. Open circles represent detachment forces of
individual cells, closed circles corresponding mean detachment forces of all cells tested.
(B) Detachment forces for contact times of 30 sec, 120 sec and 300 sec. Note that a half-
logarithmic presentation was chosen. The dashed line represents the cut-off force of 2nN
chosen to separate low- and high-adhesion cells.
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Since a single-cell technique was used, detachment forces of individual cells
could be determined (open circles, Fig. 41 A). Beginning after 60 sec of contact time, cell
detachment forces showed considerable variation (~0.5 N to 20 nN).
Monitoring adhesion of individual cells with increasing contact time revealed a
sudden adhesion reinforcement at contact times > 60 sec (Fig. 42). For the given example
detachment forces initially increased slowly and approached a saturation value. After
3 min of contact the detachment force suddenly rose approximately tenfold (120 sec
~500 pN. 180 sec ~5500 pN). The sudden increase of adhesion suggested that individual
cells switched to an elevated adhesive state.
Fig. 42. Example F-D curves displaying increasing detachment forces for prolonged
contact. F-D curve recorded for an individual CHO-A2 cell after a contact time of 5 sec
(A) and 180 sec (B). (C) Measured detachment forces for contact times between 5 and
180 sec.
This rapid transition of a low-adhesion to a high-adhesion state occurred for
different cells at different time points, normally between 60 and 600sec. Two different
cell populations were distinguished based on the detected detachment forces (Fig. 41 B,
dashed line). Whereas for contact times between 5 and 30 sec detachment forces
displayed a uniform distribution and were always below 2 nN (Fig. 41 B), with increasing
contact times higher values accumulated although low detachment forces were still
present. The fraction of cells exhibiting low detachment forces (0-2 nN) were assigned to
a “low-adhesion” group, the group that reinforced adhesion (>2 nN) to a “high-adhesion”
group (Fig.  41 B, Fig. 43).
Low-adhesion cells were present over the entire time course. They increased their
adhesion during the first 60 sec and subsequently reached a plateau of ~400 sec
(Fig. 43 A, inset). In contrast, detachment forces of high-adhesion cells continuously
increased between 60 and 600 sec. This highly-adhesive state was exclusively dependent
Chapter 4 -78-
on a2-integrins, since detachment forces of CHO-WT cells never exceeded 700 pN
during the first 600 sec of contact (not shown).
Fig. 43. Separating high- and low- adhesion cells. (A) Detachment forces (mean±SD) of
high-adhesion cells (detachment forces > 2 nN) and low-adhesion cells (detachment
forces < 2 nN) for different contact times. The dashed line indicates the cut-off
detachment force of 2 nN. (B) Time-dependent increase in percentage of high-adhesion
cells.
Notably detachment forces detected at short contact (5sec) for low- and high-
adhesion cells were similar (not shown). Thus, adhesion reinforcement was not due to
increased a2-expression levels. The ratio of high-adhesion cells increased over time
(Fig. 43 B). This indicated that differences in adhesion between both groups could not be
explained by the presence of two cell subpopulations with intrinsically distinct adhesive
properties. Instead, with increasing contact time cells appeared to switch progressively
from a low to a high adhesion state.
What caused the sudden reinforcement of adhesion? It is well established that
integrins are clustered in adhesive sites and binding avidity is increased due to
cooperative binding333. Integrin clustering might be reflected by the magnitude of single
rupture events in the F-D curves. These were analysed in the next part.
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Analyzing single rupture events in F-D curves
For contact times > 5 sec, CHO-A2 F-D curves usually contained multiple single
rupture events (j). These single rupture events represented the smallest detectable force
units. They were attributed in previous studies to the unbinding of single or few ligand-
receptor bonds319, 323. Single rupture events in F-D curves recorded for contact times
between 5 and 30 sec showed similar forces (46 ± 16 pN) (mean ± SD) as detected in
single-molecule measurements (47 ± 13 pN) at a comparable loading rate (~500 sec/sec)
(4.3.2, Fig. 44 A). 100 % of rupture events detected in single molecule experiments
(Fig 44 A) were found within a force interval of 0 to 73 pN. Similarly, most single
rupture events (90 %) in F-D curves after 5-30 sec of contact lay in this range (Table 3).
Also, for low-adhesion cells at increased contact times (120 - 300 sec), the majority of
rupture events (75 %) were smaller than 73 pN. In contrast, only 26 % of single rupture
events in F-D curves of high-adhesion cells were within the single-integrin unbinding
force interval. Magnitudes of single rupture events were significantly increased for high-
adhesion cells (159 ± 132 pN)(mean ± SD) (Fig. 44 C). Forces showed a wide
distribution and reached values as high as 700 pN, corresponding to a 15-fold force
increase above the calculated single-integrin binding strength. Thus, the increase in
detachment forces (overall adhesion) of high-adhesion cells coincided with the rise of the
single rupture events above the single-integrin level.
Overall adhesive strength (“avidity”) of an adhesion complex results from both
the total number of receptor-ligand bonds in that complex and the strength (“affinity”) of
each of these bonds334. Receptor clustering may contribute to increased binding avidity
because several bonds share the applied force333. In contrast, when receptors are
uncoupled from each other, receptors experiencing the highest load will become unbound
first and the remaining bonds will then rupture in a sequential, zipper-like manner
requiring relatively low forces335. Furthermore, rebinding events within integrin clusters
might account for a force increase of single rupture events.
In addition to cooperative binding, an affinity increase of a 2b1-integrin for
collagen type I could lead to increased rupture forces (see 1.2.3). However, previous
quantitative studies analyzing single integrin-FN rupture forces in the presence of
activating antibodies detected only a 0.3-fold force increase (from 60 to 80 pN317). Since
in the presented data a more than 10-fold enhance force was found for j (reaching values
of several hundred pN), it might be assumed that changes in the affinity of a2b1 for
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collagen are unlikely to account for the strong force increase of single rupture events.
Instead, the increase of single rupture events suggested that functional adhesive units
containing varying numbers of a2b1-integrins had formed and that cooperative binding of
these receptors within small integrin clusters was involved in the time-dependent
reinforcement of cell adhesion.
Fig. 44. Single rupture events for high- and low-adhesion. Single rupture events (“j”)
measured in single molecule experiments (SMM)(A), in low- and (B) high-adhesion F-D
curves (C). The cut-off force of 73 pN (dashed line) limits the force range encompassing
100 % of the single rupture events (A). On the right example F-D curves are shown.
Adhesion reinforcement occurred as early between 30 and 60 sec of cell-Col
contact. Focal complex formation in cell culture can be observed by fluorescence
microscopy 5 - 10 min after replating cells onto an adhesive surface. By actively bringing
the cell into contact with the collagen surface during the SCFS experiments, the
establishment of specific adhesion might have been accelerated. Furthermore, small
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integrin clusters that cannot be resolved by conventional fluorescence microscopy might
form much earlier than they can be observed optically.
During the rupture of integrin clusters several integrin receptors have to become
unbound simultaneously. Understanding the contribution of individual bonds to the
rupture force curve during multiple bond rupture is non-trivial. For parallel bond loading,
the individual rupture forces have been proposed to be both linearly336, 337 or non-linearly
additive338. In force spectroscopy studies on purified receptor/ligand pairs, quantized
peaks, corresponding to multiples of the single molecule unbinding forces, were
reported336. However, the force distribution of the smallest rupture events in high-
adhesion cells contained no clear local maxima corresponding to multiples of the single-
integrin rupture force of 47 pN. Individual integrin clusters may differ in their linkage to
the actin cytoskeleton, resulting in different elastic properties, force loading and
ultimately in slightly different rupture forces of the adhesive bridges. Furthermore, due to
the geometry of the contact area not all integrin-collagen bonds were probably loaded
simultaneously. This might further blur the distribution of single rupture events at
increased contact times (see 3.3). Because of the complexity of cooperative integrin-
binding in a living cell, the exact number of integrin receptors per cluster could not be
measured, but it was roughly estimated that small integrin contacts comprise less than 20
integrin receptors.
Previous studies have reported that myosin II-driven contractility is involved in
integrin cluster formation339. Thus in the next section the influence of drugs interfering
with acto-myosin contractility on the establishment of cooperative integrin binding was
tested.
4.4.3 Role of actomyosin contractility for cooperative integrin binding
The effect of two different inhibitors blocking actomyosin contractility on integrin
mediated cell adhesion was tested by SCFS. Addition of the myosin inhibitor butandione-
2-monoxime (BDM, 20 mM) lead to a reduction of the mean detachment force by more
than 50 % at 120 sec contact time and more than 90 % at 300 sec (Fig. 45 A). For the
same contact times, the ROCK inhibitor Y-27632 also significantly decreased
detachment forces (120 sec: by 63 % and 300 sec: by 91 %). The detachment force
decrease in BDM or ROCK inhibitor-treated cells was mirrored by a reduction in the
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percentage of high-adhesion cells from ~40 % to less than 10 % (Fig. 45 B).
Concomitantly 100% of single rupture events in F-D curves of BDM-treated cells (120-
300 sec) ranged in the single-integrin rupture force interval (0-73 pN) in contrast to
untreated cells (26%) (Table 3). Similarly, in Y27632-treated cells, about 50 % of single
rupture events were <73 pN. These findings indicate that actomyosin contractility is
required for establishment of cooperative integrin binding. The Y27632 inhibitor
suppressed the establishment of cooperative integrin adhesion less efficiently than BDM.
This might be attributed to a more downstream position of the BDM target myosin II in
the RhoA-dependent signalling cascade that controls actomyosin contractility
Fig. 45. Influence of inhibitors of
actomyosin contractility on cell
adhesion.  (A) CHO-A2 cell
detachment forces (mean+/-SD) in the
presence and absence of the ROCK
inhibitor Y27632 (10 µM) or the
MLCK inhibitor BDM (20 mM). (B)
Percentage of high-adhesion cells in
the presence and absence of Y27632
and BDM.
The finding that adhesion reinforcement could be prevented by inhibiting
actomyosin contractility was in agreement with studies demonstrating the requirement of
myosin II-driven contractility to establish and maintain functional focal complexes339.
Thus, formation of early focal complexes may be myosin II-driven. How may myosin II-
activity induce integrin clustering? While unbound integrins are freely diffusive in the
membrane plane340, 341, ligand binding promotes rapid attachment of integrins to actin
filaments342. It has been suggested in the earlier section that j events detected at contact
times of less than a second presented unbinding of cytoskeleton linked integrin in
contrast to t events. Myosin II is an effective F-actin crosslinker343, 344 and myosin-driven
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bundling and alignment of actin filaments carrying ligand-bound integrin complexes may
then lead to the clustering of integrin-cytoskeletal complexes345, 346. Furthermore, it has
been suggested that myosin-dependent forces exerted on adhesive sites induce
conformational changes in associated mechanosensitive proteins. Recently p130Cas has
been shown to have a function as mechanosensor involved in transmitting force-
dependent signals347. Protein-Protein interactions facilitated by conformational changes
of such mechanosensory proteins might then promote the growth of focal complexes.
Table 3. Percentage of single rupture events (“j”) <73 pN detected for different
experimental conditions (inhibitors, contact times). The force interval [0,73 pN]
encompassed 100 % of the single-integrin rupture events detected at comparable loading
rates during single molecule measurements.
4.4.4 Visualizing paxillin redistribution during SCFS
In the presented work an AFM was used that can be combined with different
optical microscopy techniques, for instance conventional fluorescence microscopy,
confocal microscopy and total internal reflection microscopy (TIRF). This allows the
simultaneous observation of the cell on the cantilever during contact and detachment. By
using fluorescently labeled integrins or integrin associated proteins, such as paxillin, it
should be possible to follow the formation of focal complexes.
Next, SCFS was conducted with YFP-paxillin expressing CHO-A2 cells. The
AFM was mounted on top of a confocal microscope. By adjusting the pinhole settings,
the fluorescence signal within an optical slice of <800 nm, including the contact zone
between cell and Col, could be visualized during the SCFS experiment. Fig. 46 shows
frames of a time-lapse movie recorded during cell contact (15 sec, 60 sec, 300 sec,
600 sec). Diffusive paxillin in the cytoplasm permits visualization of the contact area. In
agreement with the previously shown phase contrast images (Fig. 46), the frames indicate
that the cell did not spread during contact. Dark areas correspond to the cellular
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organelles and the nucleus in close proximity to the basal membrane. Interestingly, by the
end of the contact period (at 600 sec), bright spots of high paxillin density appear.
Whereas non-integrin-associated paxillin is distributed diffusely in the cytoplasma, it is
rapidly recruited to nascent focal complexes.
Fig. 46. Confocal microscopy images of the contact zone of a YFP-paxillin expressing
CHO-A2 cells and Col during SCFS. The cell was kept in contact with Col for 600 sec.
Frames of a itmelapse movie recorded over 610 sec are shown. Below outlines of the
contact area, determined by image J, are shown. The contact area was normalized to the
area determined in the first frame (15 sec).
Thus, the observed dots might indicate the formation of small focal complexes.
However, so far only preliminary results were obtained. Due to the limited temporal
resolution of confocal microscopy further experiments should be performed with total
internal reflection microscopy (TIRF), a technique that has recently been established in
the lab. An increased temporal resolution might enable investigation of the dynamics of
formed clusters and might even provide the possibility to correlate single rupture events
during cell detachment with optically visualized clusters. Furthermore, such experiments
should be performed with a larger number of CHO-A2 and also CHO-WT cells as a
control. Correlation of cluster appearance and high-adhesion cells may provide further
visual evidence that the switch to high-adhesion is due to the formation of integrin
clusters.
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4.5 Conclusions
In the presented work a2b1-integrin mediated cell adhesion to collagen type I was
quantified within the first 600 sec of contact. Besides characterizing interactions
mediated by single integrins, the time-dependent increase in adhesion forces could be
precisely monitored.
The generally accepted model describing the time-dependent increase of adhesion
strength proposes a two-step process consisting of initial integrin-ligand binding,
followed by strengthening of the initial link348-350. Adhesion strengthening has been
attributed to 1. increase in cell substrate contact area (spreading), 2. receptor recruitment
to adhesion sites (clustering) and 3. interactions with cytoskeletal elements342 350. This
model has been mainly formulated based on optical microscopy. So far this process has
not been investigated with a single-cell technique that allows the detection of single
molecule binding events.
The SCFS setup used in this project allowed a detailed description of the time-
dependent increase in adhesion. Thereby not only overall adhesion was quantified, but
also the contribution of single molecules was investigated. Different regimes of a2b1-
integrin mediated adhesion formation could be distinguished: At contact times <0.5 sec
adhesion was mediated by a single integrin collagen bonds. Under such conditions bond
specific parameters of a2b1-integrin-collagen type I bonds could be determined.
Advantageously F-D curves do not only provide information about the integrin-collagen
unbinding forces, but also about the mechanical properties of the integrin-cytoskeleton
link. The non-linear force increase prior single molecule unbinding suggested that single
integrins that mediated initial adhesion were anchored to the cytoskeleton351. With
increasing contact times adhesion reinforced. The initial increase in overall cell adhesion
(0-10sec) could be attributed to an enhanced number of integrin-collagen bonds formed
in the contact zone. Apparently, multiple single-integrin interactions enhanced overall
adhesion, since number, but not magnitude of single rupture events was increased.
Starting at 60 sec contact time cells rapidly reinforced overall adhesion. Concomitantly
increased single rupture events were detected that exceeded the level of single-integrin
interactions, suggesting the establishment of cooperative integrin binding. These findings
are summarized in Fig. 47. Conducting SCFS in the presence of drugs interfering with
actomyosin contractility further revealed the involvement of actomyosin contractility in
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establishment of cooperative integrin binding. This might indicate a role of myosin II in
crosslinking cytoskeleton-associated integrins343, 344. Taken together, the kinetics of
integrin-mediated adhesion could be precisely described, and insights into the
mechanisms required for cooperative integrin binding were obtained. Currently, there are
no other techniques that allow such insights in adhesion kinetics. This is owed to the high
force resolution and precise control of the contact zone and contact time in AFM SCFS
experiments.
Fig.47. Overview about the sequential build-up of a2b1-integrin-collagen type I bonds.
Initially adhesion is dominated by single molecule recognition events. Within the second-
range, multiple integrin-interactions occur. At contact times >1 min cooperative integrin
binding can be observed concomitant with reinforcement of overall cell adhesion.
It has been suggested that integrins cover the largest range of binding forces
compared to other adhesion molecules, for instance selectins and cadherins351. Indeed,
requirements on integrin binding in tissues are quite diverse. High bond dissociation rates
are suggested to permit the fast remodelling of integrin-matrix interactions which is
indispensable for cell migration346. In other situations, cell-ECM links have to be
reinforced quickly to balance raising external forces351.
It might be expected that varying off-rates between different types of adhesion
molecules reflect different requirements of the specific integrin-ligand pairs.
Surprisingly, similar binding strengths (~50 pN) (at same loading rates) are found  for
different types of adhesion molecules, for instance different types of cadherins 352 and
other integrins (e.g. a5b1, a4b1, aLb2, see above). This suggests that the large force range
covered by integrin binding is explained by the manifold regulatory mechanisms that
control integrin binding, e.g. integrin affinity regulation (number of functionally active
integrins) and cooperative integrin binding. In the presented project adhesion
reinforcement was predominantly caused by cooperative integrin binding. Thus it may be
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hypothesized that cooperative integrin binding plays a dominant role in regulating
integrin mediated adhesion, whereas affinity regulation might be more important in cell
types in which integrins are not constitutively active, for instance in platelets or
leukocytes.
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Chapter 5
Effects of cryptic integrin binding site exposure in collagen
type I on osteoblast adhesion and matrix mineralisation
5.1 Abstract
Collagen type I contains cryptic binding sites for integrins that can be exposed
upon thermal denaturation. Aim of this project was it to quantitatively study the effect of
these binding sites on pre-osteoblast adhesion and subsequent differention. Pre-osteoblast
adhesion to native (Col) and partially-denatured (pdCol) collagen I was compared by
SCFS. During early stages of cell-attachment (0-180 secs) cells showed significantly
enhanced adhesion to pdCol. Adhesion to pdCol was reduced by soluble RGD (Arg-Gly-
Asp)-peptide indicating the exposure of RGD-motifs in pdCol. Accordingly, experiments
performed in presence of integrin blocking antibodies revealed that a5b1- and a v-
integrins mediated cell adhesion to pdCol, but no to Col. Pre-osteoblasts seeded on pdCol
increased their focal adhesion kinase tyrosine-phosphorylation level compared to Col.
Concomitantly enhanced spreading and motility were observed on pdCol. Cells cultured
over six weeks on Col and pdCol showed no differences in proliferation. However, pdCol
matrix mineralisation was more pronounced at all analysed time points. The presented
data suggest that partially-denaturing collagen I exposes RGD-motifs that trigger
differential integrin binding and signalling and thereby stimulate osteoblastic cell
differentiation. The finding of this project might open new perspectives for the
development of optimized tissue culture substrate.
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5.2 Introduction
RGD-motifs are common integrin recognition sites within several ECM proteins
for instance osteopontin, FN or vitronectin353-355. Also collagens contain several RGD-
motifs. In collagen type I, for instance, the a1 and a2 polypeptide chains forming the
collagen type I triple-helices, exhibit two and four RGD-motifs, respectively356. In the
native collagen conformation these cryptic RGD-motifs are structurally not acessible to
integrin binding. Therefore, cells adhere to native collagens through RGD-independent
integrin interactions357-360 (see 4.2). This rises the question if there is a particular role of
such cryptic RGD-motifs in collagen type I and if there are situation in which these
become exposed.
Fourier transform infrared micro-spectorscopy (FTIRS) studies demonstrated that
thermal and proteolytic denaturation of collagen I leads to unwinding of the rigid triple-
helical structure361-363. Since RGD-dependent cell attachment of cells to thermally
denatured collagen I was observed in several studies358, 364, 365, it was proposed that
denaturation coming along with unwinding of the triple-helix exposes the hidden RGD-
motifs361, 364, 366 (Fig. 48).
Fig. 48. Sketch illustrating the effect of thermal denaturation on collagen type I
structure. Thermal denaturation leads to partial unwinding of the collagen triple-helices
and exposure of cryptic RGD motifs. Grey bars outline intermolecular interactions
stabilizing collagen fibril structure.
There are at least seven different integrin heterodimers that bind their ligands in a
RGD-dependent manner367. However, so far, there is controversy about the integrin
heterodimers that recognize denatured collagen type I; whereas some authors identified
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integrin aVb3 as major integrin heterodimer
364, others reported that predominantly
integrins avb1 and a5b1 mediated cell adhesion to denatured collagen type I
358. The
contradictory results might be contributed to the different integrin expression patterns and
levels of the studied cell types. Furthermore, the protocols used to produce gelatin, i.e.
duration of heat treatment and denaturation temperature, varied among different studies.
This might significantly influence the structure of denatured collagen: harsh thermal
denaturation (90 °C), for instance, has been shown to cause melting of triple-helical
strands363. Another reason for the inconsistent results might be that exclusively non-
quantitative adhesion assays were applied. In the presented work AFM-based SCFS as a
quantitative and sensitive approach has been applied.
How relevant is denatured collagen for cells in vivo? Collagen matrix degradation
occurs in many normal and pathological situations. For instance, the ECM in developing
tissues, but also in adult animals is subjected to a continuous remodeling process which is
essential to ensure tissue morphogenesis and homeostasis368-372. Collagen remodelling
occurs as a consequence of controlled biodegradation and de novo synthesis and achieves
a state of equilibrium between native and denatured collagen373. In certain pathological
situations this balance is disturbed, and massive collagen degradation occur, for instance
in osteoarthritis or in skeletal metastasis373. It has been postulated that exposure of so-
called matricryptic sites in ECM proteins represents a general mechanism by which
specific signals are conferred to cells364, 366. RGD motifs were proposed to be common
matricryptic sites, amongst others (e.g. laminins) also in collagen. Exposure of RGD-
motifs might be of physiological relevance in situations in which tissue collagen is
structurally altered, for instance during normal tissue remodeling to achieve homeostasis
or after tissue injury. The produced signals might regulate cellular behaviour within the
injury site and thereby assist tissue repair366.
Whereas collagen type I fibrils have been largely applied for coating and
patterning of non-biological surfaces to enhance biocompatibility374-376(see 1.1.1), so far
the use of denatured collagen has not been exploited. Respective studies have been
performed by Kaplan’s group377, 378. It was found that mesenchymal stem cells exhibited
enhanced osteogenic differentiation capacity during in vitro expansion on denatured
collagen compared to native collagen377, 379. Based on these findings it was suggested that
RGD-dependent integrin interactions with denatured collagen can produce cellular
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signals retaining cellular functions that are normally lost upon extensive cell passage.
This might be an interesting aspect for the development of optimised substrates for the ex
vivo expansion of stem cells in regenerative medicine.
In the presented work pre-osteoblast cell adhesion to native and denatured
collagen I was quantitatively compared. Further the contribution of specific adhesion
receptors in mediating adhesion has been studied. To test the effect of collagen type I
matricryptic sites, moreover cell proliferation and differentiation were compared among
native and denatured collagen type I matrices in six weeks´ cultures.
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5.3 Results & discussion
5.3.1 Characterization of Col and pdCol matrices
AFM imaging of native and thermally denatured collagen type I matrices
In the presented project collagen type I matrices (Col) described in chapter 4 were
used as adhesive substrates380. In a first step the topography of Col before and after
thermal denaturation (1 h, 50 °C, appendix B2) was compared by AFM (appendix B3).
AFM topographs revealed that the fibrillar assembly typically observed for Col
(Fig. 49 A) was maintained after heating. Matrices were thereupon referred to as
partially-denatured collagen type I matrices (pdCol). Topographs recorded at higher
resolution (Fig. 49 A, B; insets) confirmed that both, Col and pdCol fibrils, displayed the
67 nm D-band inherent to collagen type I fibrils assembled in vivo381. Since no major
structural differences between Col and pdCol matrices were observed, it was concluded
that thermal denaturation did not affect the macromolecular collagen type I assembly.
Fig. 49. Characterization of two-dimensional collagen type I matrices. AFM topographs
of Col (A) and pdCol (B). Insets show Col/pdCol at higher resolution. Topographs were
recorded in buffer solution and exhibit vertical scales of 6nm.
Immunofluorescence staining of Col and pdCol
To analyse thermally denatured Col matrices at the molecular level, the binding
affinity of a monoclonal collagen I antibody (mAB) to Col and pdCol was compared by
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immunofluorescence microscopy (appendix B5). mAB-stained Col showed a strong
immunofluorescence compared to pdCol exhibiting no staining (Fig. 50 A, B). The high
binding affinity of this particular mAB had been reported to depend on the triple-helical
structure of native collagen382. This affinity was lost in case of pdCol suggesting an
altered structural integrity of thermally treated collagen fibrils. Labelling Col and pdCol
with a polyclonal collagen antibody (pAB) resulted in uniform immunofluorescent
staining in both cases (Fig. 50 A), confirming- in addition to AFM topographs- that both
matrices homogenously covered the mica.
Fig. 50. Characterisation of Col and pdCol by immunofluorescence microscopy. (A)
Confocal microscopy of immuno-labelled Col/pdCol. Matrices were stained with
monoclonal antibodies (mAB, green) and polyclonal antibodies against collagen type I
(pAB, red). FITC-conjugated beads (arrows) were added as reference. (B) Mean
fluorescence intensities ± standard deviations (SD) measured for mAB-stained
Col/pdCol. Brackets give numbers of analysed images.
Comparison of the mechanical properties of Col and pdCol
Subsequently the mechanical properties of Col and pdCol were compared by
AFM (appendix B4). 2x2 µm2 sized sections of Col and pdCol were scanned applying
increasing forces to the AFM tip (Fig. 51A, B). The manipulated areas were re-imaged at
minimal forces (ª50 pN) to evaluate the structural changes. Forces of 4.3 nN structurally
altered Col matrices, whereas on pdCol major structural changes begun at 2.7 nN
(Fig. 51D). Structural rearrangements observed on Col were less severe; Col fibrils
stayed mainly intact, but were occasionally shifted by the AFM tip. In contrast, pdCol
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fibrils were frequently disjointed exposing the underlying mica (Fig. 51 A, B; arrows).
This experiment demonstrated that Col matrices were mechanically more resistant. This
might be explained by the structural changes that occurred within Col during thermal
denaturation. Unwinding of the rigid triple-helical structure might have reduced or
weakened intermolecular interactions that stabilized Col fibrils (see Fig. 48).
Fig. 51. Characterizing mechanical properties of Col and pdCol. (A, B) AFM
topographs of Col/pdCol matrices that had been scanned under increasing forces (see
C). (D) Mean forces (±SD) at which the scanning AFM tip initially induced structural
deformations (Fdamage). In brackets numbers of analysed samples are given.
5.3.2 Analyzing cellular interactions with Col and pdCol
Analyzing cell spreading and migration on Col and pdCol
Next spreading and migration of pre-osteoblastic MC3T3-E1 cells seeded on Col
and pdCol were investigated (Fig. 52 A, appendix B7 and video 3). Time-lapse movies
showed that cells spread and elongated along collagen fibrils on both types of matrices,
similarly as described for Col in earlier work of the Müller group383. There were no gross
differences in spreading morphology on both matrices. However, cells spread
significantly faster on pdCol than on Col (Fig. 52 A, B). On pdCol 50 % of cells had
spread after ~14 min, on Col only after ~26 min. This suggests that cells established more
adhesive interactions to pdCol.
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Fluorescence images revealed considerable reorganisation of Col and pdCol
fibrils. Concomitantly with enhanced spreading on pdCol, remodeling of pdCol matrices
started earlier on pdCol (Fig. 52 C). Increased matrix remodeling might be attributed to
enhanced adhesive interactions of MC3T3-E1 cells with pdCol or to the decreased
mechanical stability of pdCol. Col has been demonstrated in above experiments to be
mechanically more resistant to lateral scratching forces than pdCol. Thus, Col fibrils
might have shown more resistance to cellular traction forces compared to pdCol.
Fig. 52. Cellular behaviour on Col/pdCol matrices. (A) Frames taken from time-lapse
movies of MC3T3-E1 cells on Col/pdCol. Images correspond to time points of 12, 30 and
60 min after cell seeding. (B) Cell spreading (mean±SD) within the first 60 min after
seeding. Sigmoidal curves revealed the time after which 50 % cells have spread. In
brackets numbers of analysed cells are given. (C) Deformation of Col/pdCol matrices by
MC3T3-E1 cells (collagen-green, actin-red, nuclei-blue). (D) Migration speed of
individual MC3T3-E1 cells seeded on Col/pdCol. Mean speed±SD are annotated above
histograms.
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Furthermore, the motility of MC3T3-E1 cells seeded on Col and pdCol was
analysed. The relative displacement of single MC3T3-E1 cells was tracked in time-lapse
movies (appendix, video 3). The average migration speed was enhanced by 42 % on
pdCol (Fig. 52 D). Above observed differences in spreading, remodelling and migration
on Col and pdCol suggested that pre-osteoblasts interacted differently with both matrices.
To quantify the adhesive interactions with Col and pdCol, in a next step SCFS was
applied.
Comparing MC3T3-E1 cell adhesion to Col and pdCol by SCFS
F-D curves were recorded on Col and pdCol using contact times of 5, 30 and
180 sec (Fig. 53 A).
Fig. 53. Quantification of cell adhesion to Col/pdCol matrices by SCFS. (A)
Detachment forces of MC3T3-E1 cells adhering to Col/pdCol matrices. (B)
Quantification of single rupture forces (“j”, (b)) recorded after a contact time of 5 sec.
Brackets annotate numbers of events analysed. Data is represented as Box-Whisker plots,
white lines within boxes denote medians, and <n> total numbers of analysed F-D curves.
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Pre-osteoblastic cells showed significantly increased median detachment forces
(FD, 2.3.3) on pdCol (Fig. 53 B, C). A broader distribution of detachment forces was
found on pdCol compared to Col (Fig. 57 B). After a contact time of 5 sec, a threefold
increased detachment force was detected on pdCol (1025 pN) compared to Col (334 pN).
This difference became more prominent after enhanced contact times (2856 pN vs.
522 pN after 180 sec). This quantitatively showed that overall adhesion was enhanced,
either due to a higher number of adhesion receptors that were binding, or due to an
increased binding strength of individual receptors. To enter into this question, single
rupture events (“j”) in F-D curves were analysed (Fig. 53 A, D, see 2.3.3). These can be
correlated with the unbinding of single or few cell adhesion molecules384, 385.
A significantly higher number of j per F-D curve was detected on pdCol (7.8±5.5
vs. 3.4±2.6). The magnitude of j was also increased on pdCol (49 pN vs. 37 pN,
p<0.0001) (Fig. 53 D). The differences of j let suggest that distinct adhesion molecules
were binding to Col and pdCol.
Fig. 54. Flow cytometry analysis of cell surface associated integrins. b1-, b3-,av- and
a5b1-integrins were immuno-fluorescently labelled and analysed by flow cytometry
(black). Negative controls are shown in grey.
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Next, the role of b1-, aV-, a5b1- and b3-integrins in mediating adhesion to Col was
studied, because some of them were described to mediate adhesion to denatured
collagens358, 364, 386, 387. Firstly presentation of these integrin heterodimers on MC3T3-E1
cells was confirmed by flow cytometry (appendix B12, Fig. 54).
The contribution of these integrins to overall cell adhesion was quantitatively
investigated in presence of integrin blocking antibodies (b1, b3, aV, a5b1) or linear RGD-
peptide. Blocking of b1-integrin reduced adhesion to Col by 20 % (p=0.006) (Fig. 55 A).
In contrast, the addition of the other blocking antibodies and RGD-peptide led to
enhanced adhesion to Col (aV: +20 %, a5b1: +55 %, b3: +40 %, RGD: +10 %). Integrin
crosstalk might have caused the observed effect; blocking of a5b1-integrins and integrins
comprising aV and b3 subunits may have activated collagen-binding integrins. A similar
crosstalk has been reported for a5b1- and a2b1-integrins via a protein kinase C dependent
mechanism388. The fact that adhesion to collagen could not be completely abolished in
presence of b1-integrin blocking antibody suggested that either other collagen binding
receptors or unspecific adhesion events accounted for the residual binding. Alternatively,
b1-integrins might not have been efficiently blocked by the antibody.
Fig. 55. Quantifying the effect of integrin blocking on cell adhesion to Col (A) and
pdCol (B). Detachment forces of MC3T3-E1 cells (5 sec contact time) that had been pre-
incubated for 30 min with different antibodies blocking b1-, aV-, a5b1- or b3-integrins or
RGD peptides. Data is represented as Box-Whisker plots, lines within boxes denote
medians, and <n> total numbers of analysed F-D curves.
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In contrast, MC3T3-E1 cell adhesion to pdCol was decreased by antibodies
blocking aV-,a5b1-, and b1-integrins or by RGD peptide (aV: -45 %, a5b1: -45 %, b1: -
40 %, b3: -50 %, RGD: -30 %). Within the initial attachment period (5-180 sec, only
5 sec shown) blocking of b3-integrin had no significant effect on adhesion
(p=0.16)(Fig. 55 B). This indicated that a5b1- and aV-integrins probably as part of the
integrin heterodimers aVb1 and/or aVb5, could bind to pdCol, but not to Col matrices.
These three integrin heterodimers are known to bind in a RGD-dependent manner to
fibronectin (a5b1, aVb1), osteopontin (a5b1, aVb1, aVb5) and vitronectin (aVb1, aVb5)
367.
Similarly pre-osteoblast adhesion to pdCol was not completely reduced in presence of b1-
blocking antibody. This might indicate a role for other integrin heterodimers as aVb5 in
recognizing pdCol. Further, incomplete blocking might be attributed to unspecific
binding, inefficient antibody blocking or other non-integrin collagen receptors. Previous
studies suggested that denatured collagen is not recognized by receptors for native
collagen including collagen binding integrins as a2b1-integrin or non-integrin receptors,
such as discoidin domain receptors (DDR)361.
Above results indicate that enhanced pre-osteoblast adhesion to pdCol was
mediated by integrins that recognized RGD-motifs. These findings are in line with
previous studies analyzing cell adhesion to native or denatured collagens358, 364, 365, 386, 387.
However, there has been controversy about the involved heterodimers. Whereas some
groups suggested that aVb3-, but not a5b1-integrin is the major cell adhesion molecule
binding to denatured collagens364, 365, 387, others reported a role of a3b1 ,avb1 and a5b1
358,
386. Although avb3-integrin was present on MC3T3-E1 cells (Fig. 54), this integrin
heterodimer was apparently not binding to pdCol, since b3-blocking antibody had no
effect on cell adhesion to pdCol. These contradictory results may be given by the
different experimental setups used to characterize cell adhesion. Some studies have used
collagen I358, 364, 365, others focused on collagen II386 and VI387. The obtained results might
be further dependent on the cell type studied, since integrin expression pattern and levels
vary among different cell types. Moreover, different protocols were used for collagen
denaturation and the applied adhesion assays hardly allowed to obtain quantitative data
on cell adhesion. Previous studies either probed adhesion of isolated molecules364 or
applied washing assays. Whereas SCFS analyses the initial cell adhesion (5 - 180 sec),
washing assays are restricted to longer attachment periods (> 30 min). It is possible that
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at prolonged contact periods, different integrin heterodimers might come into play.
Furthermore, upon longer contact, additional ECM proteins might be secreted and perturb
the measurements. Moreover, results provided by washing assays do not necessarily
directly correlate with cell adhesion, since other effects, for instance cell spreading
morphology, come into play (see 2.1.1).
5.3.3 Analyzing effects of Col and pdCol on cell growth and differentiation
FAK phosphorylation at tyr 397 in MC3T3-E1 cells seeded on Col and pdCol
In a next step the consequences of different integrin-binding on focal adhesion
kinase (FAK) phosphorylation was investigated (appendix B8). FAK localizes to sites of
clustered integrins and becomes phosphorylated; one of the first FAK phosphorylation
sites upon integrin engagement is residue tyr397.
Fig. 56. FAK tyr397 phosphorylation on Col/pdCol. (A) Western blots showing FAK
phosphorylation at tyr397. Cell lysates were taken 45 and 90 min after seeding MC3T3-
E1 onto Col/pdCol. (B) FAK ptyr397 levels were quantified and normalized to loading
controls (ß-tubulin). Brackets indicate the number of western blots analysed.
FAK tyr397 phosphorylation was enhanced by 50 %/55 % in cells seeded on
pdCol after 45 min/90 min (Fig. 56). Increased FAK phosphorylation might be attributed
to differential integrin signalling. It has been shown that differential integrin binding, e.g.
in cells plated on different adhesive ECM substrates (FN, collagen), differently stimulates
FAK phosphorylation389. FAK phosphorylation generates a binding site for Src kinase
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and thereby triggers downstream signalling pathways, e.g. ERK and MAPK pathways390,
391. Beside other functions, FAK has been implicated in regulating cell migration and
spreading390, 391. This might explain enhanced spreading and motility observed for pre-
osteoblasts on pdCol. Recent studies suggested that FAK signalling regulates osteogenic
differentiation of mesenchymal stem cells (MSC) via ERK and MAPK pathways392.
Thus, it was hypothesized that Col and pdCol differently influenced osteogenic
differentiation of MC3T3-E1 cells.
Proliferation and osteogenic differentiation on Col and pdCol
Cells were cultured under osteogenic differentiation conditions for 28, 35 and
42 d. Then matrix mineralisation, i.e. the extend of calcium phosphate deposition, was
quantified (appendix B11). Mature osteoblasts secrete collagen type I and non-
collagenous proteins, such as alkaline phosphatase, FN, osteocalcin, osteonectin,
osteopontin and bone sialoprotein393. Calcium phosphate crystallization is induced by
alkaline phosphatase under the control of osteonectin, osteopontin and osteocalcin394, 395.
Fig. 57. Cell proliferation and matrix mineralisation on Col/pdCol. (A) Cell numbers
were quantified after  7, 14, 21, 28, 35 and 42 d of cell culture. For each time point six
samples were analysed. (B) Col/pdCol mineralisation was analysed by quantitative
alizarin red S staining after 28, 35 and 42 d of cell culture. Staining intensity was
normalized to staining of non-induced controls. Numbers in brackets indicate the number
of experiments. Data are presented as mean±SD. Below, example photographies of
stained 48 wells are shown (data was acquired by collaborators, Prof. D. Hutmacher).
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Since matrix mineralisation occurs due to the action of mature osteoblasts, matrix
mineralisation is a commonly used marker for osteogenic differentiation396. Matrix
mineralisation was quantitatively assessed by staining cell layers with alizarin red S
(appendix B11). During the first two weeks of culture, no significant amounts of
deposited calcium were observed (not shown). This is explained by a lag phase during
which the cells progress the process of becoming mature osteoblasts. Starting at four
weeks of cell culture, strong matrix mineralisation was observed. Matrix mineralisation
was significantly increased for pdCol compared to Col (Fig. 57 B). To exclude that
increased mineralisation was an effect of potentially increased cell numbers, cell
proliferation on Col and pdCol was compared. At all analysed time points no significant
differences in cell numbers were found (Fig. 57 A). Comparing cell proliferation between
cells that were cultured in presence and absence of osteoinductive medium it was
observed that cells grown under osteogenic differentiation conditions ceased proliferation
compared to uninduced cells. This further indicated that MC3T3-E1 cells underwent
osteogenic differentiation.
Taken together, it was concluded that pdCol stimulated osteogenic differentiation
of MC3T3-E1 cells. This finding was supported by further cell culture experiments
performed on Col and pdCol coatings prepared on thermanox discs (see appendix A3).
Whereas Col and pdCol exhibited on mica a fibrillar structure, collagen type I did not
assemble into fibrils on thermanox discs (not shown). Hence it could be concluded that
the effect of enhanced mineralisation was caused at the molecular level, not at the
macromolecular level. In addition, our collaborators obtained comparable results in
experiments using different cell types, e.g. primary human osteoblasts, and coatings of
different collagen sources (not shown). This indicates that the effect of enhanced
mineralisation found on pdCol is independent on cell type, collagen source and structural
features of the coatings. These results are also in accordance with previous studies using
human adult bone marrow stromal cells378, 379 and human dermal fibroblasts397. In both
studies an enhanced differentiation potential of cells cultured on denatured compared to
native collagen type I was reported.
Several studies have demonstrated that integrin-ECM interactions can modulate
osteogenic differentiation potential370, 392, 398. ERK and MAPK signalling pathways have
been implicated in this process by activating multiple transcription factors and growth
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factors, for instance Runt-related transcriptional factors, Smads or bone morphogenetic
protein- 2 (BMP-2)392. However, the exact mechanisms are not well understood. Since
cells adhered via different integrin heterodimers to Col and pdCol, it was concluded that
differential integrin-mediated signal transduction caused the differences in osteogenic
differentiation. Recently a functional role of FN and its receptor a5b1 in promoting
osteogenic differentiation was demonstrated398-402. Since RGD-dependent integrins -
including av and a 5b1- bound to pdCol, but not to Col, these integrins might have
activated signal transduction pathways responsible for mineralisation initiation.
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5.4 Conclusions & Outlook
In the presented work SCSF quantitatively showed that partially denaturing
collagen type I leads to the exposure of cryptic RGD-motifs and enhanced adhesive
interactions with pre-osteoblasts. av- and a5b1- integrins were identified as predominant
integrins recognizing pdCol. RGD-dependent binding mechanisms of cells to denatured
collagen I have been already demonstrated in previous studies358, 364, 365. However, most
previous studies applied adhesion assays that are limited in a way that they do not
quantitatively measure cell adhesion forces.
Concomitantly with increased adhesion, pdCol promoted spreading and migration
of pre-osteoblasts. This was in accordance with studies showing that migration of human
dermal fibroblasts cells was enhanced on denatured compared to native collagen397.
Enhanced cell attachment and migration on denatured collagen may present a mechanism
by which cells are guided to sites of collagen degradation. Such guidance may assist
removal of degraded collagen after tissue injury or during tissue remodelling to
accomplish tissue homeostasis. Indeed, matrix remodelling was previously reported to be
increased when fibroblasts were grown on denatured instead of native collagen I373.
In the presented work denaturation of collagen type I was caused by thermal
denaturation. Can such thermal denaturation be correlated with collagen degradation
occurring in vivo? It has been demonstrated that proteolytic degradation of collagen type
I destabilizes its triple-helical structure leading to unwinding of the triple helices at
physiological temperatures362. Thus, both thermal denaturation and proteolytic
degradation of collagen may induce similar local unfolding of the collagen molecules.
This suggests that the mechanisms by which cells react to thermally denatured and
proteolytically degraded collagen in vivo may be similar. It might be interesting to
analyse in a future study the effect of different collagenases on Col matrices and on cell
attachment and behaviour.
Pre-osteoblasts cultured on pdCol exhibited enhanced differentiation kinetics and
potential. Since integrin signalling was altered upon collagen denaturation, molecular
mechanisms of cell adhesion to native and partially denatured collagen I may directly
correlate with enhanced osteogenic differentiation. It appears surprising that initial matrix
contact can trigger such long-lasting effects over six weeks of cell culture. This can be
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explained by a kind of feedback loop implemented in the process of cell-ECM
interactions. There exists a bi-directional interplay between integrins and the ECM 403-405
(Fig. 58). As discussed in 1.2.3, specific ligation to ECM ligands triggers intracellular
signalling pathways. Besides receiving and transmitting chemical signals, integrins are
also mechanical linkers between contractile elements in the cell interior (acto-myosin
cytoskeleton) and the ECM. Integrin association with mechano-sensitive proteins enables
cells to sense the mechanical properties of their surrounding and to react accordingly406-
408. Thus, together with altered chemical signals, different mechanical properties of the
surrounding matrix (as seen for Col and pdCol) might affect cellular behaviour. In
response, cells can modify composition and mechanical properties of their ECM by
adding new ECM proteins or by secreting proteases degrading the ECM. Different
signals initially received by the cells grown on Col and pdCol may have lead to
alternative ECM modifications. For instance, depending on the matrix type (Col, pdCol),
distinct ECM proteins might have been secreted by the cells. Since this newly deposited
matrix stimulates cellular behaviour inversely, long-lasting signals can thereby be
produced. Ongoing studies might unravel differences in ECM composition after
prolonged culture periods.
Fig. 58. Reciprocal interactions
occurring between cell and ECM.
Cell receive signals from soluble and
matrix-bound molecules that bind to
cell-surface receptors. This activates
intracellular signalling pathways.
Vice versa the cell can act back on the
ECM modifying it by secretion/
proteolysis of ECM proteins or by
applying mechanical stress on the
matrix hence deform it. The modified
ECM sends back altered signals to the
same cell and neighbouring cells. The
figure was adapted with slight
changes from 405.
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An important issue in regenerative medicine is the development of optimised
systems for the expansion of stem cell ex vivo. A common problem is the gradual
decrease of cellular differentiation potential. Thus ex vivo culture conditions have to be
optimised to preserve cellular functions373. The presented findings may present a basis to
exploit the use of denatured collagen in various cell-expansion scenarios for tissue
engineering applications. Thereby the loss of proliferative capacity and differentiation
potential of the cells in use might be prevented.
In this work well-characterized collagen matrices consisting of parallel, highly
ordered collagen fibrils were used. These collagen fibrils exhibited the characteristic D-
band, thus shared similarities to in vivo assembled fibrils. In numerous studies cell
adhesion to non-fibrillar collagen coatings was studied. However, it was shown that cell
adhere to monomeric and fibrillar collagen type I via different integrins409. Analysing
cellular interactions with fibrillar collagen has the advantage of being more comparable
to collagen assembled in vivo. Moreover, the used Col matrices present highly ordered
pattern of integrin binding sites. Since it has been shown that ligand spacing has an
important influence on adhesion, spreading, proliferation and differentiation of cells410, 411
the used matrices may promote cell attachment and growth. However, it was observed
that MC3T3-E1 cells disassembled Col and pdCol within few hours and the homogenous
structure of the matrix is thereby lost. In contrast to native collagen type I fibrils, collagen
fibrils within Col matrices are not cross-linked (1.1.1); such crosslinks significantly
improve the mechanical stability of the matrix. Thus, to preserve the structure of highly
ordered collagen coatings over longer cell culture periods, chemical cross-linkers or
enzymatic cross-linking might be tested in future work to improve long-term stability of
Col matrices.
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Chapter 6
Quantifying adhesion of myeloid progenitors to bone marrow
derived stromal cells
6.1 Abstract
Expression of the fusion protein BCR/ABL is hallmark of chronic myeloid
leukemia (CML). BCR/ABL is a constitutively active tyrosine kinase interfering with
normal cell proliferation, apoptosis and differentiation. To which extend and by which
mechanisms BCR/ABL influences the adhesion of leukemic cells to bone marrow
stromal cells (BMSC) is not clear. In the study SCFS was applied to quantify adhesion of
BCR/ABL transformed 32D cells (32D-BCR/ABL) to the BMSC line M2-10B4. SCFS
data revealed that adhesion forces of 32D-BCR/ABL cells were three fold increased
compared to control 32D cells (32D-V). The BCR/ABL-mediated effect of enhancing
cell adhesion could be reversed to control levels by imatinib mesylate (IM), an inhibitor
of the BCR/ABL tyrosine kinase activity. SCFS further showed that adhesion forces to
FN and collagen type I were higher for 32D-BCR/ABL cells than controls, suggesting
that b1-integrin plays a major role in mediating adhesion of leukemic cells to BMSC.
Indeed, a b1-integrin blocking antibody nearly abolished adhesion of 32D-V and -
BCR/ABL cells to BMSC. Flow cytometry and western blot analysis revealed
significantly increased b1-integrin concentrations on the surface of 32D-BCR/ABL cells.
Since no significant differences of b1-integrin mRNA levels were detected, it was
suggested that b1-comprising integrin heterodimers were regulated post-transcriptionally
by BCR/ABL. The presented data indicate that specifically interfering with b1-integrins
might optimize CML therapies by circumventing effects of cell adhesion mediated drug
resistance.
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6.2  Introduction
Leukemias are cancers of the blood and bone marrow that are characterized by
abnormal proliferation of white blood cells412. Critical for the development of leukemias
are genetic alterations occurring in pluripotent hematopoietic stem cells. Four major types
of leukemias have been defined, namely chronic myeloid leukemia (CML), acute
myeloid leukemia (AML), chronic lymphoid leukemia (CLL) and acute lymphoid
leukemia (ALL). Their classification is based on the (myeloid or lymphoid) origin of the
mutated precursor cell and on the course of the disease. The current project focuses on
CML, a clonal disorder of myeloid progenitor cells originating in the bone marrow. With
1-2 new cases per 100 000 cases per year, CML is considered a relatively rare disease,
the median age of diagnosis is 53 years413. The course of CML can be divided into three
phases, an initial chronic phase characterized by an elevated white blood cell count413 that
can persist for several years. The disease either passes through an accelerated phase with
immature blood cells accumulating in the peripheral blood or directly progress to blast
crisis, the terminal stage. Blast crisis resembles acute myeloid leukemia and is
characterized by an excess of immature malignant precursors in the blood. Without
treatment the median survival time of patients after diagnosis is about 4 to 6 years414.
In most types of cancers and also other types of leukemias several cytogenetic
alterations have to account for development of the disease. In CML, however, formation
of the so-called Philadelphia chromosome (Ph chromosome)415 is considered to be the
critical event leading to oncogenesis. The Ph chromosome was firstly described in 1960
by Peter Nowell and David Hungerford as chromosomal abnormality occurring in 95%1
of CML patients 415. The reasons for the formation of the Ph chromosome are not clear,
the molecular pathogenesis of CML, however, is well understood417. The Ph chromosome
is consequence of a reciprocal translocation between chromosomes 9 and 22,
t(9;22)(q34;q11)418, 419. This translocation leads to juxtaposition of sequences of the
proto-oncogene Ableson leukemia virus (encoding for c-Abl) on chromosome 9 and the
breakpoint cluster region (Bcr) on chromosome 22420. As a result the fusion genes
BCR/ABL and ABL/BCR are formed421. There are not many reports on biological
relevance of the ABL/BCR, differently to the product of BCR/ABL that plays a central
                                                 
1 Whether the 5% of cases in which no Ph chromosome is detectable (usually referred to as
atypical or Ph negative CML) have to be classified separately is controversial416.
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role in cell transformation. Depending on the exact fusion site of exons, BCR/ABL
transcripts are translated into three major isoforms, a 210kDa protein (p210BCR/ABL)422,
the most common type, a 190kDa protein (p190BCR/ABL) or more rarely 230kDa protein
(p230BCR/ABL)413. It was demonstrated that p210BCR/ABL can transform a variety of
hematopoietic cell types in vitro423 and in vivo in animal models424-427.
c-Abl is a tightly regulated non-receptor tyrosine kinase that plays a role in actin
reorganization, cell proliferation and survival/apoptosis428. c-Abl is located at the nucleus
and in cytoplasm of the cell. Upon DNA damage c-Abl is activated, translocated into the
nucleus and induces apoptosis. In contrast, cytoplasmic c-Abl is linked to growth factor
receptor signalling pathways and promotes survival and proliferation of the cells. In that
way the location of c-Abl decides whether such opposite events as survival or apoptosis
occur. The oncogenic effects produced by mutated Abl are mediated by its exclusive
cytoplasmic localization together with its increased tyrosine kinase activity. The tyrosine
kinase activity of c-Abl is normally tightly regulated by interactions with negative
regulators, such as F-actin429, phosphoinositides 430, 431 and by intramolecular
autoinhibition mechanisms. In contrast, p190BCR/ABL and p210BCR/ABL are auto-
phosphorylated which is critical for cellular transformation432. In normal hematopoiesis
cytokines and other extracellular stimuli regulate proliferation, apoptosis and
differentiation of hematopoietic progenitor cells via intracellular signalling pathways.
These signalling cascades include Ras/Raf-1/Erk and PI3K/Akt as well as JAK/STAT5
(JAK: Janus family of tyrosine kinases, STAT: signal transducers and activators of
transcription)432-435. IL-3, a soluble highly glycosylated 26kDa protein, is such a cytokine
that promotes cell growth and division and inhibits pathways leading to apoptotic cell
death435.
In BCR/ABL transformed cells, these pathways are constitutively activated by
BCR/ABL and consequently cells become growth factor independent. It has been shown
that BCR/ABL activates Ras/Raf-1/Erk and PI3K/Akt signalling pathways as well as
JAK/STAT5434-438(Fig. 59). Deregulated activation of these pathways promotes increased
cell proliferation, decreased apoptosis and growth factor independence, respectively435.
Decreased cell death and increased proliferation lead to a massive clonal expansion of
progenitor cells occurs during CML435 436, 437, 439.
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There are also other malignancies with deregulated Abl activity. For example, v-
Abl, a virally encoded form of Abl, causes preB-cell leukemias in mice(428. Recent data
suggest that increased activation of c-Abl tyrosine kinase can also be involved in
malignant solid tumors of lung and breast428, 440.
Fig. 59. Signalling pathways affected by BCR/ABL. Note that there are more
interactions between BCR/ABL and signalling proteins that have been neglected for
simplicity. Taken with slight modification from441.
Historically, radiation was applied as first treatment against CML. Later on, so
called anti-metabolites were used, these include cytoarabine, hydroxyurea, alkylating
agents, interferon alpha and steroids have been applied in the treatment of CML. Stem
cell transplantation represents the only method by that CML patients can be completely
cured, however, its application is often limited by the advanced age of patients442. The
latest developments include targeted therapies that apply small molecules that specifically
interfere with target molecules responsible for oncogenesis. Targeted therapies have the
advantage over anti-metabolites that they can be more effective and also have less side
effects. Examples for targeted therapy are for instance tyrosine kinase inhibitors and
monoclonal antibodies. In the nineties a large random screen for several tyrosine kinases
was performed. The 2-phenylaminopyrimidines were first reported as potent inhibitors of
tyrosine kinases with high selectivity for Abl and PDGF-R tyrosine kinases443. To
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optimize 2-phenylaminopyrimidines for optimized inhibition of PDGF-R, chemically
related compounds were synthesized. The most potent molecules in the screen were all
inhibitors of both, v-Abl and the PDGF-R kinases. STI 571 or imatinib mesylate (IM)
originates from these trials and was the lead compound for preclinical development443, 444.
IM is historically of particular importance, as it was the first drug developed for targeted
therapies. In the last years IM has become medicament of choice for the treatment of
CML. IM effectively inhibits the BCR/ABL tyrosine kinase activity by binding
competitively at its ATP-binding site (Fig. 60). Adverse events with IM are usually
low443.
Fig. 60. Mechanism of
IM. The constitutively ac-
tive tyrosine kinase
BCR/ABL transfers phos-
phate from ATP hydrolysis
to tyrosine residues of
different substrates activa-
ting signalling pathways
critical for CML (left). IM
blocks ATP binding to
BCR/ABL and thereby
inhibits its tyrosine kinase
activity (right). Taken
from445.
In some cases problems of disease persistence and resistance arise. Therefore
alternate compounds have been developed, such as nilotinib and desatinib (a Src
inhibitor) that are tested in clinical trials446, 447. Alternatively other types of inhibitors
might be used that act downstream of BCR/ABL, for instance inhibitors of
Ras/Raf/MEK/ERK or PI3K/PTEN/Akt/mTOR pathways448, 449(Fig. 59). These pathways
have been targets in cancer therapies since they play a critical role in promoting
proliferation. Respective inhibitors have been developed and applied for different types
of cancers. These could be useful for IM-resistant CMLs, clinical trials are planned 449.
Normal hematopoiesis is guided by dynamic interactions between hematopoietic
stem cells and the bone marrow microenvironment. The bone marrow microenvironment
is composed of stromal cells and extracellular matrix components, such as FN450, 451 and
collagens. Bone marrow cells secrete soluble factors controlling proliferation and
differentiation of hematopoietic cells. However, beside soluble factors, direct interactions
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between hematopoietic stem cells and bone marrow cells via adhesion molecules occur.
Those interactions have been also suggested to be critical to a phenomenon referred to as
cell-adhesion mediated drug resistance (CAM-DR). Thereby integrins on leukemic cells
bind to bone marrow cells or to secreted ECM proteins and activate anti-apoptotic
signalling pathways. Recently, a crucial role in CAM-DR has been proposed for b1-
integrin452 and, more specifically, for interactions between a4b1-integrins on leukemic
cells and VCAM-1 on bone marrow cells or FN. Several studies have also suggested an
anti-apoptotic effect of the bone marrow microenvironment in vivo: Matsunaga et al.
demonstrated in a murine model for AML that bone marrow cells protect leukemic cells
from the chemotherapeutic drug cytoarabine, by inhibiting apoptosis via Bcl-2 and Bcl-
X453. Furthermore combinations of blocking antibodies directed against integrins (VLA-
4) and chemotherapeutic drugs could increase survival of diseased mice. Thus, integrin
signalling represents an interesting therapeutic target when combined with
chemotherapeutic drugs. This might involve antibodies interfering with integrin function
or inhibitors acting more downstream.
The named examples point out, that it is of great importance to understand the
molecular basis underlying the interactions between myeloid cells and BMSC. A better
knowledge about the involved molecules may aid the development of targeted therapies.
Several published studies have addressed the influence of BCR/ABL on cell adhesion.
Commonly cell adhesion to FN model surfaces was analysed, only a few studies have
addressed cell adhesion to BMSC454, 455. The performed studies gave controversial
results456-458. While adhesion of BCR/ABL-transformed hematopoietic cell lines,
including 32D cells, to FN coated surfaces was found to be increased in some studies456,
457 459, others observed reduced adhesion460-462. The inconsistent results are presumably
attributable to the properties of the modified cells and the experimental strategy being
used. None of these studies applied cell adhesion assays that characterized cell-cell
adhesion quantitatively. Thus, objective methods to quantitatively characterize adhesion
of leukemic cells are clearly needed.
In this work the effect of BCR/ABL on adhesion of myeloid progenitor cells to a
BMSC cell line (M2-10B4) or ECM proteins (FN, Col) was quantitatively investigated.
For that purpose, adhesion of 32D cells that were retrovirally transfected to stably express
BCR/ABL (32D-BCR/ABL cells) was quantitatively compared to control cells
transfected with empty vector (32D-V cells).
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6.3 Results & discussion
6.3.1 Quantifying cell adhesion between 32D and BMSC
Our collaborators had performed washing assays to compare the attachment of
adherent 32D-V and 32D–BCR/ABL cells to BMSC. A significantly higher percentage of
32D-BCR/ABL cells adhered to BMSC than of 32D-V control cells (t-test: p < 0.001)
(Fig. 61 A, B). Importantly, depending on incubation time and concentration of IM the
increased percentage of adherent 32D-BCR/ABL cells could be reduced to that of 32D-V
cells. In contrast IM showed no effect on the percentage of 32D-V cells attached to
BMSC.
Fig. 61. Quantification of cell-cell adhesion using washing assays. 32D-V and 32D
cells (-V and -–BCR/ABL cells) were pre-incubated with or without IM prior to their co-
culture with BMSC. (A) 32D cell adhesion to BMSC depending on the IM pre-incubation
time. (B) 32D cell adhesion to BMSC depending on IM concentration.
Since washing assays cannot provide quantitative data on cell adhesion forces
adhesion of 32D cells to BMSC was subsequently analysed by SCFS. Individual 32D
cells were attached to the AFM cantilever and F-D curves were recorded on BMSC
grown on glass coverslips (Fig. 62). For all analysed contact times (5, 30, 120 sec)
detachment forces of 32D-BCR/ABL cells lied significantly (p < 0.001) above that of
32D-V cells. At a contact time of 120 sec 32D-BCR/ABL cells showed a median
detachment force of 3317 ± 2169 pN, an approximately three-fold higher detachment
force than that observed for 32D-V cells (998 ± 362 pN).
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Fig. 62. Experimental setup to quantify cell-cell adhesion by SCFS. (A) Phase contrast
image of a 32D cell attached to a tippless AFM cantilever. Below, a sparse layer of
BMSC is visible. The small inset (bottom left) illustrates the sideview during the contact
between a single 32D cell and a stromal cell during a F-D cycle. (B) Representative F-D
curves recorded for 32D-V control cells, 32D-BCR/ABL cells and for 32D–BCR/ABL
cells incubated with 0.5mM IM for 18-22h. (contact time 120sec).
Pre-incubating 32D-BCR/ABL cells with 0.5 µM IM for 18 – 22 h reduced
detachment forces to similar values (889 ± 505 pN, 120 sec) as observed for untreated
32D-V cells (Fig. 63 A). Detachment forces of 32D-BCR/ABL cells (Fig. 63 B) showed
a wider distribution indicating that their adhesion varied more compared to that of the
32D-V control cells.
Fig. 63. Quantification of cell-cell adhesion by SCFS. (A) Detachment forces for 32D-V
and 32D-BCR/ABL after a contact time of 120sec. (B) Detachment forces for 32D cells at
contact times of 5, 30 or 120 sec. Data are presented as boxplots. Inserted numbers
within bars (<n>) indicate the total number of analysed force curves. Brackets above the
bars represent the results of a statistical test (Mann- Whitney) (* p < 0.05, n.s.  ≥ 0.05).
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Both, washing assays and SCFS, revealed that 32D cells expressing BCR/ABL
fusion proteins adhered significantly stronger to BMSC compared to 32D-V control cells.
Pre-incubation of 32D cells with IM reversed the increased adhesion of 32D-BCR/ABL
cells to BMSC to that of 32D-V cells. Since 32D-V and 32D-BCR/ABL cells differed
only in the expression of the BCR/ABL oncogene and IM could reverse enhanced
adhesion of 32D-BCR/ABL, it was concluded that the enhanced cell-cell adhesion was
consequence of the tyrosine kinase activity of BCR/ABL. To analyse the adhesive
interactions in more detail, in the next step single rupture events in F-D curves were
analysed.
6.3.2 Analyzing single rupture events in F-D curves
Next the magnitude of single rupture events (“j”) (Fig. 62 B, Table 4) was
analysed in F-D curves recorded with 32D-V and 32D-BCR/ABL on BMSC after 5 sec
contact. The most frequent force was 53 ± 35 pN for 32D-BCR/ABL and similar for
32D-V cells (47 ± 32 pN). These results suggested that the binding strength of most
unbinding events remained the same for both cell types. Incubation of 32D-BCR/ABL
cells for 18 – 22 h with 0.5 µM IM, decreased the most frequent rupture force to
37 ± 24 pN. A similar effect was observed in 32D-V cells in presence of IM. IM reduced
single rupture events to similar forces (36 ± 24 pN). Since the effect of reduced single
rupture events was also seen in 32D-V, this indicated that IM had further effects on
myeloid progenitor cells than blocking BCR/ABL tyrosine kinase activity. It is known
that IM inhibits -besides BCR/ABL- c-Abl, c-kit and platelet derive growth factor
receptor (PDGF). However, it may be speculated that interfering with c-Abl that locates
to adhesion sites and is involved in actin cytoskeleton organization429, alters the
mechanical properties of the adhesion receptor-cytoskeleton linkage.
F-D curves of 32D-BCR/ABL cells exhibited about 47 % more force jumps than
F-D curves recorded with 32D-V cells (Table 4). Addition of 0.5 µM IM to 32D-
BCR/ABL cells reduced the number of single rupture events from 7.8 ± 6.0 to 5.5 ± 3.8, a
similar value as found for 32-V control cells (5.3 ± 5.0). IM had no effect on the number
of single unbinding events observed for 32D-V cells (not shown). Thus, it was concluded
that 32D-BCR/ABL cells exhibited more active adhesion molecules compared to 32D-V
cells.
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Table 4. Analysis of single force jumps for cell-cell and cell-ECM measurements. Mean
numbers of single force jumps (±SD) per F-D curve for 32D-V cells, 32D-BCR/ABL cells,
and 32D-BCR/ABL cells after incubation of 0.5 µM IM for 18 – 22 h (contact time 5 sec).
6.3.3 Analyzing 32D cell adhesion to FN and collagen type I coated surfaces
Next, adhesion of 32D-V and 32D-BCR/ABL cells to FN-coated surfaces and
collagen type I matrices (Col) was quantified. Compared to 32D-V cells, 32D-BCR/ABL
cells showed significantly higher detachment forces (Fig. 64 A, B) on both FN and Col.
Concomitant with the elevated overall adhesion to FN, for 32D-BCR/ABL cells more
unbinding events (9.1 ± 3.9, 5 sec) were detected than for 32D-V cells (4.2 ± 2.6, 5 sec)
(Table 4). The magnitude of single unbinding events was similar for 32D-BCR/ABL
(67 ± 36 pN) and 32D-V control cells (72 ± 28pN). This suggested that 32D-BCR/ABL
cells exposed an increased number of active adhesion molecules. Concomitant with this
observation, 32D-BCR/ABL cells increased their detachment forces with contact time
while 32D-V cells did not. Pre-incubation of 32D-BCR/ABL cells with 0.5 µM IM for 18
to 22 h significantly reduced detachment forces (Fig. 64 A, B) and the number of rupture
events j (Table 4). In general, detachemnt forces of 32D cells were found to be much
higher on FN than on Col, which coincided with an elevated number of single rupture
events.
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Fig. 64. Quantifying adhesion of 32D cells to ECM proteins. Adhesion of 32D (-V and
–BCR/ABL) to Col (A) or FN (B)) coated surfaces was quantified for contact times of 5
or 30sec. Data are presented as boxplots. The results of a Mann-Whitney test are shown.
Above results indicate that adhesion of 32D-BCR/ABL to BMSC, but also to FN
and Col was increased. As mentioned above, there are conflicting reports on the effects of
BCR/ABL on cell adhesion. Whereas several research groups found enhanced adhesion
of BCR/ABL positive cells to FN 456, 457, 459, others reported a loss of adhesion 460-462.
These controversial results might be explained by different culture conditions and the
respective cell model used463. Indeed, most of the studies that used human BCR/ABL
positive CD34+ progenitor cells showed decreased adhesion to FN, whereas other studies
using the murine cell lines 32D or BAF3 reported an increased adhesion to FN upon
BCR/ABL expression. However, there is no clear indication that cell adhesion varies in a
species-specific manner. Hence, additional factors as the expression level of BCR/ABL
may define the effect on cell adhesion. Barnes et al. demonstrated that low levels of
BCR/ABL decreased adhesion to FN, cells whereas high levels lead to enhanced
adhesion464. The cellular system used in this study compares favorably with the high
expression clones reported by Barnes et al.464 since BCR/ABL expression and tyrosine
kinase activity were strong (immunoprecipitation assays of BCR/ABL phosphorylation,
data not shown). Typically such increased levels of BCR/ABL expression have been
observed in BCR/ABL positive blast crisis of CML patients459, 465.
None of the previous studies could correlate enhanced adhesion of BCR/ABL
expressing cells with its tyrosine kinase activity457, 466. Even though these experiments
applied much higher concentrations of IM (10µM) for a time period of 15 – 17 h, no
effect on the adhesion of BCR/ABL expressing cells could be observed. In contrast to
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these experiments, SCFS measurements showed that incubation with 0.5 µM IM over a
time period of 18 – 24 h was effective to reduce adhesion of 32D-BCR/ABL cells to that
observed for 32D-V control cells. The concentration of 0.5 µM IM lies close to that
found in the blood of CML patients (≤1 µM) receiving IM as a therapeutic drug467, 468. It
might be assumed that the strongest IM mediated inhibition of 32D-BCR/ABL cell
adhesion was reached after a pre-incubation time of 24h. Thus, a time period of 15 – 17 h
may not be sufficient to observe an effect of IM on the BCR/ABL induced cell adhesion.
The obtained controversial results might be further attributed to the non-quantitative
adhesion assay used.
Increased adhesion of BCR/ABL expressing 32D cells FN and Col suggested that
receptors of the integrin family were responsible for the amplified adhesion of 32D-
BCR/ABL cells. As b1-integrins are involved in cell binding to FN (mainly a4b1- and
a5b1-integrin) and Col (predominantly through a2b1-integrin), it became the primary
target in the following experiments.
6.3.4 Role of b1-integrins in mediating adhesion of 32D cells to BMSC
To analyse the role of b1-integrin, 32D-V and 32D-BCR/ABL cells were pre-
incubated for 1 h with 20 µg/ml of the b 1-integrin blocking antibody Ha2/5
469.
Characterizing these Ha2/5-treated cells by SCFS revealed that adhesion of 32D-V cells
and of 32D-BCR/ABL cells to BMSC was almost completely abrogated (Fig. 65). For
32D-BCR/ABL cells, the median detachment forces went down from 1016 ± 500 pN to
269 ± 55 pN after a contact time of 5 sec. In the presence of Ha2/5, the detachment forces
of 32D-V cells after 5 sec of contact decreased from 512 ± 272 pN to similarly low
values of 235 ± 49pN. This indicated that b1-integrin significantly contributed to the
adhesion of 32D cells to BMSC. Since detachment forces of 32D-BCR/ABL and 32D-V
cells were diminished to similar forces, b1-integrin was concluded to be responsible for
the BCR/ABL enhanced adhesion. The fact that cell adhesion was not completely
abrogated by blocking b1-integrin might indicate that further adhesion molecules were
involved at a low level. Alternatively, it is possible that b1-integrins were not completely
blocked by the antibody.
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Fig. 65. Quantifying adhesion of 32D cells to BMSC blocking b1-integrins. To inhibit
b1-integrin function, 32D-V and 32D–BCR/ABL cells were pre-incubated for 1 h with
20µg/ml blocking antibody Ha2/5. Subsequently adhesion to stromal cells was measured
for contact times of 5 or 120 sec. Data are presented as boxplots. The number of
analysed F-D curves is indicated in brackets. Results of a Mann-Whitney test are shown.
These results could be confirmed qualitatively, performing washing assays after
pre-incubation of 32D-V and 32D-BCR/ABL cells for 1 h with 20 µg/ml of the b1-
integrin blocking antibody Ha2/5 and 3 h of co-culture (not shown). This indicated that
most interactions of 32D cells and BMSC involved b1-integrin both during early adhesion
events within 2 min, as monitored by SCFS, but also in prolonged adhesion processes as
observed by washing assays.
SCFS further showed that the absence of Mg2+ and/or Ca2+ ions in the medium
significantly reduced adhesion of 32D-V and 32D-BCR/ABL cells to BMSC (not
shown). This was in agreement with above findings, since several integrin heterodimers
require both Mg2+ and Ca2+ ions for ligand binding470, 471.
SCFS is a functional method that detects unbinding of adhesion molecules that are
in an active ligand-binding conformation. Since SCFS showed that cell-cell adhesion was
dominated by integrins comprising subunit b1, this pointed to an increased number of
active b1-integrin molecules present on 32D-BCR/ABL cells. However, SCFS does not
permit to distinguish if a higher total number of b1-integrins was present, or if a higher
proportion of b1-integrins was in a high-affinity conformation. This had to be tested by
complementary experiments, such as flow cytometry and western blots.
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6.3.5 b1-integrin protein and mRNA levels
Analyzing protein concentrations by flow cytometry revealed that 32D-BCR/ABL
exposed higher levels of cell surface associated b1-integrin compared to 32D-V. This
increased level of b1-integrin expression could be reversed upon addition of IM in a time
(not shown) and concentration dependent manner (Fig. 66 B, C).
Fig. 66. b1-integrin and gene expression in 32D cells. (A) Itgb1 (b1-integrin gene)
mRNA transcripts were evaluated by quantitative real time-PCR. Glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) was used as house keeping.cell surface b1-integrin
(CD29) was characterized by flow cytometry (black). Isotype controls are shown in grey.
Mean fluorescence intensities are shown in the upper right corners. (B) Concentrations
of mature b1-integrins analysed by western blots. Actin was used as loading control.
Similarly western blot analysis showed increased concentrations of mature
130 kDa b1-integrin on the cell surface (Fig. 66 A). When carbohydrate moieties were
digested by PNGase F, similar b1-integrin concentrations were found for 32D-V and
32D-BCR/ABL indicating that cell-surface associated b1-integrin, but not total
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concentrations were changed (not shown). In agreement with this observation, no
differences in expression of the b1-integrin encoding gene (Itgb1) between 32D-V and
32D-BCR/ABL cells were detected by real time PCR (Fig. 66 D).
Differing b1-integrin concentrations at the cell surface might be due to differences
in concentrations of a-integrin combining with b1-integrin. b1-integrins are usually
synthesized in excess, whereas a-integrin subunits are rate limiting for the formation of
different integrin heterodimers472. Twelve different a-integrins were described to form
heterodimers with b1-integrins
473. Among these, expression of genes encoding for a1-,
a2-, a3-, a4-, a5-, a6-, a6-, a7- and av-integrins was found in 32D (-V and –BCR/ABL)
cells. By flow cytometry surface concentrations of a4-, a5- and a v-integrins were
analysed in 32D (-V, -BCR/ABL and -BCR/ABL + IM) cells. These three a-integrins are
major fibronectin receptors. Compared to 32D-V cells 32D-BCR/ABL cells showed a
lower a4-integrin concentration and an increased aV-integrin concentration. However,
concentration differences could not be reversed by IM. Thus, different levels of a4- and
av- integrins cannot explain the observed differences in cell adhesion. In contrast,
enhanced concentrations of a5-integrin were detected at the surface of 32D-BCR/ABL
cells. Similarly to b1-integrin (Fig. 67), the increase of the a5-integrin concentrations
could be partially reversed upon pre-incubation with 0.5 µM IM for 18 h (Fig. 67). a5-
integrin exclusively combines with b1-integrin to form a5b1. Since a5b1-integrin is a FN
receptor, this might explain enhanced adhesion of 32D-BCR/ABL to FN, but not
increased adhesion to Col, because Col and FN binding integrins are mutually different.
Thus, it might be suggested that concentrations of a certain set of integrin heterodimers
were enhanced in BCR/ABL expressing 32D cells. Previous studies have also found an
increase of a5- and b1-integrin concentrations in BCR/ABL expressing 32D cells
456
which is in accordance with the presented data. Flow cytometry revealed lower a4-
integrin and consequently a4b1-integirn concentration on the cell surface of 32D-
BCR/ABL cells.
Considering that a4b1-integrins are the only integrins mediating cell-cell adhesion
(a4b1-VCAM-1), it appears surprising that adhesion of 32D-BCR/ABL cells to BMSC
was enhanced. Thus, it was hypothesized that interactions between 32D cells and BMCS
were not primarily due to integrin mediated cell-cell interactions (VLA-4-VCAM-1), but
dominated by other b1-integrins that bound to secreted ECM proteins.
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Fig. 67. Effect of BCR/ABL on 32D cell surface concentrations of integrins. Mean
fluorescence intensities (+/- SD) (a.u.=arbitrary unit) of a4-, a5- and av-integrin-labelled
32D cells. Brackets above the bars show the results of a one-way ANOVA t-test test (*
p<0.05, n.s. ≥0.05).
6.3.6 32D-V and 32D-BCR/ABL attachment to FN secreted by BMSC
Subsequently localisations of FN and VCAM were analysed by laser scanning
confocal microscopy. A large meshwork of FN fibrils was found on top of the BMSC
monolayer. Apparently BMSC secreted FN and assembles it into fibrils (Fig. 68).
VCAM-1 expressed by BMSC was homogenously distributed on the cell surface (not
shown). After co-culture of BMSC with 32D-V or 32D-BCR/ABL cells, most of attached
32D cells were located at the fibronectin fibrils produced by BMSC. FN was found
deposited in the interface between BMSC and 32D cells (Fig. 68, insets). After 3 h of co-
culture most 32D-V and 32D-BCR/ABL cells localized with the FN bundles. Thus,
confocal microscopy suggested that a major ligand for 32D-V and 32D-BCR/ABL cells
was fibronectin expressed by BMSC. However, adhesion of leukemic cells and BMSC
certainly involves further molecular interactions than that occurring between a5b1-
integrin and fibronectin, for instance integrin-mediated interactions to other ECM
proteins secreted by BMSC, such as collagens.
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Fig. 68. Confocal imaging of 32D cells on a BMSC monolayer. 32D-V and
32D–BCR/ABL cells were co-cultured for 3h with BMSC. Fixed samples were stained for
b1–integrin (red), fibronectin (green) and nuclei (blue). The 3D image was constructed
from acquired Z stacks and projected to a X-Y plane. Scale bar corresponds to 50µm.
Images were acquired by F. Fierro.
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6.4 Conclusions & Outlook
Previous studies have studied the effect of BCR/ABL on cell adhesion. However,
in none of these studies cell adhesion was quantitatively measured. Thus, the presented
SCFS data provide the first quantitative proof for the enhanced adhesion of BCR/ABL
32D cells to the stromal compartment. Moreover, adhesion to FN and Col was
significantly increased. Previous studies reporting enhanced adhesion of BCR/ABL
expressing cells contributed the effect of increased adhesion to integrin clustering and
cytoskeleton rearrangements without changing b1-integrin expression
459. However, above
presented flow cytometry data clearly showed enhanced cell surface concentrations of b1-
integrin comprising integrin heterodimers. There might be more than one mechanism by
which b1-integrin mediated adhesion of 32D-BCR/ABL cells is increased. However,
since a clear difference of b1-integrins was observed between 32D-V and –BCR/ABL it
might be concluded that different b1-integrin levels were predominantly responsible for
enhanced adhesion of 32D-BCR/ABL. The analysis of single rupture events further
suggested that enhanced adhesion was not due to integrin cluster formation. Enhanced
integrin clustering in 32D-BCR/ABL cells might have resulted in an increased magnitude
of single rupture events compared to 32D-V cells (similar as observed in Chapter 1).
Both enhanced b1-integrin concentrations and increased adhesion could be
reversed by IM in a concentration and time-dependent manner. This confirmed that
BCR/ABL tyrosine kinase activity was responsible for the seen effect. Since the
inhibition of the BCR/ABL tyrosine kinase by IM occurs within one hour474 the question
arises why such long pre-incubation periods are required to observe an effect of IM on
cell adhesion. The prolonged delay until IM incubation effected cell adhesion points to a
mechanism that involves secondary signals to reduce cell adhesion. Experiments
blocking de novo protein synthesis by cycloheximide have shown, that the b1-integrin
concentration on the cell surface required between 4 and 8h to decrease475. This might
explain why IM treatment of BCR/ABL expressing cells required several hours to affect
cell surface b1-integrin levels.
Taken together, the results show that high BCR/ABL-levels leads to enhanced
adhesion of 32D cells to BMSC due to increased b1-integrin levels. Comparatively high
BCR/ABL expression levels have recently been associated with terminal blast crisis of
CML and has been detected in the stem cell pool of patients suffering from CML459, 465.
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Since BCR/ABL expression correlates with increased cell adhesion, this increased
adhesion may assist leukemic cells to adhere to protected areas of the bone marrow
stroma and to become drug resistant. Such an anti-apoptotic effect of the bone marrow
microenvironment in vivo has been previously demonstrated453. In the presented work
interactions between progenitor cells and bone marrow cells were dominated by b1-
integrins which is interesting since a crucial role for b1-integrin in mediating CAM-DR
was proposed452. Taken together, the presented data suggest that targeting integrin-
mediated interaction of CML cells with the bone marrow microenvironment represents a
strategy to decrease CAM-DR effects. This might involve antibodies interfering with
integrin function or inhibitors acting more downstream. Targeting integrin function and
signalling might be interesting especially in cases of imatinib-resistance and might
further improve the success of chemotherapeutic drugs.
In the presented work the specific b1-comprising integrin heterodimers enhancing
adhesion of 32D-BCR/ABL to BCSC were not completely characterized. In future work
the role of specific integrin heterodimers might be explored by combining RT-PCR, flow
cytometry and SCFS experiments. Detailed knowledge about the involved molecules may
represent a useful basis to enter the question by which mechanisms BCR/ABL influences
b1-integrin-mediated adhesion.
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Final remarks
In the three described projects AFM-based SCFS was applied to investigate
integrin-mediated adhesion at the molecular level. In chapter four the kinetics of a2b1-
integrin mediated cell adhesion to collagen type I was explored. The high force resolution
of the measurements permitted to decipher the contribution of single-integrin interactions
in the time-dependent build-up of overall cell adhesion and to elucidate mechanisms of
a2b1-integrin regulation. Moreover, dynamic force spectroscopy allowed bond specific
parameters to be determined for the a2b1-integrin collagen type I interaction. In chapter
five overall cell adhesion of pre-osteoblasts to native and denatured collagen type I was
compared. Distinct binding mechanisms and integrins involved in the adhesion process
were revealed by using different blocking reagents such as function blocking antibodies
and RGD peptide. By combining SCFS with further techniques that permitted analysis of
cell spreading, migration, signaling and osteogenic differentiation, the observed
differences in cell adhesion could be directly correlated with structural changes of
collagen type I that occurred during thermal denaturation at the molecular level. The
findings of this project further indicated that the initial phase of cell adhesion, such as
assessed by AFM-SCFS, may trigger long-lasting effects on cellular behaviour, such as
differentiation. This demonstrates the relevance of studying these initial adhesion events.
In chapter six, overall adhesion of BCR/ABL expressing and control cells was compared.
By quantifying adhesion in presence of a specific drug, imatinib mesylate, the observed
enhanced adhesion of BCR/ABL expressing cells could be correlated with BCR/ABL
tyrosine kinase activity. By using a combinatorial approach of SCFS, flow cytometry,
RT-PCR and western blots, the molecular mechanisms leading to enhanced adhesion
could be investigated. Based on the presented results, it can be concluded that in
combination with complementary techniques AFM-SCFS represents a powerful tool to
address interesting aspects of cell biological, biophysical and medical relevance.
-127-
References
1. Cukierman, E., Pankov, R. & Yamada, K.M. Cell interactions with three-dimensional matrices. Curr
Opin Cell Biol 14, 633-639 (2002).
2. Berrier, A.L. & Yamada, K.M. Cell-matrix adhesion. J Cell Physiol 213, 565-573 (2007).
3. Grinnell, F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13, 264-269
(2003).
4. Hay, E.D. Biogenesis and organization of extracellular matrix. Faseb J 13 Suppl 2, S281-283
(1999).
5. Alberts, B. et al. Molecular Biology of the Cell. (Garland Science, New York; 2002).
6. Pollard, T.D. & Earnshaw, W.C. Cell Biology, Edn. 1st. (Philadelphia; 2004).
7. Wang, X., Bank, R.A., TeKoppele, J.M. & Agrawal, C.M. The role of collagen in determining bone
mechanical properties. J Orthop Res 19, 1021-1026 (2001).
8. Katz, J.L. Hard tissue as a composite material. I. Bounds on the elastic behavior. J Biomech 4, 455-
473 (1971).
9. Kjaer, M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical
loading. Physiol Rev 84, 649-698 (2004).
10. Holmes, D.F. et al. Corneal collagen fibril structure in three dimensions: Structural insights into
fibril assembly, mechanical properties, and tissue organization. Proc Natl Acad Sci U S A 98, 7307-
7312 (2001).
11. Vakonakis, I. & Campbell, I.D. Extracellular matrix: from atomic resolution to ultrastructure.
Current Opinion in Cell Biology 19, 578-583 (2007).
12. Kadler, K.E., Baldock, C., Bella, J. & Boot-Handford, R.P. Collagens at a glance. J Cell Sci 120,
1955-1958 (2007).
13. van der Rest, M. & Garrone, R. Collagen family of proteins. Faseb J 5, 2814-2823 (1991).
14. Canty, E.G. & Kadler, K.E. Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118,
1341-1353 (2005).
15. Kadler, K.E., Holmes, D.F., Trotter, J.A. & Chapman, J.A. Collagen fibril formation. Biochem J 316
( Pt 1), 1-11 (1996).
16. Orgel, J.P., Irving, T.C., Miller, A. & Wess, T.J. Microfibrillar structure of type I collagen in situ.
Proc Natl Acad Sci U S A 103, 9001-9005 (2006).
17. Smith, J.W. Molecular pattern in native collagen. Nature 219, 157-158 (1968).
18. Gross, J. & Schmitt, F.O. The structure of human skin collagen as studied with the electron
microscope. J Exp Med 88, 555-568 (1948).
19. Petruska, J.A. & Hodge, A.J. A Subunit Model for the Tropocollagen Macromolecule. Proc Natl
Acad Sci U S A 51, 871-876 (1964).
20. Hodge, A.J. & Petruska, J.A. Some recent results on the electron microscopy of tropocollagen
structures, Vol. 1. (Academic Press, New York; 1962).
21. Mould, A.P. et al. D-Periodic Assemblies of Type I Procollagen. J. Mol. Biol. 211, 581-594 (1990).
22. Holmes, D.F. & Kadler, K.E. The precision of lateral size control in the assembly of corneal
collagen fibrils. J Mol Biol 345, 773-784 (2005).
23. Christiansen, D.L., Huang, E.K. & Silver, F.H. Assembly of type I collagen: fusion of fibril subunits
and the influence of fibril diameter on mechanical properties. Matrix Biology 19, 409-420 (2000).
24. Gross, J., Highberger, J.H. & Schmitt, F.O. Some factors involved in the fibrogenesis of collagen in
vitro. Proc Soc Exp Biol Med 80, 462-465 (1952).
25. Payne, K.J. & Veis, A. Fourier transform IR spectroscopy of collagen and gelatin solutions:
deconvolution of the amide I band for conformational studies. Biopolymers 27, 1749-1760 (1988).
26. Kadler, K.E., Hill, A. & Canty-Laird, E.G. Collagen fibrillogenesis: fibronectin, integrins, and minor
collagens as organizers and nucleators. Curr Opin Cell Biol 20, 495-501 (2008).
27. Lee, C.H., Singla, A. & Lee, Y. Biomedical applications of collagen. Int J Pharm 221, 1-22 (2001).
28. Ramshaw, J.A., Peng, Y.Y., Glattauer, V. & Werkmeister, J.A. Collagens as biomaterials. J Mater
Sci Mater Med (2008).
29. Abraham, L.C., Zuena, E., Perez-Ramirez, B. & Kaplan, D.L. Guide to collagen characterization for
biomaterial studies. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 264
(2008).
30. Cancedda, R., Dozin, B., Giannoni, P. & Quarto, R. Tissue engineering and cell therapy of cartilage
and bone. Matrix Biology 22, 81-91 (2003).
References -128-
31. Damsky, C., Sutherland, A. & Fisher, S. Extracellular matrix 5: adhesive interactions in early
mammalian embryogenesis, implantation, and placentation. Faseb J 7, 1320-1329 (1993).
32. Damsky, C.H. & Ilic, D. Integrin signalling: it´s where the action is. Current Opinion in Cell Biology
14, 594-602 (2002).
33. Juliano, R.L. & Haskill, S. Signal transduction from the extracellular matrix. J Cell Biol 120, 577-
585 (1993).
34. Bissell, M.J., Hall, H.G. & Parry, G. How does the extracellular matrix direct gene expression? J
Theor Biol 99, 31-68 (1982).
35. Adams, J.C. & Watt, F.M. Regulation of development and differentiation by the extracellular matrix.
Development 117, 1183-1198 (1993).
36. Meighan, C.M. & Schwarzbauer, J.E. Temporal and spatial regulation of integrins during
development. Curr Opin Cell Biol 20, 520-524 (2008).
37. West, C.M. et al. Fibronectin alters the phenotypic properties of cultured chick embryo
chondroblasts. Cell 17, 491-501 (1979).
38. Reddi, A.H. & Huggins, C.B. Formation of bone marrow in fibroblast-transformation ossicles. Proc
Natl Acad Sci U S A 72, 2212-2216 (1975).
39. Gullberg, D. & Ekblom, P. Extracellular matrix and its receptors during development. Int J Dev Biol
39, 845-854 (1995).
40. Dufour, S., Duband, J.L., Kornblihtt, A.R. & Thiery, J.P. The role of fibronectins in embryonic cell
migrations. Trends Genet 4, 198-203 (1988).
41. Darribere, T. et al. Integrins: regulators of embryogenesis. Biol Cell 92, 5-25 (2000).
42. Yost, H.J. Regulation of vertebrate left-right asymmetries by extracellular matrix. Nature 357, 158-
161 (1992).
43. Meredith, J.E., Jr., Fazeli, B. & Schwartz, M.A. The extracellular matrix as a cell survival factor.
Mol Biol Cell 4, 953-961 (1993).
44. Marastoni, S., Ligresti, G., Lorenzon, E., Colombatti, A. & Mongiat, M. Extracellular matrix: a
matter of life and death. Connect Tissue Res 49, 203-206 (2008).
45. Gilmore, A.P. Anoikis. Cell Death Differ 12 Suppl 2, 1473-1477 (2005).
46. Giancotti, F.G. Integrin signaling: specificity and control of cell survival and cell cycle progression.
Curr Opin Cell Biol 9, 691-700 (1997).
47. Porter, J.C. & Hogg, N. Integrins take partners: cross-talk between integrins and other membrane
receptors. trends in Cell Biology 8, 390-396 (1998).
48. Nathan, C. & Sporn, M. Cytokines in context. J Cell Biol 113, 981-986 (1991).
49. Schwartz, M.A., Schaller, M.D. & Ginsberg, M.H. Integrins: emerging paradigms of signal
transduction. Annu Rev Cell Dev Biol 11, 549-599 (1995).
50. Ignotz, R.A. & Massague, J. Cell adhesion protein receptors as targets for transforming growth
factor-beta action. Cell 51, 189-197 (1987).
51. Ignotz, R.A., Endo, T. & Massague, J. Regulation of fibronectin and type I collagen mRNA levels
by transforming growth factor-beta. J Biol Chem 262, 6443-6446 (1987).
52. Heino, J., Ignotz, R.A., Hemler, M.E., Crouse, C. & Massague, J. Regulation of cell adhesion
receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a
common beta 1 subunit. J Biol Chem 264, 380-388 (1989).
53. Blatti, S.P., Foster, D.N., Ranganathan, G., Moses, H.L. & Getz, M.J. Induction of fibronectin gene
transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc
Natl Acad Sci U S A 85, 1119-1123 (1988).
54. Ruoslahti, E. & Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins. Science
238, 491-497 (1987).
55. Hynes, R.O. Integrins: a family of cell surface receptors. Cell 48, 549-554 (1987).
56. Bell, G.I. Models for Specific Adhesion of Cells to Cells. Science 200, 618-627 (1978).
57. Greenwalt, D.E. et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal
transduction, and transfusion medicine. Blood 80, 1105-1115 (1992).
58. Leitinger, B. & Hohenester, E. Mammalian collagen receptors. Matrix Biol 26, 146-155 (2007).
59. Vuoriluoto, K. et al. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen. Exp
Cell Res 314, 3369-3381 (2008).
60. Cohen, M., Joester, D., Geiger, B. & Addadi, L. Spatial and temporal sequence of events in cell
adhesion: from molecular recognition to focal adhesion assembly. Chembiochem 5, 1393-1399
(2004).
61. Hadari, Y.R. et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell
Sci 113 ( Pt 13), 2385-2397 (2000).
62. Hughes, R.C. Galectins as modulators of cell adhesion. Biochimie 83, 667-676 (2001).
References -129-
63. Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002).
64. Humphries, J.D., Byron, A. & Humphries, M.J. Integrin ligands at a glance. J Cell Sci 119, 3901-
3903 (2006).
65. Carrell, N.A., Fitzgerald, L.A., Steiner, B., Erickson, H.P. & Phillips, D.R. Structure of human
platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy. J Biol Chem
260, 1743-1749 (1985).
66. Nermut, M.V., Green, N.M., Eason, P., Yamada, S.S. & Yamada, K.M. Electron microscopy and
structural model of human fibronectin receptor. Embo J 7, 4093-4099 (1988).
67. Xiong, J.P. et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294,
339-345 (2001).
68. Emsley, J., Knight, C.G., Farndale, R.W., Barnes, M.J. & Liddington, R.C. Structural basis of
collagen recognition by integrin alpha2beta1. Cell 101, 47-56 (2000).
69. Xiong, J.P. et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex
with an Arg-Gly-Asp ligand. Science 296, 151-155 (2002).
70. Arnaout, M.A., Goodman, S.L. & Xiong, J.P. Structure and mechanics of integrin-based cell
adhesion. Curr Opin Cell Biol 19, 495-507 (2007).
71. White, D.J., Puranen, S., Johnson, M.S. & Heino, J. The collagen receptor subfamily of the integrins.
Int J Biochem Cell Biol 36, 1405-1410 (2004).
72. Salminen, T.A. et al. Production, crystallization and preliminary X-ray analysis of the human
integrin alpha1 I domain. Acta Crystallogr D Biol Crystallogr 55, 1365-1367 (1999).
73. Lee, J.O., Rieu, P., Arnaout, M.A. & Liddington, R. Crystal structure of the A domain from the
alpha subunit of integrin CR3 (CD11b/CD18). Cell 80, 631-638 (1995).
74. Qu, A. & Leahy, D.J. Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta
2) integrin. Proc Natl Acad Sci U S A 92, 10277-10281 (1995).
75. Qu, A. & Leahy, D.J. The role of the divalent cation in the structure of the I domain from the
CD11a/CD18 integrin. Structure 4, 931-942 (1996).
76. Emsley, J., King, S.L., Bergelson, J.M. & Liddington, R.C. Crystal structure of the I domain from
integrin alpha2beta1. J Biol Chem 272, 28512-28517 (1997).
77. Shimaoka, M., Takagi, J. & Springer, T.A. Conformational regulation of integrin structure and
function. Annu Rev Biophys Biomol Struct 31, 485-516 (2002).
78. Ginsberg, M.H., Du, X. & Plow, E.F. Inside-out integrin signalling. Curr Opin Cell Biol 4, 766-771
(1992).
79. Coppolino, M.G. & Dedhar, S. Bi-directional signal transduction by integrin receptors. Int J
Biochem Cell Biol 32, 171-188 (2000).
80. Pellinen, T. & Ivaska, J. Integrin traffic. J Cell Sci 119, 3723-3731 (2006).
81. Hotchin, N.A., Gandarillas, A. & Watt, F.M. Regulation of cell surface beta 1 integrin levels during
keratinocyte terminal differentiation. J Cell Biol 128, 1209-1219 (1995).
82. Zhu, J., Boylan, B., Luo, B.H., Newman, P.J. & Springer, T.A. Tests of the extension and deadbolt
models of integrin activation. J Biol Chem 282, 11914-11920 (2007).
83. Calderwood, D.A. Integrin activation. J Cell Sci 117, 657-666 (2004).
84. Hughes, P.E. et al. Breaking the integrin hinge. A defined structural constraint regulates integrin
signaling. J Biol Chem 271, 6571-6574 (1996).
85. Ginsberg, M.H. et al. A membrane-distal segment of the integrin alpha IIb cytoplasmic domain
regulates integrin activation. J Biol Chem 276, 22514-22521 (2001).
86. Takagi, J., Erickson, H.P. & Springer, T.A. C-terminal opening mimics 'inside-out' activation of
integrin alpha5beta1. Nat Struct Biol 8, 412-416 (2001).
87. Tadokoro, S. et al. Talin binding to integrin beta tails: a final common step in integrin activation.
Science 302, 103-106 (2003).
88. Calderwood, D.A. Talin controls integrin activation. Biochem Soc Trans 32, 434-437 (2004).
89. Kolanus, W. et al. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a
cytoplasmic regulatory molecule. Cell 86, 233-242 (1996).
90. Kashiwagi, H. et al. Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a
selective binding partner of the beta3 integrin cytoplasmic tail. J Cell Biol 137, 1433-1443 (1997).
91. Montanez, E. et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev 22, 1325-1330
(2008).
92. O'Toole, T.E. et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol
124, 1047-1059 (1994).
93. Liddington, R.C. & Ginsberg, M.H. Integrin activation takes shape. J Cell Biol 158, 833-839 (2002).
94. Emsley, J., Knight, C.G., Farndale, R.W. & Barnes, M.J. Structure of the integrin alpha2beta1-
binding collagen peptide. J Mol Biol 335, 1019-1028 (2004).
References -130-
95. Luo, B.H. & Springer, T.A. Integrin structures and conformational signaling. Curr Opin Cell Biol
18, 579-586 (2006).
96. Schoenwaelder, S.M. & Burridge, K. Bidirectional signaling between the cytoskeleton and integrins.
Curr Opin Cell Biol 11, 274-286 (1999).
97. Miyamoto, S., Akiyama, S.K. & Yamada, K.M. Synergistic roles for receptor occupancy and
aggregation in integrin transmembrane function. Science 267, 883-885 (1995).
98. Felsenfeld, D.P., Choquet, D. & Sheetz, M.P. Ligand binding regulates the directed movement of
beta1 integrins on fibroblasts. Nature 383, 438-440 (1996).
99. Hato, T., Pampori, N. & Shattil, S.J. Complementary roles for receptor clustering and
conformational change in the adhesive and signaling functions of integrin alphaIIb beta3. J Cell Biol
141, 1685-1695 (1998).
100. Connors, W.L. et al. Two synergistic activation mechanisms of alpha2beta1 integrin-mediated
collagen binding. J Biol Chem 282, 14675-14683 (2007).
101. Huang, M.M. et al. Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine
phosphorylation of novel protein substrates before phosphorylation of pp125FAK. J Cell Biol 122,
473-483 (1993).
102. Delanoe-Ayari, H., Al Kurdi, R., Vallade, M., Gulino-Debrac, D. & Riveline, D. Membrane and
acto-myosin tension promote clustering of adhesion proteins. Proc Natl Acad Sci U S A 101, 2229-
2234 (2004).
103. Galbraith, C.G., Yamada, K.M. & Sheetz, M.P. The relationship between force and focal complex
development. J Cell Biol 159, 695-705 (2002).
104. Burridge, K., Chrzanowska-Wodnicka, M. & Zhong, C. Focal adhesion assembly. Trends Cell Biol
7, 342-347 (1997).
105. Giancotti, F.G. & Tarone, G. Positional control of cell fate through joint integrin/receptor protein
kinase signaling. Annu Rev Cell Dev Biol 19, 173-206 (2003).
106. Moursi, A.M. et al. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109 ( Pt 6),
1369-1380 (1996).
107. Schwartz, M.A. & Assoian, R.K. Integrins and cell proliferation: regulation of cyclin-dependent
kinases via cytoplasmic signaling pathways. J Cell Sci 114, 2553-2560 (2001).
108. Giancotti, F.G. Integrin signaling: specificity and control of cell survival and cell cycle progression.
Curr Opin Cell Biol 9, 691-700 (1997).
109. Gilmore, A.P. Anoikis. Cell Death Differ 12 Suppl 2, 1473-1477 (2005).
110. Clark, E.A., King, W.G., Brugge, J.S., Symons, M. & Hynes, R.O. Integrin-mediated signals
regulated by members of the rho family of GTPases. J Cell Biol 142, 573-586 (1998).
111. Nobes, C.D. & Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal
complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62 (1995).
112. Rottner, K., Hall, A. & Small, J.V. Interplay between Rac and Rho in the control of substrate contact
dynamics. Curr Biol 9, 640-648 (1999).
113. Geiger, B. & Bershadsky, A. Assembly and mechanosensory function of focal contacts. Curr Opin
Cell Biol 13, 584-592 (2001).
114. Zamir, E. et al. Molecular diversity of cell-matrix adhesions. J Cell Sci 112 ( Pt 11), 1655-1669
(1999).
115. Zamir, E. & Geiger, B. Components of cell-matrix adhesions. J Cell Sci 114, 3577-3579 (2001).
116. Abercrombie, M. & Dunn, G.A. Adhesions of fibroblasts to substratum during contact inhibition
observed by interference reflection microscopy. Exp Cell Res 92, 57-62 (1975).
117. Izzard, C.S. & Lochner, L.R. Cell-to-substrate contacts in living fibroblasts: an interference reflexion
study with an evaluation of the technique. J Cell Sci 21, 129-159 (1976).
118. Zamir, E. & Geiger, B. Molecular complexity and dynamics of cell-matrix adhesions. J. Cell Science
114, 3583 (2001).
119. Riveline, D. et al. Focal contacts as mechanosensors: externally applied local mechanical force
induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell
Biol 153, 1175-1186 (2001).
120. Woods, A. & Couchman, J.R. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and
widespread focal adhesion component. Mol. Biol. Cell 5 (1994).
121. Borowsky, M.L. & Hynes, R.O. Layilin, a novel talin-binding transmembrane protein homologous
with C-type lectins, is localized in membrane ruffles. J Cell Biol 143, 429-442 (1998).
122. Tang, H., Kerins, D.M., Hao, Q., Inagami, T. & Vaughan, D.E. The urokinase-type plasminogen
activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of
mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 273, 18268-18272
(1998).
References -131-
123. Wei, Y., Yang, X., Liu, Q., Wilkins, J.A. & Chapman, H.A. A role for caveolin and the urokinase
receptor in integrin-mediated adhesion and signaling. J Cell Biol 144, 1285-1294 (1999).
124. Yebra, M., Goretzki, L., Pfeifer, M. & Mueller, B.M. Urokinase-type plasminogen activator binding
to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Exp Cell Res 250, 231-240 (1999).
125. Gardner, H., Broberg, A., Pozzi, A., Laato, M. & Heino, J. Absence of integrin alpha1beta1 in the
mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J
Cell Sci 112 ( Pt 3), 263-272 (1999).
126. Fassler, R. & Meyer, M. Consequences of lack of beta 1 integrin gene expression in mice. Genes
Dev 9, 1896-1908 (1995).
127. Hynes, R.O. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol
180, 402-412 (1996).
128. Brakebusch, C., Hirsch, E., Potocnik, A. & Fassler, R. Genetic analysis of beta1 integrin function:
confirmed, new and revised roles for a crucial family of cell adhesion molecules. J Cell Sci 110 ( Pt
23), 2895-2904 (1997).
129. van der Flier, A. & Sonnenberg, A. Function and interactions of integrins. Cell Tissue Res 305, 285-
298 (2001).
130. Hogg, N. & Bates, P.A. Genetic analysis of integrin function in man: LAD-1 and other syndromes.
Matrix Biol 19, 211-222 (2000).
131. Guo, W. & Giancotti, F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5,
816-826 (2004).
132. Tang, C.H. & Wei, Y. The urokinase receptor and integrins in cancer progression. Cell Mol Life Sci
65, 1916-1932 (2008).
133. Ivaska, J. et al. A peptide inhibiting the collagen binding function of integrin alpha2I domain. J Biol
Chem 274, 3513-3521 (1999).
134. Kerr, J.R. Cell adhesion molecules in the pathogenesis of and host defence against microbial
infection. Mol Pathol 52, 220-230 (1999).
135. Garcia, A.J. & Gallant, N.D. Stick and grip: measurement systems and quantitative analyses of
integrin-mediated cell adhesion strength. Cell Biochem Biophys 39, 61-73 (2003).
136. Klebe, R.J., Hall, J.R., Rosenberger, P. & Dickey, W.D. Cell attachment to collagen: the ionic
requirements. Exp Cell Res 110, 419-425 (1977).
137. Connors, W.L. & Heino, J. A duplexed microsphere-based cellular adhesion assay. Anal Biochem
337, 246-255 (2005).
138. Kucik, D.F. Measurement of adhesion under flow conditions. Curr Protoc Cell Biol Chapter 9, Unit
9 6 (2003).
139. Pierres, A. et al. Experimental study of the interaction range and association rate of surface-attached
cadherin 11. Proc Natl Acad Sci U S A 95, 9256-9261 (1998).
140. Masson-Gadais, B., Pierres, A., Benoliel, A.M., Bongrand, P. & Lissitzky, J.C. Integrin (alpha) and
beta subunit contribution to the kinetic properties of (alpha)2beta1 collagen receptors on human
keratinocytes analyzed under hydrodynamic conditions. J Cell Sci 112 ( Pt 14), 2335-2345 (1999).
141. Marshall, B.T. et al. Direct observation of catch bonds involving cell-adhesion molecules. Nature
423, 190-193 (2003).
142. Vitte, J., Benoliel, A.M., Eymeric, P., Bongrand, P. & Pierres, A. Beta-1 integrin-mediated adhesion
may be initiated by multiple incomplete bonds, thus accounting for the functional importance of
receptor clustering. Biophys J 86, 4059-4074 (2004).
143. Robert, P., Benoliel, A.M., Pierres, A. & Bongrand, P. What is the biological relevance of the
specific bond properties revealed by single-molecule studies? J Mol Recognit 20, 432-447 (2007).
144. Lotz, M.M., Burdsal, C.A., Erickson, H.P. & McClay, D.R. Cell adhesion to fibronectin and
tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell
Biol 109, 1795-1805 (1989).
145. McClay, D.R., Wessel, G.M. & Marchase, R.B. Intercellular recognition: quantitation of initial
binding events. Proc Natl Acad Sci U S A 78, 4975-4979 (1981).
146. Curtis, A.S. The Mechanism of Adhesion of Cells to Glass. a Study by Interference Reflection
Microscopy. J Cell Biol 20, 199-215 (1964).
147. Gupton, S.L. & Waterman-Storer, C.M. Spatiotemporal feedback between actomyosin and focal-
adhesion systems optimizes rapid cell migration. Cell 125, 1361-1374 (2006).
148. Owen, G.R., Meredith, D.O., ap Gwynn, I. & Richards, R.G. Focal adhesion quantification - a new
assay of material biocompatibility? Review. Eur Cell Mater 9, 85-96; discussion 85-96 (2005).
149. Hunter, A., Archer, C.W., Walker, P.S. & Blunn, G.W. Attachment and proliferation of osteoblasts
and fibroblasts on biomaterials for orthopaedic use. Biomaterials 16, 287-295 (1995).
References -132-
150. Richards, R.G., Owen, G.R., Rahn, B.A. & Gwynn, A.P. A quantitative method of measuring cell-
substrate adhesion areas. Cells and materials 7, 15-30 (1997).
151. Charo, I.F., Nannizzi, L., Phillips, D.R., Hsu, M.A. & Scarborough, R.M. Inhibition of fibrinogen
binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 266, 1415-1421 (1991).
152. O'Toole, T.E. et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol
124, 1047-1059 (1994).
153. Helenius, J., Heisenberg, C.P., Gaub, H.E. & Muller, D.J. Single-cell force spectroscopy. J Cell Sci
121, 1785-1791 (2008).
154. Evans, E., Ritchie, K. & Merkel, R. Sensitive force technique to probe molecular adhesion and
structural linkages at biological interfaces. Biophys J 68, 2580-2587 (1995).
155. Evans, E., Berk, D. & Leung, A. Detachment of agglutinin-bonded red blood cells. Biophys J 59,
838-848 (1991).
156. Zarnitsyna, V.I. et al. Memory in receptor-ligand-mediated cell adhesion. Proc Natl Acad Sci U S A
104, 18037-18042 (2007).
157. Simson, D.A., Ziemann, F., Strigl, M. & Merkel, R. Micropipet-based pico force transducer: in
depth analysis and experimental verification. Biophys J 74, 2080-2088 (1998).
158. Leckband, D. & Israelachvili, J. Intermolecular forces in biology. Q Rev Biophys 34, 105-267
(2001).
159. Andersson, M. et al. Using optical tweezers for measuring the interaction forces between human
bone cells and implant surfaces: System design and force calibration. Rev Sci Instrum 78, 074302
(2007).
160. Neuman, K.C. & Nagy, A. Single-molecule force spectroscopy: optical tweezers, magnetic tweezers
and atomic force microscopy. Nat methods 5, 491-505 (2008).
161. Neuman, K.C., Chadd, E.H., Liou, G.F., Bergman, K. & Block, S.M. Characterization of
photodamage to escherichia coli in optical traps. Biophys J 77, 2856-2863 (1999).
162. Liang, H. et al. Wavelength dependence of cell cloning efficiency after optical trapping. Biophys J
70, 1529-1533 (1996).
163. Kollmannsberger, P. & Fabry, B. High-force magnetic tweezers with force feedback for biological
applications. Rev Sci Instrum 78, 114301 (2007).
164. Walter, N., Selhuber, C., Kessler, H. & Spatz, J.P. Cellular unbinding forces of initial adhesion
processes on nanopatterned surfaces probed with magnetic tweezers. Nano Lett 6, 398-402 (2006).
165. Matthews, B.D. et al. Mechanical properties of individual focal adhesions probed with a magnetic
microneedle. Biochem Biophys Res Commun 313, 758-764 (2004).
166. Binnig, G., Quate, C.F. & Gerber, C. Atomic force microscope. Phys Rev Lett 56, 930-933 (1986).
167. Schönenberger, C. & Alvarado, S.F. A differential interferometer for force spectroscopy. Rev. Sci.
Instrum. 60, 3131 (1989).
168. Hoogenboom, B.W., Frederix, P.L.T.M., Fotiadis, D., Hug, H.J. & Engel, A. Potential of
interferometric cantilever detection and its application for SFM/AFM in liquids. Nanotechnology 19,
6pp (2008).
169. Tortonese, M. Cantilevers and tips for atomic force microscopy. IEEE Eng Med Biol Mag 16, 28-33
(1997).
170. Meyer, G. & Amer, N.M. Novel optical approach to atomic force microscopy. Appl. Phys. Lett. 53,
1045 (1988).
171. Alexander, S. et al. An atomic-resolution atomic-force microscope implemented using an optical
lever. J. appl. phys. 65, 164 (1988).
172. Putman, C.A.J., de Grooth, B.G., Van Hulst, N.F. & Greve, J. A detailed analysis of the optical
beam deflection technique for use in atomic force microscopy. J. Appl. Phys. 72, 6-12 (1992).
173. Evans, E. Probing the relation between force- lifetime- and chemistry in single molecular bonds.
Annu. Rev. Biophys. Biomol. Struct. 30, 105-128 (2001).
174. Florin, E.L., Moy, V.T. & Gaub, H.E. Adhesion forces between individual ligand-receptor pairs.
Science 264, 415-417 (1994).
175. Moy, V.T., Florin, E.L. & Gaub, H.E. Intermolecular forces and energies between ligands and
receptors. Science 266, 257-259 (1994).
176. Merkel, R., Nassoy, P., Leung, A., Ritchie, K. & Evans, E. Energy landscapes of receptor-ligand
bonds explored with dynamic force spectroscopy. Nature 397, 50-53 (1999).
177. Lee, G.U., Chrisey, L.A. & Colton, R.J. Direct measurement of the forces between complementary
strands of DNA. Science 266, 771-773 (1994).
178. Dettmann, W. et al. Differences in zero-force and force-driven kinetics of ligand dissociation from
beta-galactoside-specific proteins (plant and animal lectins, immunoglobulin G) monitored by
References -133-
plasmon resonance and dynamic single molecule force microscopy. Arch Biochem Biophys 383,
157-170 (2000).
179. Puntheeranurak, T., Wildling, L., Gruber, H.J., Kinne, R.K. & Hinterdorfer, P. Ligands on the string:
single-molecule AFM studies on the interaction of antibodies and substrates with the Na+-glucose
co-transporter SGLT1 in living cells. J Cell Sci 119, 2960-2967 (2006).
180. Ros, R. et al. Antigen binding forces of individually addressed single-chain Fv antibody molecules.
Proc Natl Acad Sci U S A 95, 7402-7405 (1998).
181. Hinterdorfer, P., Baumgartner, W., Gruber, H.J., Schilcher, K. & Schindler, H. Detection and
localization of individual antibody-antigen recognition events by atomic force microscopy. Proc
Natl Acad Sci U S A 93, 3477-3481 (1996).
182. Tees, D.F., Waugh, R.E. & Hammer, D.A. A microcantilever device to assess the effect of force on
the lifetime of selectin-carbohydrate bonds. Biophys J 80, 668-682 (2001).
183. Zhang, X., Bogorin, D.F. & Moy, V.T. Molecular basis of the dynamic strength of the sialyl Lewis
X--selectin interaction. Chemphyschem 5, 175-182 (2004).
184. Barsegov, V. & Thirumalai, D. Dynamics of unbinding of cell adhesion molecules: transition from
catch to slip bonds. Proc Natl Acad Sci U S A 102, 1835-1839 (2005).
185. Hanley, W. et al. Single molecule characterization of P-selectin/ligand binding. J Biol Chem 278,
10556-10561 (2003).
186. Evans, E., Leung, A., Heinrich, V. & Zhu, C. Mechanical switching and coupling between two
dissociation pathways in a P-selectin adhesion bond. Proc Natl Acad Sci U S A 101, 11281-11286
(2004).
187. Marshall, B.T., Sarangapani, K.K., Lou, J., McEver, R.P. & Zhu, C. Force history dependence of
receptor-ligand dissociation. Biophys J 88, 1458-1466 (2005).
188. Ratto, T.V., Rudd, R.E., Langry, K.C., Balhorn, R.L. & McElfresh, M.W. Nonlinearly additive
forces in multivalent ligand binding to a single protein revealed with force spectroscopy. Langmuir
22, 1749-1757 (2006).
189. Baumgartner, W., Golenhofen, N., Grundhofer, N., Wiegand, J. & Drenckhahn, D. Ca2+
dependency of N-cadherin function probed by laser tweezer and atomic force microscopy. J
Neurosci 23, 11008-11014 (2003).
190. Baumgartner, W. et al. Cadherin interaction probed by atomic force microscopy. Proc Natl Acad Sci
U S A 97, 4005-4010 (2000).
191. Kokkoli, E., Ochsenhirt, S.E. & Tirrell, M. Collective and single-molecule interactions of
alpha5beta1 integrins. Langmuir 20, 2397-2404 (2004).
192. Thie, M. et al. Interactions between trophoblast and uterine epithelium: monitoring of adhesive
forces. Hum Reprod 13, 3211-3219 (1998).
193. Li, F., Redick, S.D., Erickson, H.P. & Moy, V.T. Force measurements of the alpha5beta1 integrin-
fibronectin interaction. Biophys J 84, 1252-1262 (2003).
194. Puech, P.H. et al. Measuring cell adhesion forces of primary gastrulating cells from zebrafish using
atomic force microscopy. J Cell Sci 118, 4199-4206 (2005).
195. Lehenkari, P.P. & Horton, M.A. Single integrin molecule adhesion forces in intact cells measured by
atomic force microscopy. Biochem Biophys Res Commun 259, 645-650 (1999).
196. Wojcikiewicz, E.P., Zhang, X., Chen, A. & Moy, V.T. Contributions of molecular binding events
and cellular compliance to the modulation of leukocyte adhesion. J Cell Sci 116, 2531-2539 (2003).
197. Benoit, M. Cell adhesion measured by force spectroscopy on living cells. Methods Cell Biol 68, 91-
114 (2002).
198. Panorchan, P. et al. Single-molecule analysis of cadherin-mediated cell-cell adhesion. J Cell Sci 119,
66-74 (2006).
199. Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys J 72, 1541-1555
(1997).
200. Evans, E.A. & Calderwood, D.A. Forces and bond dynamics in cell adhesion. Science 316, 1148-
1153 (2007).
201. Krieg, M., Helenius, J., Heisenberg, C.P. & Muller, D.J. A bond for a lifetime: employing membrane
nanotubes from living cells to determine receptor-ligand kinetics. Angew. Chem. Int. Ed. Engl. 47,
9775-9777 (2008).
202. Waugh, R.E. & Hochmuth, R.M. Mechanical equilibrium of thick, hollow, liquid membrane
cylinders. Biophys J 52, 391-400 (1987).
203. Derenyi, I., Julicher, F. & Prost, J. Formation and interaction of membrane tubes. Phys Rev Lett 88,
238101 (2002).
204. Hochmuth, R.M. & Marcus, W.D. Membrane tethers formed from blood cells with available area
and determination of their adhesion energy. Biophys J 82, 2964-2969 (2002).
References -134-
205. Sheetz, M.P. Cell control by membrane-cytoskeleton adhesion. Nat Rev Mol Cell Biol 2, 392-396
(2001).
206. Shao, J.Y. & Hochmuth, R.M. Micropipette suction for measuring piconewton forces of adhesion
and tether formation from neutrophil membranes. Biophys J 71, 2892-2901 (1996).
207. Davis, D.M. & Sowinski, S. Membrane nanotubes: dynamic long-distance connections between
animal cells. Nat. Rev. Mol. Cell Biol. 9, 431-436 (2008).
208. Radmacher, M. Measuring the elastic properties of living cells by the atomic force microscope.
Methods Cell Biol 68, 67-90 (2002).
209. Radmacher, M., Fritz, M., Kacher, C.M., Cleveland, J.P. & Hansma, P.K. Measuring the viscoelastic
properties of human platelets with the atomic force microscope. Biophys J 70, 556-567 (1996).
210. Franz, C.M., Taubenberger, A., Puech, P.H. & Muller, D.J. Studying integrin-mediated cell adhesion
at the single-molecule level using AFM force spectroscopy. Sci STKE 2007, pl5 (2007).
211. Benoit, M., Gabriel, D., Gerisch, G. & Gaub, H.E. Discrete interactions in cell adhesion measured by
single-molecule force spectroscopy. Nat Cell Biol 2, 313-317 (2000).
212. Selhuber-Unkel, C., Lopez-Garcia, M., Kessler, H. & Spatz, J.P. Cooperativity in adhesion cluster
formation during initial cell adhesion. Biophys J 95, 5424-5431 (2008).
213. Zhang, X., Wojcikiewicz, E.P. & Moy, V.T. Dynamic adhesion of T lymphocytes to endothelial
cells revealed by atomic force microscopy. Exp Biol Med (Maywood) 231, 1306-1312 (2006).
214. Zhang, X. et al. Atomic force microscopy measurement of leukocyte-endothelial interaction. Am J
Physiol Heart Circ Physiol 286, H359-367 (2004).
215. Zhang, X., Wojcikiewicz, E. & Moy, V.T. Force spectroscopy of the leukocyte function-associated
antigen-1/intercellular adhesion molecule-1 interaction. Biophys J 83, 2270-2279 (2002).
216. Zhang, X., Craig, S.E., Kirby, H., Humphries, M.J. & Moy, V.T. Molecular basis for the dynamic
strength of the integrin alpha4beta1/VCAM-1 interaction. Biophys J 87, 3470-3478 (2004).
217. Wojcikiewicz, E. et al. LFA-1 binding destabilizes the JAM-A homophilic interaction during
leukocyte transmigration. Biophys J 96, 285-293 (2009).
218. Puech, P.H., Poole, K., Knebel, D. & Muller, D.J. A new technical approach to quantify cell
adhesion forces by AFM. Ultramicroscopy 106, 637-644 (2006).
219. Taubenberger, A. et al. Revealing early steps of alpha2beta1 integrin-mediated adhesion to collagen
type I by using single-cell force spectroscopy. Mol Biol Cell 18, 1634-1644 (2007).
220. Ulrich, F. et al. Wnt11 functions in gastrulation by controlling cell cohesion through Rab5c and E-
cadherin. Dev Cell 9, 555-564 (2005).
221. Krieg, M. et al. Tensile forces govern germ-layer organization in zebrafish. Nat Cell Biol 10, 429-
436 (2008).
222. Friedrichs, J. et al. Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single
cell force spectroscopy. J Biol Chem 282, 29375-29383 (2007).
223. Friedrichs, J., Manninen, A., Muller, D.J. & Helenius, J. Galectin-3 regulates integrin alpha2beta1-
mediated adhesion to collagen-I and -IV. J Biol Chem 283, 32264-32272 (2008).
224. Tulla, M. et al. TPA primes alpha2beta1 integrins for cell adhesion. FEBS Lett 582, 3520-3524
(2008).
225. Panorchan, P., George, J.P. & Wirtz, D. Probing intercellular interactions between vascular
endothelial cadherin pairs at single-molecule resolution and in living cells. J Mol Biol 358, 665-674
(2006).
226. Bajpai, S. et al. {alpha}-Catenin mediates initial E-cadherin-dependent cell-cell recognition and
subsequent bond strengthening. Proc Natl Acad Sci U S A 105, 18331-18336 (2008).
227. Hanley, W.D., Wirtz, D. & Konstantopoulos, K. Distinct kinetic and mechanical properties govern
selectin-leukocyte interactions. J Cell Sci 117, 2503-2511 (2004).
228. Rosenbluth, M.J., Lam, W.A. & Fletcher, D.A. Force microscopy of nonadherent cells: a
comparison of leukemia cell deformability. Biophys J 90, 2994-3003 (2006).
229. Alcaraz, J. et al. Microrheology of human lung epithelial cells measured by atomic force
microscopy. Biophys J 84, 2071-2079 (2003).
230. Benoit, M. & Gaub, H.E. Measuring cell adhesion forces with the atomic force microscope at the
molecular level. Cells Tissues Organs 172, 174-189 (2002).
231. Lam, W.A., Rosenbluth, M.J. & Fletcher, D.A. Chemotherapy exposure increases leukemia cell
stiffness. Blood 109, 3505-3508 (2007).
232. Wu, H.W., Kuhn, T. & Moy, V.T. Mechanical properties of L929 cells measured by atomic force
microscopy: effects of anticytoskeletal drugs and membrane crosslinking. Scanning 20, 389-397
(1998).
233. Francius, G., Domenech, O., Mingeot-Leclercq, M.P. & Dufrene, Y.F. Direct observation of
Staphylococcus aureus cell wall digestion by lysostaphin. J Bacteriol 190, 7904-7909 (2008).
References -135-
234. Reich, A., Meurer, M., Eckes, B., Friedrichs, J. & Muller, D.J. Surface morphology and mechanical
properties of fibroblasts from scleroderma patients. J Cell Mol Med (2008).
235. Cross, S.E., Jin, Y.S., Rao, J. & Gimzewski, J.K. Nanomechanical analysis of cells from cancer
patients. Nat. Nanotechnol. 2 (2007).
236. Li, Q.S., Lee, G.Y., Ong, C.N. & Lim, C.T. AFM indentation study of breast cancer cells. Biochem
Biophys Res Commun 374 (2008).
237. Faria, E.C. et al. Measurements of elastic properties of prostate cancer cells using AFM. Analyst 133
(2008).
238. Charras, G.T., Lehenkari, P.P. & Horton, M.A. Atomic force microscopy can be used to
mechanically stimulate osteoblasts and evaluate cellular strain distribution. Ultramicroscopy 86, 85-
95 (2001).
239. Prass, M., Jacobson, K., Mogilner, A. & Radmacher, M. Direct measurement of the lamellipodial
protrusive force in a migrating cell. J Cell Biol 174, 767-772 (2006).
240. Brunner, C.A. et al. Cell migration through small gaps. Eur. Biophys. J. 35, 713-719 (2006).
241. Grandbois, M., Dettmann, W., Benoit, M. & Gaub, H.E. Affinity imaging of red blood cells using an
atomic force microscope. J Histochem Cytochem 48, 719-724 (2000).
242. Hinterdorfer, P. & Dufrene, Y.F. Detection and localization of single molecular recognition events
using atomic force microscopy. Nat Methods 3, 347-355 (2006).
243. Sotres, J. et al. Unbinding molecular recognition force maps of localized single receptor molecules
by atomic force microscopy. Chemphyschem 9, 590-599 (2008).
244. Dufrene, Y.F. & Hinterdorfer, P. Recent progress in AFM molecular recognition studies. Pflugers
Arch 456, 237-245 (2008).
245. Dufrene, Y.F. Nanoscale exploration of microbial surfaces using the atomic force microscope.
Future Microbiol 1, 387-396 (2006).
246. Bell, G.I. Models for Specific Adhesion of Cells to Cells. Science 200, 618-627 (1978).
247. Cohen, M., Joester, D., Geiger, B. & Addadi, L. Spatial and temporal sequence of events in cell
adhesion: from molecular recognition to focal adhesion assembly. Chembiochem 5, 1393-1399
(2004).
248. Chen, Y., Lagerholm, B.C., Yang, B. & Jacobson, K. Methods to measure the lateral diffusion of
membrane lipids and proteins. Methods 39, 147-153 (2006).
249. Yauch, R.L. et al. Mutational evidence for control of cell adhesion through integrin
diffusion/clustering, independent of ligand binding. J Exp Med 186, 1347-1355 (1997).
250. de Brabander, M. et al. Lateral diffusion and retrograde movements of individual cell surface
components on single motile cells observed with Nanovid microscopy. J Cell Biol 112, 111-124
(1991).
251. Jacobson, K., Ishihara, A. & Inman, R. Lateral diffusion of proteins in membranes. Annu Rev
Physiol 49, 163-175 (1987).
252. Hammer, D.A. & Lauffenburger, D.A. A dynamical model for receptor-mediated cell adhesion to
surfaces. Biophys J 52, 475-487 (1987).
253. Evans, E. & Williams, P. Dynamic Force Spectroscopy: I. Single Bonds. (2002).
254. Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys J 72, 1541-1555
(1997).
255. Evans, E. Energy landscapes of biomolecular adhesion and receptor anchoring at interfaces explored
with dynamic force spectroscopy. Faraday Discuss. 111, 1-16 (1998).
256. Evans, E.A. & Calderwood, D.A. Forces and bond dynamics in cell adhesion. Science 316, 1148-
1153 (2007).
257. Marshall, B.T. et al. Direct observation of catch bonds involving cell-adhesion molecules. Nature
423, 190-193 (2003).
258. Zhurkov, S.N. International Journal of Fracture Mechanics 1, 311-323 (1965).
259. Ray, C., Brown, J.R. & Akhremitchev, B.B. Rupture force analysis and the associated systematic
errors in force spectroscopy by AFM. Langmuir 23, 6076-6083 (2007).
260. Thomas, W. Catch bonds in adhesion. Annu Rev Biomed Eng 10, 39-57 (2008).
261. Li, F., Redick, S.D., Erickson, H.P. & Moy, V.T. Force measurements of the alpha5beta1 integrin-
fibronectin interaction. Biophys J 84, 1252-1262 (2003).
262. Zhang, X., Craig, S.E., Kirby, H., Humphries, M.J. & Moy, V.T. Molecular basis for the dynamic
strength of the integrin alpha4beta1/VCAM-1 interaction. Biophys J 87, 3470-3478 (2004).
263. Zhang, X., Wojcikiewicz, E. & Moy, V.T. Force spectroscopy of the leukocyte function-associated
antigen-1/intercellular adhesion molecule-1 interaction. Biophys J 83, 2270-2279 (2002).
264. Baumgartner, W. et al. Cadherin interaction probed by atomic force microscopy. Proc Natl Acad Sci
U S A 97, 4005-4010 (2000).
References -136-
265. Baumgartner, W., Golenhofen, N., Grundhofer, N., Wiegand, J. & Drenckhahn, D. Ca2+
dependency of N-cadherin function probed by laser tweezer and atomic force microscopy. J
Neurosci 23, 11008-11014 (2003).
266. Marshall, B.T., Sarangapani, K.K., Lou, J., McEver, R.P. & Zhu, C. Force history dependence of
receptor-ligand dissociation. Biophys J 88, 1458-1466 (2005).
267. Barsegov, V. & Thirumalai, D. Dynamics of unbinding of cell adhesion molecules: transition from
catch to slip bonds. Proc Natl Acad Sci U S A 102, 1835-1839 (2005).
268. Zhang, X., Bogorin, D.F. & Moy, V.T. Molecular basis of the dynamic strength of the sialyl Lewis
X--selectin interaction. Chemphyschem 5, 175-182 (2004).
269. Evans, E., Leung, A., Heinrich, V. & Zhu, C. Mechanical switching and coupling between two
dissociation pathways in a P-selectin adhesion bond. Proc Natl Acad Sci U S A 101, 11281-11286
(2004).
270. Thomas, W. Catch bonds in adhesion. Annu. Rev. Biomed. Eng. 10, 39-57 (2008).
271. Thomas, W. et al. Catch bond model derived from allostery explains force-activated bacterial
adhesion. Biophys J 90, 753-764 (2006).
272. White, D.J., Puranen, S., Johnson, M.S. & Heino, J. The collagen receptor subfamily of the integrins.
Int J Biochem Cell Biol 36, 1405-1410 (2004).
273. Heino, J. The collagen family members as cell adhesion proteins. Bioessays 29, 1001-1010 (2007).
274. Wayner, E.A. & Carter, W.G. Identification of multiple cell adhesion receptors for collagen and
fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell
Biol 105, 1873-1884 (1987).
275. Gullberg, D. et al. Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell--
collagen interactions: identification of conformation dependent alpha 1 beta 1 binding sites in
collagen type I. Embo J 11, 3865-3873 (1992).
276. Voigt, S. et al. Distribution and quantification of alpha 1-integrin subunit in rat organs. Histochem J
27, 123-132 (1995).
277. Zutter, M.M. & Santoro, S.A. Widespread histologic distribution of the alpha 2 beta 1 integrin cell-
surface collagen receptor. Am J Pathol 137, 113-120 (1990).
278. Santoro, S.A. & Zutter, M.M. The alpha 2 beta 1 integrin: a collagen receptor on platelets and other
cells. Thromb Haemost 74, 813-821 (1995).
279. Camper, L., Hellman, U. & Lundgren-Akerlund, E. Isolation, cloning, and sequence analysis of the
integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes. J
Biol Chem 273, 20383-20389 (1998).
280. Eckes, B. et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J
Investig Dermatol Symp Proc 11, 66-72 (2006).
281. Velling, T., Kusche-Gullberg, M., Sejersen, T. & Gullberg, D. cDNA cloning and chromosomal
localization of human alpha(11) integrin. A collagen-binding, I domain-containing, beta(1)-
associated integrin alpha-chain present in muscle tissues. J Biol Chem 274, 25735-25742 (1999).
282. Gardner, H., Broberg, A., Pozzi, A., Laato, M. & Heino, J. Absence of integrin alpha1beta1 in the
mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J
Cell Sci 112 ( Pt 3), 263-272 (1999).
283. Pozzi, A., Wary, K.K., Giancotti, F.G. & Gardner, H.A. Integrin alpha1beta1 mediates a unique
collagen-dependent proliferation pathway in vivo. J Cell Biol 142, 587-594 (1998).
284. Langholz, O. et al. Collagen and collagenase gene expression in three-dimensional collagen lattices
are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 131, 1903-1915
(1995).
285. Riikonen, T., Vihinen, P., Potila, M., Rettig, W. & Heino, J. Antibody against human alpha 1 beta 1
integrin inhibits HeLa cell adhesion to laminin and to type I, IV, and V collagens. Biochem Biophys
Res Commun 209, 205-212 (1995).
286. Tiger, C.F., Fougerousse, F., Grundstrom, G., Velling, T. & Gullberg, D. alpha11beta1 integrin is a
receptor for interstitial collagens involved in cell migration and collagen reorganization on
mesenchymal nonmuscle cells. Dev Biol 237, 116-129 (2001).
287. Popova, S.N. et al. The mesenchymal alpha11beta1 integrin attenuates PDGF-BB-stimulated
chemotaxis of embryonic fibroblasts on collagens. Dev Biol 270, 427-442 (2004).
288. Velling, T., Risteli, J., Wennerberg, K., Mosher, D.F. & Johansson, S. Polymerization of type I and
III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta
1. J Biol Chem 277, 37377-37381 (2002).
289. Nykvist, P. et al. Distinct recognition of collagen subtypes by alpha(1)beta(1) and alpha(2)beta(1)
integrins. Alpha(1)beta(1) mediates cell adhesion to type XIII collagen. J Biol Chem 275, 8255-8261
(2000).
References -137-
290. Heino, J. The collagen receptor integrins have distinct ligand recognition and signaling functions.
Matrix Biol 19, 319-323 (2000).
291. Zhang, W.M. et al. alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial
collagens. J Biol Chem 278, 7270-7277 (2003).
292. Jokinen, J. et al. Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem 279, 31956-
31963 (2004).
293. Nolte, M. et al. Crystal structure of the alpha1beta1 integrin I-domain: insights into integrin I-
domain function. FEBS Lett 452, 379-385 (1999).
294. Kern, A., Eble, J., Golbik, R. & Kuhn, K. Interaction of type IV collagen with the isolated integrins
alpha 1 beta 1 and alpha 2 beta 1. Eur J Biochem 215, 151-159 (1993).
295. Kern, A., Briesewitz, R., Bank, I. & Marcantonio, E.E. The role of the I domain in ligand binding of
the human integrin alpha 1 beta 1. J Biol Chem 269, 22811-22816 (1994).
296. Tulla, M. et al. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I
domains. J Biol Chem 276, 48206-48212 (2001).
297. Knight, C.G. et al. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1)
recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J
Biol Chem 275, 35-40 (2000).
298. Emsley, J., Knight, C.G., Farndale, R.W., Barnes, M.J. & Liddington, R.C. Structural basis of
collagen recognition by integrin alpha2beta1. Cell 101, 47-56 (2000).
299. Masson-Gadais, B., Pierres, A., Benoliel, A.M., Bongrand, P. & Lissitzky, J.C. Integrin (alpha) and
beta subunit contribution to the kinetic properties of (alpha)2beta1 collagen receptors on human
keratinocytes analyzed under hydrodynamic conditions. J Cell Sci 112 ( Pt 14), 2335-2345 (1999).
300. Geiger, B., Bershadsky, A., Pankov, R. & Yamada, K.M. Transmembrane crosstalk between the
extracellular matrix--cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2, 793-805 (2001).
301. Jiang, F., Horber, H., Howard, J. & Muller, D.J. Assembly of collagen into microribbons: effects of
pH and electrolytes. J Struct Biol 148, 268-278 (2004).
302. Cisneros, D.A., Friedrichs, J., Taubenberger, A., Franz, C.M. & Muller, D.J. Creating ultrathin
nanoscopic collagen matrices for biological and biotechnological applications. Small 3, 956-963
(2007).
303. Cisneros, D.A., Hung, C., Franz, C.M. & Muller, D.J. Observing growth steps of collagen self-
assembly by time-lapse high-resolution atomic force microscopy. J Struct Biol 154, 232-245 (2006).
304. Petruska, J.A. & Hodge, A.J. A Subunit Model for the Tropocollagen Macromolecule. Proc Natl
Acad Sci U S A 51, 871-876 (1964).
305. Holmes, D.F., Graham, H.K. & Kadler, K.E. Collagen fibrils forming in developing tendon show an
early and abrupt limitation in diameter at the growing tips. J Mol Biol 283, 1049-1058 (1998).
306. Holmes, D.F. et al. Corneal collagen fibril structure in three dimensions: Structural insights into
fibril assembly, mechanical properties, and tissue organization. Proc Natl Acad Sci U S A 98, 7307-
7312 (2001).
307. Poole, K. et al. Molecular-scale topographic cues induce the orientation and directional movement of
fibroblasts on two-dimensional collagen surfaces. J Mol Biol 349, 380-386 (2005).
308. Friedrichs, J., Taubenberger, A., Franz, C.M. & Muller, D.J. Cellular remodelling of individual
collagen fibrils visualized by time-lapse AFM. J Mol Biol 372, 594-607 (2007).
309. Tuckwell, D. & Humphries, M.J. Integrin-collagen binding. Seminars in Cell & Developmental
Biology 7, 649-657 (1996).
310. Ivaska, J. et al. A peptide inhibiting the collagen binding function of integrin alpha2 I domain. J Biol
Chem 274, 3513-3521. (1999).
311. Tulla, M. et al. TPA primes alpha2beta1 integrins for cell adhesion. FEBS Lett 582, 3520-3524
(2008).
312. Vogel, W. et al. Discoidin domain receptor 1 is activated independently of beta(1) integrin. J Biol
Chem 275, 5779-5784 (2000).
313. Krensel, K. & Lichtner, R.B. Selective increase of alpha2-integrin sub-unit expression on human
carcinoma cells upon EGF-receptor activation. Int J Cancer 80, 546-552 (1999).
314. Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys J 72, 1541-1555
(1997).
315. Zhu, J., Boylan, B., Luo, B.H., Newman, P.J. & Springer, T.A. Tests of the extension and deadbolt
models of integrin activation. J Biol Chem 282, 11914-11920 (2007).
316. Xu, Y. et al. Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1.
J Biol Chem 275, 38981-38989 (2000).
317. Li, F., Redick, S.D., Erickson, H.P. & Moy, V.T. Force measurements of the alpha5beta1 integrin-
fibronectin interaction. Biophys J 84, 1252-1262 (2003).
References -138-
318. Zhang, X. et al. Atomic force microscopy measurement of leukocyte-endothelial interaction. Am J
Physiol Heart Circ Physiol 286, H359-367 (2004).
319. Wojcikiewicz, E.P., Abdulreda, M.H., Zhang, X. & Moy, V.T. Force spectroscopy of LFA-1 and its
ligands, ICAM-1 and ICAM-2. Biomacromolecules 7, 3188-3195 (2006).
320. Zhang, X., Craig, S.E., Kirby, H., Humphries, M.J. & Moy, V.T. Molecular basis for the dynamic
strength of the integrin alpha4beta1/VCAM-1 interaction. Biophys J 87, 3470-3478 (2004).
321. Robert, P., Benoliel, A.M., Pierres, A. & Bongrand, P. What is the biological relevance of the
specific bond properties revealed by single-molecule studies? J Mol Recognit 20, 432-447 (2007).
322. Bustamante, C., Chemla, Y.R., Forde, N.R. & Izhaky, D. Mechanical processes in biochemistry.
Annu Rev Biochem 73, 705-748 (2004).
323. Zhang, X., Wojcikiewicz, E. & Moy, V.T. Force spectroscopy of the leukocyte function-associated
antigen-1/intercellular adhesion molecule-1 interaction. Biophys J 83, 2270-2279 (2002).
324. Waugh, R.E. & Hochmuth, R.M. Mechanical equilibrium of thick, hollow, liquid membrane
cylinders. Biophys J 52, 391-400 (1987).
325. Bo, L. & Waugh, R.E. Determination of bilayer membrane bending stiffness by tether formation
from giant, thin-walled vesicles. Biophys J 55, 509-517 (1989).
326. Derenyi, I., Julicher, F. & Prost, J. Formation and interaction of membrane tubes. Phys Rev Lett 88,
238101 (2002).
327. Hochmuth, R.M. & Marcus, W.D. Membrane tethers formed from blood cells with available area
and determination of their adhesion energy. Biophys J 82, 2964-2969 (2002).
328. Sheetz, M.P. Cell control by membrane-cytoskeleton adhesion. Nat Rev Mol Cell Biol 2, 392-396
(2001).
329. Shao, J.Y. & Hochmuth, R.M. Micropipette suction for measuring piconewton forces of adhesion
and tether formation from neutrophil membranes. Biophys J 71, 2892-2901 (1996).
330. Krieg, M., Helenius, J., Heisenberg, C.P. & Muller, D.J. A bond for a lifetime: employing membrane
nanotubes from living cells to determine receptor-ligand kinetics. Angew. Chem. Int. Ed. Engl. 47,
9775-9777 (2008).
331. Hosu, B.G., Sun, M., Marga, F., Grandbois, M. & Forgacs, G. Eukaryotic membrane tethers
revisited using magnetic tweezers. Phys Biol 4, 67-78 (2007).
332. Sun, M. et al. Multiple membrane tethers probed by atomic force microscopy. Biophys J 89, 4320-
4329 (2005).
333. Hato, T., Pampori, N. & Shattil, S.J. Complementary roles for receptor clustering and
conformational change in the adhesive and signaling functions of integrin alphaIIb beta3. J Cell Biol
141, 1685-1695 (1998).
334. Carman, C.V. & Springer, T.A. Integrin avidity regulation: are changes in affinity and conformation
underemphasized? Curr Opin Cell Biol 15, 547-556 (2003).
335. Chen, A. & Moy, V.T. Cross-linking of cell surface receptors enhances cooperativity of molecular
adhesion. Biophys J 78, 2814-2820 (2000).
336. Florin, E.L., Moy, V.T. & Gaub, H.E. Adhesion forces between individual ligand-receptor pairs.
Science 264, 415-417 (1994).
337. Lehenkari, P.P. & Horton, M.A. Single integrin molecule adhesion forces in intact cells measured by
atomic force microscopy. Biochem Biophys Res Commun 259, 645-650 (1999).
338. Ratto, T.V., Rudd, R.E., Langry, K.C., Balhorn, R.L. & McElfresh, M.W. Nonlinearly additive
forces in multivalent ligand binding to a single protein revealed with force spectroscopy. Langmuir
22, 1749-1757 (2006).
339. Rottner, K., Hall, A. & Small, J.V. Interplay between Rac and Rho in the control of substrate contact
dynamics. Curr Biol 9, 640-648 (1999).
340. Duband, J.L. et al. Fibronectin receptor exhibits high lateral mobility in embryonic locomoting cells
but is immobile in focal contacts and fibrillar streaks in stationary cells. J Cell Biol 107, 1385-1396
(1988).
341. Felsenfeld, D.P., Choquet, D. & Sheetz, M.P. Ligand binding regulates the directed movement of
beta1 integrins on fibroblasts. Nature 383, 438-440 (1996).
342. Choquet, D., Felsenfeld, D.P. & Sheetz, M.P. Extracellular matrix rigidity causes strengthening of
integrin-cytoskeleton linkages. Cell 88, 39-48 (1997).
343. Humphrey, D., Duggan, C., Saha, D., Smith, D. & Kas, J. Active fluidization of polymer networks
through molecular motors. Nature 416, 413-416 (2002).
344. Laevsky, G. & Knecht, D.A. Cross-linking of actin filaments by myosin II is a major contributor to
cortical integrity and cell motility in restrictive environments. J Cell Sci 116, 3761-3770 (2003).
345. Riento, K. & Ridley, A.J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4,
446-456 (2003).
References -139-
346. Chrzanowska-Wodnicka, M. & Burridge, K. Rho-stimulated contractility drives the formation of
stress fibers and focal adhesions. J Cell Biol 133, 1403-1415 (1996).
347. Sawada, Y. et al. Force sensing by mechanical extension of the src family kinase substrate p130cas.
Cell 127, 1015-1026 (2006).
348. Cohen, M., Joester, D., Geiger, B. & Addadi, L. Spatial and temporal sequence of events in cell
adhesion: from molecular recognition to focal adhesion assembly. Chembiochem 5, 1393-1399
(2004).
349. Lotz, M.M., Burdsal, C.A., Erickson, H.P. & McClay, D.R. Cell adhesion to fibronectin and
tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell
Biol 109, 1795-1805 (1989).
350. Gallant, N.D. & Garcia, A.J. Model of integrin-mediated cell adhesion strengthening. J Biomech 40,
1301-1309 (2007).
351. Evans, E.A. & Calderwood, D.A. Forces and bond dynamics in cell adhesion. Science 316, 1148-
1153 (2007).
352. Panorchan, P. et al. Single-molecule analysis of cadherin-mediated cell-cell adhesion. J Cell Sci 119,
66-74 (2006).
353. Pierschbacher, M.D. & Ruoslahti, E. Variants of the cell recognition site of fibronectin that
retain attachment-promoting activity. Proc Natl Acad Sci U S A 81, 5985-5988 (1984).
354. Pierschbacher, M.D., Hayman, E.G. & Ruoslahti, E. The cell attachment determinant in
fibronectin. J Cell Biochem 28, 115-126 (1985).
355. Ruoslahti, E. & Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins.
Science 238, 491-497 (1987).
356. Bernard, M.P. et al. Structure of a cDNA for the pro alpha 2 chain of human type I
procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved
features of the protein and the gene. Biochemistry 22, 1139-1145 (1983).
357. Hayman, E.G., Pierschbacher, M.D. & Ruoslahti, E. Detachment of cells from culture
substrate by soluble fibronectin peptides. J Cell Biol 100, 1948-1954 (1985).
358. Gullberg, D. et al. Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in
cell--collagen interactions: identification of conformation dependent alpha 1 beta 1 binding
sites in collagen type I. Embo J 11, 3865-3873 (1992).
359. White, D.J., Puranen, S., Johnson, M.S. & Heino, J. The collagen receptor subfamily of the
integrins. Int J Biochem Cell Biol 36, 1405-1410 (2004).
360. Tulla, M. et al. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha
10I domains. J Biol Chem 276, 48206-48212 (2001).
361. Heino, J. The collagen family members as cell adhesion proteins. Bioessays 29, 1001-1010
(2007).
362. Federman, S., Miller, L.M. & Sagi, I. Following matrix metalloproteinases activity near the
cell boundary by infrared micro-spectroscopy. Matrix Biol 21, 567-577 (2002).
363. George, A. & Veis, A. FTIRS in H2O demonstrates that collagen monomers undergo a
conformational transition prior to thermal self-assembly in vitro. Biochemistry 30, 2372-2377
(1991).
364. Davis, G.E. Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to
denatured collagen type I through RGD sites. Biochem Biophys Res Commun 182, 1025-1031
(1992).
365. Yamamoto, M., Yamato, M., Aoyagi, M. & Yamamoto, K. Identification of integrins involved
in cell adhesion to native and denatured type I collagens and the phenotypic transition of
rabbit arterial smooth muscle cells. Exp Cell Res 219, 249-256 (1995).
366. Davis, G.E., Bayless, K.J., Davis, M.J. & Meininger, G.A. Regulation of tissue injury
responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J
Pathol 156, 1489-1498 (2000).
367. Humphries, J.D., Byron, A. & Humphries, M.J. Integrin ligands at a glance. J Cell Sci 119,
3901-3903 (2006).
368. Grinnell, F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13,
264-269 (2003).
369. Damsky, C., Tremble, P. & Werb, Z. Signal transduction via the fibronectin receptor: do
integrins regulate matrix remodeling? Matrix Suppl 1, 184-191 (1992).
370. Damsky, C.H. Extracellular matrix-integrin interactions in osteoblast function and tissue
remodeling. Bone 25, 95-96 (1999).
371. Adams, J.C. & Watt, F.M. Regulation of development and differentiation by the extracellular
matrix. Development 117, 1183-1198 (1993).
References -140-
372. Adams, J.C. & Watt, F.M. Changes in keratinocyte adhesion during terminal differentiation:
reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface.
Cell 63, 425-435 (1990).
373. Abraham, L.C., Dice, J.F., Lee, K. & Kaplan, D.L. Phagocytosis and remodeling of collagen
matrices. Exp Cell Res 313, 1045-1055 (2007).
374. Lloyd, A.W. Interfacial bioengineering to enhance surface biocompatibility. Med Device
Technol 13, 18-21 (2002).
375. Lee, K.B., Park, S.J., Mirkin, C.A., Smith, J.C. & Mrksich, M. Protein nanoarrays generated
by dip-pen nanolithography. Science 295, 1702-1705 (2002).
376. Sato, K. et al. Possible involvement of aminotelopeptide in self-assembly and thermal stability
of collagen I as revealed by its removal with proteases. J Biol Chem 275, 25870-25875
(2000).
377. Mauney, J.R. et al. Matrix-mediated retention of in vitro osteogenic differentiation potential
and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem
cells during ex vivo expansion. J Biomed Mater Res A 79, 464-475 (2006).
378. Mauney, J.R., Kaplan, D.L. & Volloch, V. Matrix-mediated retention of osteogenic
differentiation potential by human adult bone marrow stromal cells during ex vivo expansion.
Biomaterials 25, 3233-3243 (2004).
379. Mauney, J.R., Volloch, V. & Kaplan, D.L. Matrix-mediated retention of adipogenic
differentiation potential by human adult bone marrow-derived mesenchymal stem cells during
ex vivo expansion. Biomaterials 26, 6167-6175 (2005).
380. Cisneros, D.A., Friedrichs, J., Taubenberger, A., Franz, C.M. & Muller, D.J. Creating
ultrathin nanoscopic collagen matrices for biological and biotechnological applications. Small
3, 956-963 (2007).
381. Holmes, D.F. et al. Corneal collagen fibril structure in three dimensions: Structural insights
into fibril assembly, mechanical properties, and tissue organization. Proc Natl Acad Sci U S A
98, 7307-7312 (2001).
382. Werkmeister, J.A., Ramshaw, J.A. & Ellender, G. Characterisation of a monoclonal antibody
against native human type I collagen. Eur J Biochem 187, 439-443 (1990).
383. Poole, K. et al. Molecular-scale topographic cues induce the orientation and directional
movement of fibroblasts on two-dimensional collagen surfaces. J Mol Biol 349, 380-386
(2005).
384. Zhang, X., Wojcikiewicz, E. & Moy, V.T. Force spectroscopy of the leukocyte function-
associated antigen-1/intercellular adhesion molecule-1 interaction. Biophys J 83, 2270-2279
(2002).
385. Helenius, J., Heisenberg, C.P., Gaub, H.E. & Muller, D.J. Single-cell force spectroscopy. J
Cell Sci 121, 1785-1791 (2008).
386. Tuckwell, D.S., Ayad, S., Grant, M.E., Takigawa, M. & Humphries, M.J. Conformation
dependence of integrin-type II collagen binding. Inability of collagen peptides to support
alpha 2 beta 1 binding, and mediation of adhesion to denatured collagen by a novel alpha 5
beta 1-fibronectin bridge. J Cell Sci 107 ( Pt 4), 993-1005 (1994).
387. Pfaff, M. et al. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and
unfolded triple helix of collagen type VI. Exp Cell Res 206, 167-176 (1993).
388. Pacifici, R. et al. Ligand binding to monocyte a5/b1 integrin activates the a2/b1 receptor via
the a5 subunit cytoplasmic domain and protein kinase C. J. Immunol. 153, 2222-2233 (1994).
389. Salasznyk, R.M., Williams, W.A., Boskey, A., Batorsky, A. & Plopper, G.E. Adhesion to
Vitronectin and Collagen I Promotes Osteogenic Differentiation of Human Mesenchymal
Stem Cells. J Biomed Biotechnol 2004, 24-34 (2004).
390. Schwartz, M.A., Schaller, M.D. & Ginsberg, M.H. Integrins: emerging paradigms of signal
transduction. Annu Rev Cell Dev Biol 11, 549-599 (1995).
391. Sieg, D.J., Hauck, C.R. & Schlaepfer, D.D. Required role of focal adhesion kinase (FAK) for
integrin-stimulated cell migration. J Cell Sci 112 ( Pt 16), 2677-2691 (1999).
392. Salasznyk, R.M., Klees, R.F., Williams, W.A., Boskey, A. & Plopper, G.E. Focal adhesion
kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem
cells. Exp Cell Res 313, 22-37 (2007).
393. Fisher, L.W., Hawkins, G.R., Tuross, N. & Termine, J.D. Purification and partial
characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin
from the mineral compartment of developing human bone. J Biol Chem 262, 9702-9708
(1987).
References -141-
394. Hoshi, K., Ejiri, S. & Ozawa, H. Localization alterations of calcium, phosphorus and
calcification-related organics such as proteoglycans and alkaline phosphatase during bone
calcification. J Bone Miner Res 16, 289-298 (2001).
395. Bellows, C.G., Reimers, S.M. & Heersche, J.N. Expression of mRNAs for type-I collagen,
bone sialoprotein, osteocalcin and osteopontin at different stages of osteoblastic
differentiation and their regulation by 1,25 dihydroxyvitamin D3. Cell Tissue Res 297, 249-
259 (1999).
396. Gregory, C.A., Gunn, W.G., Peister, A. & Prockop, D.J. An Alizarin red-based assay of
mineralization by adherent cells in culture: comparison with cetylpyridinium chloride
extraction. Anal Biochem 329, 77-84 (2004).
397. Egles, C. et al. Denatured collagen modulates the phenotype of normal and wounded human
skin equivalents. J Invest Dermatol 128, 1830-1837 (2008).
398. Moursi, A.M. et al. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109 (
Pt 6), 1369-1380 (1996).
399. Stephansson, S.N., Byers, B.A. & Garcia, A.J. Enhanced expression of the osteoblastic
phenotype on substrates that modulate fibronectin conformation and integrin receptor binding.
Biomaterials 23, 2527-2534 (2002).
400. Moursi, A.M., Globus, R.K. & Damsky, C.H. Interactions between integrin receptors and
fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 110 ( Pt 18),
2187-2196 (1997).
401. Garcia, A.J., Vega, M.D. & Boettiger, D. Modulation of cell proliferation and differentiation
through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 10, 785-798
(1999).
402. Keselowsky, B.G., Collard, D.M. & Garcia, A.J. Integrin binding specificity regulates
biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 102,
5953-5957 (2005).
403. Bissell, M.J., Hall, H.G. & Parry, G. How does the extracellular matrix direct gene
expression? J Theor Biol 99, 31-68 (1982).
404. Juliano, R.L. & Haskill, S. Signal transduction from the extracellular matrix. J Cell Biol 120,
577-585 (1993).
405. Vogel, V. & Baneyx, G. The tissue engineeting puzzle: a molecular perspective. Annu Rev
Biomed Eng 5, 441-463 (2003).
406. Schwartz, M.A. & DeSimone, D.W. Cell adhesion receptors in mechanotransduction. Curr
Opin Cell Biol 20, 551-556 (2008).
407. Engler, A.J., Sweeney, H.L., Discher, D.E. & Schwarzbauer, J.E. Extracellular matrix
elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact 7, 335 (2007).
408. Engler, A.J., Sen, S., Sweeney, H.L. & Discher, D.E. Matrix elasticity directs stem cell
lineage specification. Cell 126, 677-689 (2006).
409. Jokinen, J. et al. Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem 279,
31956-31963 (2004).
410. Comisar, W.A., Kazmers, N.H., Mooney, D.J. & Linderman, J.J. Engineering RGD
nanopatterned hydrogels to control preosteoblast behaviour: A combined computational and
experimental approach. Biomaterials 28, 4409-4417 (2007).
411. Arnold, M., Calvalcanti-Adam, E.A. & Spatz, J.P. xxx. ChemPhysChem 5, 383-388 (200).
412. Virchow, R. Weisses Blut. Frorieps Notitzen 36, 151-156 (1845).
413. Wertheim, J.A., Miller, J.P., Xu, L., He, Y. & Pear, W.S. The biology of chronic myelogenous
leukemia:mouse models and cell adhesion. Oncogene 21, 8612-8628 (2002).
414. Pasternak, G., Hochhaus, A., Schultheis, B. & Hehlmann, R. Chronic myelogenous leukemia:
molecular and cellular aspects. J Cancer Res Clin Oncol 124, 643-660 (1998).
415. Nowell, P.C. & Hungerford, D.A. A minute chromosome in human granulocytic leukemia.
Science 132, 1407 (1960).
416. Kurzrock, R. et al. BCR rearrangement-negative chronic myelogenous leukemia revisited. J
Clin Oncol 19, 2915-2926 (2001).
417. Ren, R. Mechanisms of BCR-ABL in the pathogenesis of hcronic myelogenous leukemia. Nat
Rev Cancer 5, 172-183 (2005).
418. Rowley, J.D. Letter: A new consistent chromosomal abnormality in chronic myelogenous
leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293
(1973).
References -142-
419. Heisterkamp, N. et al. Localization of the c-ab1 oncogene adjacent to a translocation break
point in chronic myelocytic leukaemia. Nature 306, 239-242 (1983).
420. de Klein, A., Van Kessel, A.G. & Grosveld, G. A cellular oncogene is translocated to the
Philadelphia chromosome in chronic myelocytic leukemia. Nature 300, 765-767 (1982).
421. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. Fused transcript of abl and bcr genes in
chronic myelogenous leukaemia. Nature 315, 550-554 (1985).
422. Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.-M., Witte, O.N. & Baltimore, D. The chronic
myelogenous leukemia-specifc P210 protein is the product of the bcr/abl hybrid gene. Science
233, 212-214 (1986).
423. Daley, G.Q. & Baltimore, D. PNAS 85, 9312-9316 (1988).
424. McLaughlin, J., Chianese, E. & Witte, O.N. PNAS 84, 6558-6562. (1987).
425. Hariharan, I.K. et al. Mol. Cell Biol. 9, 2798-2805 (1989).
426. Pear, W.S. & al., e. Efficient and rapid induction of a chronic myelogenous leukemia-like
myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92,
3780-3792 (1998).
427. Daley, G.Q., Van Etten, R.A. & Baltimore, D. Induction of chronic myelogenous leukemia in
mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830 (1990).
428. Lin, J. & Arlinghaus, R. Activated c-Abl tyrosine kinase in malignant solid tumors. Oncogene
27, 4385-4391 (2008).
429. Woodring, P.J., Hunter, T. & Wang, J.Y. Regulation of F-actin-dependent processes by the
Abl family of tyrosine kinases. J Cell Sci 116, 2613-2626 (2003).
430. Plattner, R. & Pendergast, A.M. Activation and signaling of the Abl tyrosine kinase:
bidirectional link with phosphoinositide signaling. Cell Cycle 2, 273-274 (2003).
431. Plattner, R. et al. A new link between the c-Abl tyrosine kinase and phosphoinositide
signalling through PLC-gamma1. Nat Cell Biol 5, 309-319 (2003).
432. Chu, S., Li, L., Singh, H. & Bhatia, R. BCR-tyrosine 177 plays an essential role in Ras and
Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous
leukemia. Cancer Res 67, 7045-7053 (2007).
433. Kharas, M.G. & Fruman, D.A. ABL oncogenes and phosphoinositide 3-kinase: mechanism of
activation and downstream effectors. Cancer Res 65, 2047-2053 (2005).
434. Chai, S.K., Nichols, G.L. & Rothman, P. Constitutive activation of JAKs and STATs in BCR-
Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J
Immunol 159, 4720-4728 (1997).
435. Steelman, L.S. et al. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle
progression and leukemogenesis. Leukemia 18, 189-218 (2004).
436. Jin, A. et al. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt
signaling pathways and to regulate proliferation, apoptosis, and adhesion. Oncogene 25, 4332-
4340 (2006).
437. Chu, S., Holtz, M., Gupta, M. & Bhatia, R. BCR/ABL kinase inhibition by imatinib mesylate
enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells. Blood 103,
3167-3174 (2004).
438. Kim, J.H. et al. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased
production of reactive oxygen species. Blood 105, 1717-1723 (2005).
439. Hall, A.G. & Irving, J. New drugs, new drug resistance mechanisms. Expert Rev Anticancer
Ther 2, 239-240 (2002).
440. Srinivasan, D. & Plattner, R. Activation of Abl tyrosine kinases promotes invasion of
aggressive breast cancer cells. Cancer Res 66, 5648-5655 (2006).
441. Deininger, M.W., Goldman, J.M. & Melo, J.V. The molecular biology of chronic myeloid
leukemia. Blood 96, 3343-3356 (2000).
442. Hehlmann, R., Hochhaus, A. & Baccarani, M. Chronic myeloid leukaemia. Lancet 370, 342-
350 (2007).
443. Druker, B.J. & Lydon, N.B. Lessons learned from the development of an abl tyrosine kinase
inhibitor for chronic myelogenous leukemia. J Clin Invest 105, 3-7 (2000).
444. Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase
in chronic myeloid leukemia. N Engl J Med 344, 1031-1037 (2001).
445. Druker, B.J. Translation of the Philadelphia chromosome into therapy for CML. Blood 112,
4808-4817 (2008).
446. Kantarjian, H., Giles, F., Quintás-Cardama, A. & Cortes, J. Important therapeutic targets in
chronic myelogenous leukemia. Clin Cancer Res 13, 1089-1097 (2007).
References -143-
447. Heaney, N.B. & Holyoake, T.L. Therapeutic targets in chronic myeloid leukaemia. Hematol
Oncol 25, 66-75 (2007).
448. McCubrey, J.A. et al. Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.
Curr Opin Investig Drugs 9, 614-630 (2008).
449. McCubrey, J.A. et al. Targeting survival cascades induced by activation of
Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia
therapy. Leukemia 22, 708-722 (2008).
450. Li, Z. & Li, L. Understanding hematopoietic stem-cell microenvironment. Trends Biochem.
Sci. 31, 589-595 (2006).
451. Rizo, A., Vallenga, E., de Haan, G. & Schuringa, J.J. Hum. Mol. Genet. 15, R210-R219.
(2006).
452. Hazlehurst, L.A., Damiano, J.S., Buyuksal, I., Pledger, W.J. & Dalton, W.S. Adhesion to
fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion
mediated drug resistance (CAM-DR). Oncogene 19, 4319-4327 (2000).
453. Matsunaga, T. et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a
decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 9,
1158-1165 (2003).
454. Eaves, A.C., Cashman, J.D., Gaboury, L.A., Kalousek, D.K. & Eaves, C.J. Unregulated
proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal
marrow adherent cells. Proc Natl Acad Sci U S A 83, 5306-5310 (1986).
455. Gordon, M.Y., Dowding, C.R., Riley, G.P., Goldman, J.M. & Greaves, M.F. Altered adhesive
interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid
leukaemia. Nature 328, 342-344 (1987).
456. Kramer, A. et al. Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-
transfected murine hematopoietic cells. Proc Natl Acad Sci U S A 96, 2087-2092 (1999).
457. Wertheim, J.A. et al. Localization of BCR-ABL to F-actin regulates cell adhesion but does not
attenuate CML development. Blood 102, 2220-2228 (2003).
458. Bhatia, R., Munthe, H.A. & Forman, S.J. Abnormal growth factor modulation of beta1-
integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors. Br
J Haematol 115, 845-853 (2001).
459. Bazzoni, G., Carlesso, N., Griffin, J.D. & Hemler, M.E. Bcr/Abl expression stimulates
integrin function in hematopoietic cell lines. J Clin Invest 98, 521-528 (1996).
460. Ramaraj, P. et al. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-
induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Cancer Res 64, 5322-5331 (2004).
461. Zhao, R.C., Jiang, Y. & Verfaillie, C.M. A model of human p210(bcr/ABL)-mediated chronic
myelogenous leukemia by transduction of primary normal human CD34(+) cells with a
BCR/ABL-containing retroviral vector. Blood 97, 2406-2412 (2001).
462. Bhatia, R. & Verfaillie, C.M. Inhibition of BCR-ABL expression with antisense
oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition
in chronic myelogenous leukemia hematopoietic progenitors. Blood 91, 3414-3422 (1998).
463. Salesse, S. & Verfaillie, C.M. Mechanisms underlying abnormal trafficking and expansion of
malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML.
Oncogene 21, 8605-8611 (2002).
464. Barnes, D.J., Schultheis, B., Adedeji, S. & Melo, J.V. Dose-dependent effects of Bcr-Abl in
cell line models of different stages of chronic myeloid leukemia. Oncogene 24, 6432-6440
(2005).
465. Jamieson, C.H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in
blast-crisis CML. N Engl J Med 351, 657-667 (2004).
466. Wertheim, J.A. et al. BCR-ABL-induced adhesion defects are tyrosine kinase-independent.
Blood 99, 4122-4130 (2002).
467. Peng, B. et al. Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with
chronic myeloid leukemia patients. J Clin Oncol 22, 935-942 (2004).
468. Schleyer, E. et al. Liquid chromatographic method for detection and quantitation of STI-571
and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture
medium and cell preparations. J Chromatogr B Analyt Technol Biomed Life Sci 799, 23-36
(2004).
469. Springer, T.A. Adhesion receptors of the immune system. Nature 346, 425-434 (1990).
References -144-
470. Mould, A.P., Akiyama, S.K. & Humphries, M.J. Regulation of integrin alpha 5 beta 1-
fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for
Mn2+, Mg2+, and Ca2+. J Biol Chem 270, 26270-26277 (1995).
471. Kirchhofer, D., Grzesiak, J. & Pierschbacher, M.D. Calcium as a potential physiological
regulator of integrin-mediated cell adhesion. J Biol Chem 266, 4471-4477 (1991).
472. Heino, J., Ignotz, R.A., Hemler, M.E., Crouse, C. & Massague, J. Regulation of cell adhesion
receptors by transforming growth factor-beta. Journal of Biological Chemistry 264, 380-388
(1998).
473. Humphries, J.D., Byron, A. & Humphries, M.J. Integrin ligands at a glance. J Cell Sci 111,
3901-3903 (2006).
474. Gambacorti-Passerini, C. et al. Inhibition of the ABL kinase activity blocks the proliferation
of BCR/ABL+ leukemic cells and induces apoptosis. Blood Cells Mol Dis 23, 380-394 (1997).
475. Dalton, S.L., Scharf, E., Briesewitz, R., Marcantonio, E.E. & Assoian, R.K. Cell adhesion to
extracellular matrix regulates the life cycle of integrins. Mol Biol Cell 6, 1781-1791 (1995).
-145-
Index of figures and tables
Index of figures
   Page
Fig. 1. Chicken fibro-blast in the connective tissue of the skin     8
Fig. 2. Axial structure of D-periodic collagen type I fibrils   11
Fig. 3. Overview of integrin heterodimers   14
Fig. 4. Combinations of integrin-ECM interactions   14
Fig. 5. Molecular model of integrin a2b1 ectodomain in its extended
Conformation   15
Fig. 6. Structure of the a2I-domain in complex with a collagen like peptide   16
Fig. 7.  Different mechanisms to regulate integrin mediated adhesion   17
Fig. 8. Integrin structural changes during activation   19
Fig. 9. Integrin-cytoskeleton interactions   21
Fig. 10: Integrin inside-out and outside-in signaling   22
Fig. 11. Focal adhesions visualized by fluorescence microscopy   23
Fig. 12. AFM cantilever and principle of force detection   34
Fig. 13. AFM force spectroscopy   35
Fig. 14. Possible SCFS experimental setups to measure cell interactions with 
adhesive substrates.   36
Fig. 15. Attaching a living cell onto the AFM cantilever   37
Fig. 16. Monitoring the force signal during a F-D cycle   38
Fig. 17. F-D curve and extracted information   38
Fig. 18. Schematic representation of the cell detachment process   39
Fig. 19. Sketch illustrating the different events causing j and t-like events   41
Fig. 20 Image of a membrane tether pulled from a embryonic zebrafish cell   42
Fig. 21. F-D curves in presence of Cytochalasin D   43
Fig. 22. Alternative SCFS setups   46
Fig. 23. Sketch illustrating the contact zone established between a cell and
a ligand-coated surfaces during AFM SCFS   49
Fig. 24. Schematic representation of receptor-ligand bond dissociation   51
Fig. 25 Influence of an external force on the energy barrier separating the
bond and the unbound state   52
Fig. 26. Representative F-D curve recorded in AFM-SCFS experiments   54
Fig. 27. Schematic representation showing the effects of force on average bond
Lifetime and binding strength   55
Fig. 28 . AFM topographs of two-dimensional collagen I matrices   61
Fig. 29. Integrin a2 expression in Saos-WT/-A2 and CHO-WT/-A2 cells   62
Fig. 30. Effect of trypsin treatment on a2- and b1-integrins   63
Fig. 31. Spreading of Saos-WT and –A2 cells on Col matrices   64
Fig. 32. Spreading of CHO-WT and –A2 cells on Col matrices   64
Fig. 33: Quantifying adhesion of Saos-A2 and -WT cells to Col   65
Fig. 34. Quantifying cell adhesion of CHO-WT and -A2 cells to Col   66
Fig. 35. Analysis of CHO cell diameter and a2-integrin expression   68
Fig. 36. Detecting single a2b1- integrin Col interactions   69
Fig. 37. Analyzing a2b1-integrin-collagen interactions by dynamic force
spectroscopy   70
Index of figures and tables -146-
Fig. 38. j- and t- events at different pulling velocities   73
Fig. 39. Monitoring cell shape during contact   75
Fig. 40. Detachment forces of CHO-A2 and -WT cells for 0 - 30 sec contact   76
Fig. 41. Dependence of detachment forces on contact time   76
Fig. 42. Example F-D curves displaying increasing detachment forces for
prolonged contact   77
Fig. 43. Separating high- and low- adhesion cells   78
Fig. 44. Single rupture events for high- and low-adhesion   80
Fig. 45. Influence of inhibitors of actomyosin contractility on cell adhesion   82
Fig. 46. Confocal microscopy images of the contact zone of a YFP-paxillin
expressing CHO-A2 cells and Col during SCFS   84
Fig. 47. Overview about the sequential build-up of a2b1-integrin-collagen
type I bonds   86
Fig. 48. Sketch illustrating the effect of thermal denaturation on collagen type I
structure   89
Fig. 49. Characterization of two-dimensional collagen type I matrices   92
Fig. 50. Characterisation of Col and pdCol by immunofluorescence microscopy   93
Fig. 51. Characterizing mechanical properties of Col and pdCol   94
Fig. 52. Cellular behaviour on Col/pdCol matrices   95
Fig. 53. Quantification of cell adhesion to Col/pdCol matrices by SCFS   96
Fig. 54. Flow cytometry analysis of cell surface associated integrins   97
Fig. 55. Quantifying the effect of integrin blocking on cell adhesion to Col
and pdCol   98
Fig. 56. FAK tyr397 phosphorylation on Col/pdCol 100
Fig. 57. Cell proliferation and matrix mineralization 101
Fig. 58. Reciprocal interactions between cells and ECM 105
Fig. 59. Signalling pathways affected by BCR/ABL 110
Fig. 60. Mechanism of IM 111
Fig. 61. Quantification of cell-cell adhesion using washing assays 113
Fig. 62. Experimental setup to quantify cell-cell adhesion by SCFS 114
Fig. 63. Quantification of cell-cell adhesion by SCFS 114
Fig. 64. Quantifying adhesion of 32D cells to ECM proteins 117
Fig. 65. Quantifying adhesion of 32D cells to BMSC blocking b1-integrins 119
Fig. 66. b1-integrin and gene expression in 32D cells 120
Fig. 67. Effect of BCR/ABL on 32D cell surface concentrations of integrins 122
Fig. 68. Confocal imaging of 32D cells on a BMSC monolayer 123
Index of tables
Table 1. Overview about ECM macromolecules     9
Table 2. Overview about cell adhesion assays   34
Table 3. Percentage of single rupture events (“j”) <73 pN detected for different
experimental conditions (inhibitors, contact times)   83
Table 4. Analysis of single force jumps for cell-cell and cell-ECM measurements 116
-147-
Appendix
Quantifying adhesive interactions between cells and
extracellular matrix by single-cell force spectroscopy
Contents of Appendix
          Page
A Supplementary information S1
A1 Supplementary information for chapter 2 S1
A2 Supplementary information for chapter 4 S1
A2.1 Testing the effect of repeated F-D cycles S1
A2.2 Testing the mechanical stability of Col S2
A2.3 Statistics of SCFS data S3
A3 Supplementary information for chapter 5 S4
B Experimental procedures S6
B1  AFM-SCFS S6
B1.1 Experiments S11
B1.2 Data analysis- Overall cell adhesion S11
B1.3 Modified setup for single-molecule measurements S14
B2 Preparation of adhesive ECM substrates S17
B3 AFM imaging S18
B4 Analyzing mechanical properties of collagen type I matrices S18
B5 Immunostaining of Col/pdCol matrices (mica) S19
B6 Immunostaining of cells S20
B7 Analysis of cell migration and spreading S20
B8 FAK phosphorylation at tyr 397 S20
B9 Washing assays S21
B10 Cell proliferation assay S21
B11 Matrix mineralization- Alizarin red stain S21
B12 Flow cytometry S22
B13 SDS-PAGE and western blots S22
B14 Reverse transcription and quantitative real-time PCR S23
B15 Statistical analysis S23
C Cell culture            S24
D Materials            S27
D1 Chemicals and media            S27
D2 Plastic equipment            S28
D3 AFM cantilevers            S28
D4 ECM proteins            S28
D5 Proteins for cantilever functionalization            S29
D6 Antibodies and blocking peptides            S29
E Supplementary movies        CD-ROM
Appendix -S1-
A Supplementary information
A1 Supplementary information for chapter 2
Covariance between parameters extracted from F-D curves
Covariances for detachment force (F), work (W), separation distance d and cell
elasticity were determined using Matlab (MathWorks) for a dataset recorded for 32D-V
cells. E was determined using the area under the approach curve in the contact regime
according to*. F and W are clearly related (cov=0.67). Furthermore, there is a higher
covariance for W-E (cov=0.33) compared to F-E (cov=0.08). This indicates that W is
more influenced by cell elasticity than F. Similarly, separation distance d has more
impact on W than on F. Membrane nanotubes that increase the separation distance,
contribute substantially to increase W.
Table S1. Covariance between parameters extracted form F-D curves. For a dataset
recorded with 32D cells (5sec contact, 75F-D cycles) the covariance between detachment
work W, force F, elasticity E and separation distance d was calculated.
A2 Supplementary information for chapter 4
A2.1 Testing the effect of repeated F-D cycles.
To test if repeating F-D cycles had an effect on subsequent F-D cycles, detachment forces
of five repeatedly recorded F-D cycles were compared (Fig. S1). Since detachment forces
did not significantly change for the tested contact times, it was concluded that the contact
history did not bias the measurements.
                                                 
* Rosenbluth, M.J., Lam, W.A. & Fletcher, D.A. Force microscopy of nonadherent cells: a
comparison of leukemia cell deformability. Biophys J 90, 2994-3003 (2006).
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Fig. S1. Force history. Presented are mean detachment forces ± SD detected for several
cells. Number of analysed cells are annotated. In independent experiments two different
contact times were applied (5 sec (A) and 30 sec (B)).
A.2.2 Testing the mechanical stability of Col
To test wether Col was disrupted by high cell detachment forces, Col was imaged by
AFM after recording F-D cycles. Col matrix were apparently not to affected by the
detachment process.
Fig. S2. Testing the mechanical stability of collagen type I matrices. (A) Detachment
force curve for a strongly adherent cell (detachment force > 15 nN). (B) AFM topograph
showing Col after several F-D cycles.
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A.2.3 Statistics of SCFS in chapter 4.
Table S2. Number of cells (# cells) analysed and number of force curves (n) generated.
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A3 Supplementary information for chapter 5
A3.1 Characterisation of Col/pdCol coated thermanox discs
In addition to coated mica discs, MC3T3-E1 cells were cultured on Col and pdCol
coated thermanox discs.
Fig. S3. Characterisation of Col and pdCol- coated thermanox discs. (A) Binding of
mAB and pAB collagen antibodies to Col/pdCol coated thermanox discs. Mean DAB
(3,3´Diaminobenzidine) stain intensities ± SD are shown. Numbers in brackets indicate
the number of analysed thermanox surfaces. (B) Detachment forces of MC3T3-E1 cells
after 5 sec contact with Col/pdCol thermanox measured by SCFS. (C) Attachment of
MC3T3-E1 cells to Col/pdCol (thermanox) analysed by washing assays in presence and
absence of b1-integrin blocking antibody and RGD peptide. (D) Cell proliferation and
matrix mineralization (E) on Col/pdCol coated thermanox discs. Methods are explained
in B10 and B11.
Appendix -S5-
Antibody staining of coated thermanox discs confirmed that structural changes
occurred in Col after thermal treatment (1 h, 50 °C) similar as observed on coated mica
(Fig. S3 A). Moreover, SCFS revealed higher MC3T3-E1 cell adhesion to pdCol than to
Col coated thermanox discs (Fig. S3 B), such as observed for collagen coated mica.
Washing assays confirmed that cell attachment to pdCol coated thermanox was RGD-
dependent (Fig. S3 C). In line with experiments performed on Col and pdCol coated mica
discs, matrix mineralization was more pronounced after 35 d on pdCol compared to Col
(Fig. S3 E), whereas cell proliferation was similar (Fig. S3 D).
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B Experimental procedures
B1 AFM- SCFS
B1.1 Experiments
AFM & equipment
For SCFS a Nanowizard I (JPK instruments) was mounted on top of an inverted
light microscope (Axiovert 200 (Carl Zeiss, Jena)) equipped with a CCD Camera
(Coolsnap cf, Diagnostic Instruments Inc.). This setup allowed combined use of AFM
and light microscopy (Fig. S4). A special feature of the SCFS setup used was the
extended piezo range of 100 µm (CellHesion module, JPK instruments), which was
essential to cell-cell and cell-ECM experiments performed at longer contact times. All
experiments were conducted at 37 °C using a temperature-controlled chamber that
enabled precise temperature-control in the chamber (±  0.1 K) (BioCell, JPK
instruments)*.
Fig. S4. Photography of the AFM setup. AFM head (1) mounted on an inverted light
microscope (2) equipped with a CCD Camera. The sample was mounted in the biocell
(3). The setup was placed on a damping table (5) to reduce vibrations transmitted by the
building. The whole setup was in an acoustic noise chamber (6).
                                                 
* Puech, P.H., Poole, K., Knebel, D. & Muller, D.J. A new technical approach to quantify cell
adhesion forces by AFM. Ultramicroscopy 106, 637-644 (2006).
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The bottom of the Biocell consisted of a standard glass coverslip (Ø=24 mm) that
was coated with the substrate of interest (ECM proteins or monolayer of cells grown on
the coverslip, see table S2). V-shaped, 200 µm long tipless silicium nitride cantilevers
with a nominal spring constant of 0.06 N/m (NP-0, Veeco Instruments, Woodbury,NY;
USA) were used.
Cantilever functionalization for cell attachment
For cantilever functionalization a modified version of the published protocol of V.
Moy´s group was used*. NP-O cantilevers (Veeco probes) were cleaned in a plasma
cleaner (Plasma Cleaner/Sterilizer PDC-32G (Harrick Plasma)) at maximal power for
2 min prior to coating. Then cantilevers were incubated overnight in 50 µl droplets of
0.5 mg/ml BSA-Biotin (see D.6) in NaCHO3 buffer (100 mM, pH 8.6) in a humified
chamber at 37 °C. The next day, cantilevers were washed three times in PBS and
incubated in 50 µl droplets of 0.5 mg/ml streptavidin in PBS at RT in a humified chamber
for 45 min. Thereafter cantilevers were washed three times in PBS and incubated for
45 min in 50 µl droplets of 0.5 mg/ml Concanavalin A (ConA)- Biotin in PBS at RT in a
humified chamber. Finally, they were rinsed and stored in PBS. Functionalized
cantilevers could be stored at 4 °C for at least two weeks. After use, cantilevers were
recycled:  for cleaning cantilevers were immersed in 1 M sulfuric acid for 1 h, then rinsed
three times with H2O and plasma-cleaned before re-functionalisation.
Preparation of a cell suspension for SCFS
 Cells (table S2 and C) were grown to confluency in cell culture medium. They
were harvested using Accutase† (PAA) or 0.05 % trypsin-EDTA solution 10-15 min
before starting experiments. If trypsin was used, it was inactivated by adding trypsin
inhibitor. Cells were suspended in CO2-independent medium (see table S2 and C),
                                                 
* Wojcikiewicz, E.P., Zhang, X. & Moy, V.T. Force and Compliance Measurements on Living
Cells Using Atomic Force Microscopy (AFM). Biol Proced Online 6, 1-9 (2004).
† Accutase might be more suitable for most experiments than trypsin-EDTA since the effect of
adhesion receptor degradation is decreased..
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centrifuged at 1000 rpm for 3 min and transferred into CO2-independent medium, either
commercially available CO2-independent medium or DMEM supplemented with 20 mM
Hepes. Cells were then kept at 37 °C until they were added into the Biocell to start
experiments (usually within 10-20 min). For integrin-function blocking experiments,
cells were pre-incubated with 10 mg/ml blocking antibodies or 100 mM RGD peptide for
30-60 min before performing experiments in presence of inhibitors.
Setting up the experiment
A coverslip with the adhesive substrate (table S2) was mounted into the AFM
BioCell sample holder (JPK Instruments). The surface was rinsed several times with
CO2-independent medium. A Con A-functionalized cantilever was fastened onto the
cantilever holder and the holder was mounted into the AFM head. Then the AFM head
was set onto the sample stage.
Cantilever calibration
Cantilever spring constants were determined in situ prior to every experiment
using procedures implemented into the SPM software (JPK Instruments). The conversion
of cantilever deflection into voltage change was determined by pushing the cantilever
onto a stiff surface. Then the cantilever spring constant was measured using the so-called
thermal noise method*.
Cell capture
After cantilever calibration ~103 suspended cells were injected into the BioCell to
obtain a sparse distribution on the substrate. Cells have to be captured before they
establish firm contact to the substrate. Thus, the following steps should occur as fast as
possible, approximately within the first five minutes after cell injection. Immediately
after the cells settled down on the substrate, the AFM cantilever was positioned above a
single cell by adjusting the position of the AFM head. X-Y positions of AFM head and
                                                 
* Hutter, J.L. & Bechhoefer, J. Calibration of atomic-force microscope tips. Rev Sci Instrum 64,
1868-1873 (1993).
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sample were modified by manually moving the sample stage or the AFM head. The Z
position of the AFM head was changed using implemented stepper motors. Cell and
cantilever were observed by light microscope throughout the experiment. For cell capture
the AFM cantilever was lowered onto a selected cell using the Z piezo. By controlling the
relative position of cell and cantilever during approach, it was ensured that the cell was
positioned precisely at the extreme end of the cantilever. Usually a contact force of 300-
600 pN and a contact time of 2-3 sec were used for cell capture. Thereafter, the cantilever
with the bound cell was retracted and brought to a distance of 30-80 mm from the
substrate. Before the experiment was started, the cell was allowed to establish firm
contact with the cantilever for ~10 min.
Recording force-distance (F-D) curves
The cantilever with the attached cell was brought into contact with the surface at a
preset speed until a defined contact force was reached, then the piezo position was
maintained constant (=constant height mode). After a defined attachment period
(=contact time) the cantilever/cell couple was retracted and the cell was detached from
the substrate. During the described process (=F-D cycle), the force (F) was recorded for
each piezo position. Between F-D cycles the cell was allowed to rest. The recovery time
depended on the contact time used. For short contact times (1-5 sec) recoveries of 1-5 sec
were taken, and numerous F-D cycles were performed (10-50). When cells were in
contact with the substrate for longer periods, fewer F-D cycles were made, for contact
times > 60 sec only one F-D cycle was performed. To avoid structural defects due to
repeated contacts, the position on the substrate where contact with the cell occurred was
changed between a small set of F-D cycles (1-3). This also compensated for substrate
inhomogenities. In table S2 the parameters used for different projects are listed. They
were empirically optimized for each experimental setup.
Note: Nonlinearity of piezo movements leads to incorrect piezo height data. This
problem can be eliminated by the use of a sensor (e.g. implemented in the JPK
Nanowizard) that measures the actual z-piezo position. Thereby non-linearity and
hysteresis effects in F-D curves were eliminated..
Furthermore, residual piezo polarization may result in piezo position overshoot
after the setpoint is reached (“creep”). This piezo creep may result in a considerable
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increase of the force applied to the cell, especially at prolonged contact time (>1sec). A
“closed-loop” mode was implemented in the JPK instrument. It activates a feedback
system that linearizes the piezo movement and minimizes piezo creep. A disadvantage of
the feedback is that the feedback mechanism additions noise of the sensor to the data. For
single-molecule experiments contact periods are usually in the millisecond range and the
contribution of piezo creep is neglectable. To reduce signal noise, for single-molecule
experiments the instrument was used in “open-loop”.
Table S3. Overview about experimental setups/parameters used.
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B1.2 Data analysis –Overall cell adhesion
Raw data files containing force and measured piezo height data (.txt) were
imported into an Igor Pro 5 procedure window using automated procedures written by
P.H. Puech and J. Helenius in Igor Pro 5 (Wavemetrics). F-D curves were plotted and
corrected as described below (Fig. S5 A, B). In the corrected F-D curves the detachment
force corresponding to the minimum force was determined. In a separated procedure j
and t events in F-D curves were automatically detected and quantified (Fig. S5 C, D).
Fig. S5. Analysis of overall cell adhesion and j events in F-D curves after their
correction. (A, B) Correction of F-D curves for thermal drift. A line is fitted to the
baselines and substracted from the force data. (C) The detachment force is automatically
measured by determing the minimum force in the corrected F-D curve. (D) Analysis of j
events is done by an automated Igor procedure written by J. Helenius.
Corrections of F-D curves
Unprocessed data F-D curves occasionally have tilted baselines and offsets
between trace and retrace baselines (Fig. S5). Trace and retrace baselines tilt in opposite
direction are typical for thermal drift. Thermal drift is due to the sensitivity of AFM
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cantilevers to temperature gradients that are most evident at the beginning of the
experiment. Thermal drift is more pronounced when metal-coated cantilevers are used.
NP-O cantilevers that were used in the experiments are coated asymmetrically with thin
layers of chrome and gold. As these metal layers have different thermal expansion
coefficients, temperature changes cause the cantilever to bend. In F-D curves thermal
drift is easily corrected by substracting a line (fitted to the baselines) from the force data
(Fig. S5). However, high thermal drift affects the performance of the experiment since
the contact force cannot be precisely controlled. In such cases the system had to be
equilibrated for a longer period. In addition, an offset between approach and retraction
baselines due to the hydrodynamic drag may appear, especially for high pulling speeds.
When the cantilever is moved through the medium, hydrodynamic forces act opposed to
the cantilever movement. Hydrodynamic drag forces increase with the viscosity of the
medium, the speed of the cantilever (Fig. S6) and cantilever proximity to the surface. Far
from the surface, the drag force is equal to half of the force separating trace and retrace
baselines. At low pulling speeds hydrodynamic drag is neglectable, whereas for high
pulling speeds e.g. for NP-O smaller 10 µm/sec the hydrodynamic drag force reaches the
magnitude of single-molecule binding strength* (~ 50 pN, Fig. S6). Thus, corrections for
the hydrodrag were only applied for single molecules experiments since high pulling
speeds were used (see B1.3).
 Fig. S6. Hydro-dynamic
drag forces versus pulling
speed. The hydrodynamic
drag force was measured
as half of the offset
between approach and
retraction baselines in F-D
curves recorded at
different pulling speeds. A
NPO cantilever with a
bound cell was used.
                                                 
* Alcaraz, J. et al. Microrheology of human lung epithelial cells measured by atomic force
microscopy. Biophys J 84, 2071-2079 (2003).
Janovjak, H., Struckmeier, J. & Muller, D.J. Hydrodynamic effects in fast AFM single-molecule
force measurements. Eur Biophys J 34, 91-96 (2005).
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Other artifacts
In some cases loose objects (e.g. other cell, or dirt particle) floating in proximity
or above of the cantilever disturb the cantilever movement or the laser path. In these
cases non-linear baselines are observed (Fig. S7, inset). These hinder the precise
measurement of FD and are therefore discarded.
Fig. S7. Typical discarded F-
D curve. Apparently an object
in the medium interfered with
cantilever movement during
approach and retraction.
Since the baseline is difficult
to determine, such F-D curves
are discarded.
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B1.3 Modified setup for single-molecule measurements
Data acquisition
To perform single molecule measurements, interactions between cell and adhesive
substrate have to be reduced such that in the majority of F-D curves only a single
receptor/ligand bond unbinds upon cantilever retraction (Fig. S8). This was achieved by
choosing a short time period (100-500 msec) and by applying only a small contact force
(typically 100-200 pN).
Fig. S8. Representative F-D curve
recorded in single-molecules
experiments. The F-D curve was
recorded with a CHO-A2 cell on
collagen type I. Contact time
200msec, contact force 250pN.
The probability that a single unbinding event occurs in repeated F-D curves is -
based on Poisson statistics- given by*:
† 
P(Nb =1/Nb > 0) =
l
exp(l) -1
Eq. S1
where Nb is the number of bonds and l the frequency of binding events.
Thus, given the case that in only 30 % of the F-D curves a force peak appears, the
probability of detecting a single-unbinding event is 86 %.
Since interactions occur under the described conditions rarely, >300 F-D curves can be
collected per cell without causing any apparent (as observed by light microscopy)
damage to the cell.
                                                 
* Tees, D.F., Waugh, R.E. & Hammer, D.A. A microcantilever device to assess the effect of force
on the lifetime of selectin-carbohydrate bonds. Biophys J 80, 668-682 (2001).
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F-D cycles were performed at pulling speeds ranging between 0.5–25 µm/sec. By varying
the cantilever retraction speed 
† 
v  different 
† 
reff  are applied. reff is defined as follows:
† 
reff = v ⋅ keff Eq. S3
with the effective spring constant 
† 
keff  of the cantilever-cell-substrate-bond system
*. keff
was determined by fitting a line through the final third of the force increase prior to bond
rupture (Fig. S8).
Analysis of F-D curves for single-molecule analysis
To obtain statistically significant data, at least 50 F-D curves displaying binding
events were collected per pulling speed. To acquire the data, several cells (n > 8) were
tested for all pulling speeds. All F-D curves were examined to see if a single rupture
event was present. By using an automated software procedure the magnitudes of single
rupture events were measured. The F-D data files (.txt) were imported sequentially into
an Igor Pro Procedure window, corrected for tilted baselines, baselines were also set to
zero. Then the force at the moment of bond rupture was measured (Fig. S 8)
Correction for the hydrodynamic drag force
Each single force value was corrected to account for the acting hydrodynamic
drag force that resulted in a non-neglectable underestimation of unbinding forces at the
high pulling speeds that were applied (up to 25 µm/sec). The drag force acting on the
cantilever was calculated as follows†:
Fd=vtip*(6*!*h*aeff)/(h+heff) Eq. S2
with the coefficients aeff and heff being the effective cantilever area and height, h
the cantilever-substrate distance, h the viscosity of the medium. vtip is the tip velocity
                                                 
* Zhang, X., Wojcikiewicz, E. & Moy, V.T. Force spectroscopy of the leukocyte function-
associated antigen-1/intercellular adhesion molecule-1 interaction. Biophys J 83, 2270-2279
(2002).
† † Alcaraz, J. et al. Correction of Microrhelogical Measurements of Soft Samples with Atomic
Force Microscopy for the Hydrodynamic Drag on the Cantilever. Langmuir 18, 716-721 (2002).
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immediately before bond rupture. The tip velocity is equal to “(piezo position)-(cantilever
deflection)”. vtip was measured for each unbinding event. aeff and heff depend on the
cantilever geometry and were determined by moving the cantilever through the medium
and measuring the hydrodynamic drag for the distance separating cantilever and surface
(h). For NP-O cantilevers values of aeff =57.9 mm and heff=6.3 mm were obtained. These
values were similar to previously reported values for similar cantilevers*.
Calculation of the bond dissociation rate 
† 
koff and the barrier width 
† 
xu
To generate the dynamic force spectrum, mean rupture forces 
† 
fm (here interpreted
as binding strength) were calculated for each pulling speed. 
† 
fm  were plotted versus the
logarithm of the corresponding loading rate 
† 
ln(reff )(see 3.3)
†. Since recorded data
(chapter four) were mainly normally distributed, there was no significant difference of
using mean, most probable or median rupture force. Rupture force data were fitted using
Eq. S4 and the bond dissociation rate 
† 
koff  and the barrier width 
† 
xu  (see chapter 3) were
extracted (Igor Pro software).
† 
fm =
kBT
xu
⋅ ln( xu
kBT ⋅ koff
) + kBT
xu
⋅ ln(reff ) Eq. S4
with the Boltzman constant 
† 
kB (1.3806504*10
-23 J/K) and the 
† 
T  the absolute temperature
(310 K).
                                                 
* Janovjak, H., Struckmeier, J. & Muller, D.J. Hydrodynamic effects in fast AFM single-molecule
force measurements. Eur Biophys J 34, 91-96 (2005).
† Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys J 72, 1541-
1555 (1997).
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Analysis of single membrane tethers
The force of single tethers t were measured by Yi-Ping using a procedure written
in Igor Pro by Jonne Helenius. t was plotted versus the pulling speed and fitted with
following equation:
† 
f = f0 + 2pheff v Eq. S5
where 
† 
f  is the tether force at finite velocity, 
† 
v  the tether formation velocity
(=pulling speed), 
† 
f0  the tether force at v=0 and 
† 
heff the effective viscosity.
A linear relationship between force and tether extractions speed (i.e. pulling
speed) is expected due to both membrane viscosity and friction between membrane and
cytoskeleton*.
                                                 
* Shao, J.Y. & Hochmuth, R.M. Micropipette suction for measuring piconewton forces of
adhesion and tether formation from neutrophil membranes. Biophys J 71, 2892-2901 (1996).
Hochmuth, R.M. & Marcus, W.D. Membrane tethers formed from blood cells with available area
and determination of their adhesion energy. Biophys J 82, 2964-2969 (2002).
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B2 Preparation of adhesive ECM substrates
Collagen type I matrices (Col)
Whereas collagen fibrillogenesis in vivo is a complex process involving cells and
numerous proteins, collagen fibrillogenesis in vitro occurs as a straightforward entropy-
driven process*. This enables the in vitro preparation of pure fibrillar collagen coatings.
Concentrated collagen type I solutions can be obtained by acid extraction from collagen-
rich tissues, such as skin or tendon. By neutralizing the acidic collagen solution in
physiologic buffer solutions, in vitro fibril growth can be initiated. The group of Prof. D.
Müller has developed several years ago a protocol by which ultra-thin, two-dimensional
and highly ordered collagen type I matrices (Col) can be produced on mica surfaces†:
To allow mounting into the AFM Biocell chamber, mica discs (Ø=4 mm) were
glued onto glass cover slips using an optical adhesive (Optical adhesive OP-29, Dymax
corporation, Torrington, USA). Then 30 µl of buffer (200 mM KCl, 50 mM Glycine,
pH 9.2) were applied onto the freshly cleaved mica discs. Then 1 µl collagen type I
solution (2.7 mg/ml) (see D4) was injected into the buffer droplet to yield a final collagen
concentration of 90 µg/ml. Samples were incubated overnight at room temperature (RT)
in a humid chamber. Prior experiments, surfaces were rinsed with PBS to remove not-
attached collagen. The matrices were always kept hydrated.
Partially denatured collagen type I matrices (PdCol)
 PdCol matrices were prepared by heating Col matrices for 1 h at 50 °C in a humid
chamber. Thereafter matrices were kept at RT for at least 2 h prior to experiments. Col
and pdCol surfaces were always kept in buffer solution.
                                                 
* Kadler, K.E., Hill, A. & Canty-Laird, E.G. Collagen fibrillogenesis: fibronectin, integrins, and
minor collagens as organizers and nucleators. Curr Opin Cell Biol 20, 495-501 (2008).
† Jiang, F., Khairy, K., Poole, K., Howard, J. & Müller, D.J. Creating nanoscopic collagen
matrices using atomic force microscopy. Microsc. Res. Tech. 64, 435-440 (2004).
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Col/pdCol coated thermanox discs
150 µl (450 µl) of buffer (200 mM KCl, 50 mM Glycine, pH 9.2) were applied
onto sterile thermanox discs (Ø=13 or 24 mm, depending on their use). Then 5µl (15µl)
collagen type I solution (2.7 mg/ml, D4) were injected into the buffer droplet to yield a
final collagen concentration of 90 µg/ml. Samples were incubated overnight at room
temperature (RT) in a humid chamber. Prior experiments, surfaces were rinsed with PBS
to remove not-attached collagen. The matrices were always kept hydrated.
FN coated surfaces
FN was adsorbed to acid-washed coverslips. These were prepared by a 5 h acid
wash with 1 M HCl at 50 °C. Subsequently cover slips were rinsed three times with pure
ethanol and water and dried. Then coverslips were incubated with 50 µg/ml human
plasma FN in PBS containing Ca2+ and Mg2+ for 90 min at RT. Subsequently, surfaces
were rinsed with PBS to remove unbound protein.
B3. AFM Imaging
AFM imaging of protein samples was conducted at RT in buffer solution (PBS)
using a Nanowizard I (JPK Instruments, Berlin, Germany). The piezoelectric scanner had
a maximal X-Y scanning range of 100 µm. For AFM imaging in tapping mode (TM)
SiO2 cantilevers (NPS, Veeco Probes, Plainview, USA) having a nominal spring constant
of 0.06 N/m were used. Drive frequencies close to the resonance frequency of the
cantilevers (10-15 kHz) were chosen.
B4. Analyzing mechanical properties of collagen type I matrices
To compare the mechanical stability of native and partially denatured collagen
type I matrices (Col/pdCol) (see B2), perpendicularly acting scratching forces were
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applied to them*. First, an area of 10 x 10 µm2 within Col/pdCol matrices was imaged in
contact mode AFM at non-destructive contact forces (ª50 pN). MSCT cantilevers
(k = 0.01 N/m, Veeco Probes, USA) were used. Scanning of samples was always
performed perpendicular to the collagen fibril direction. Next, 2 x 2 µm2 sections within
the previously imaged area were scanned by applying increasing contact forces to the
AFM stylus; contact forces ranged from 2 nN to 5 nN. Subsequently, the manipulated
10 x 10 µm2 area was re-imaged at minimal force (ª50 pN) to evaluate the structural
changes. For quantification the force at which the AFM stylus started to induce structural
deformations (=Fdamage) was determined. Eight different Col and pdCol matrices,
prepared in independent sample preparations, were analysed in total.
B5. Immunostaining of Col/pdCol matrices
Col/pdCol assembled on mica
Col and pdCol matrices were assembled on Ø=10 mm mica discs. Matrices were
fixed with 4 % paraformaldehyde (PFA) in PBS for 15 min. After washing with PBS,
Col/pdCol surfaces (except negative controls) were incubated for 45 min at RT with
5 µg/ml primary antibodies raised against collagen type I. As primary antibodies a
murine monoclonal antibody (mAB) that recognized not-denatured collagen type I and
additionally a rabbit polyclonal antibody (pAB) were used (see D6). Antibodies were
diluted in 0.5 % bovine serum albumin (BSA) in PBS. After washing three times with
PBS, all samples were incubated for 45 min with 3 µg/ml fluorescently labeled secondary
antibodies in 0.5 % BSA/PBS. FITC-conjugated anti-mouse IgG and TRITC-conjugated
anti-rabbit IgG were used (D6). After washing twice in PBS and a final washing step in
ddH2O for salt removal, FITC labeled reference beads (Calibrite
TM3, BD Biosciences)
were applied onto the surfaces. Samples were mounted upside down onto glass cover
slips using an anti-bleaching reagent (ProLong Gold, Invitrogen). Col/pdCol matrices
were examined by confocal microscopy (LSM 510 Meta, Zeiss, Göttingen, Germany)
using identical imaging parameters. To quantitatively compare mAB binding to
                                                 
* Friedrichs, J., Taubenberger, A., Franz, C.M. & Muller, D.J. Cellular remodelling of individual
collagen fibrils visualized by time-lapse AFM. J Mol Biol 372, 594-607 (2007).
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Col/pdCol, surfaces were incubated solely with mAB and FITC-conjugated anti-mouse.
Then mean fluorescence intensities of respective confocal images were determined using
Image J software (National Institutes of Health).
Col and pdcol assembled on thermanox discs could not be analysed using
fluorescently labelled secondary antibodies, because thermanox discs exhibited a strong
autofluorescence. Instead 3 µg/ml HRP-conjugated secondary antibodies in 0.5 %
BSA/PBS were used. After washing them, matrices were then incubated for 15 min with
3,3´Diaminobenzidine (DAB). Thermanox discs were scanned on a standard office
scanner and staining intensities were quantified at three different spots per disc using
Image J software. In total six different surfaces (Col/pdCol) were analysed in two
independent experiments.
B6 Immunostaining of cells
Cells were seeded in cell culture medium onto the respective substrate (~25 000
cells /cm2) for a certain time period. Then the cell layer was washed with PBS (w/ Mg2+,
Ca2+), fixed in 4 % PFA/PBS (20 min) and permeabilized with 0.2 % Triton X-100 in
PBS for 5min. Next, samples were incubated for 45 min with 5 µg/ml primary in 0.5 %
BSA/PBS. After washing three times with PBS, samples were stained with 5 µg/ml
fluorescently labelled secondary antibodies, 1µg/ml fluorescently-conjugated phalloidin
and 1 µg/ml DAPI for 45 min in 0.5 % BSA/PBS. After washing twice in PBS and a final
washing step in ddH2O for salt removal, samples were mounted upside down on glass
cover slips using an anti-bleaching reagent. Confocal microscopy images were acquired
using a LSM 510 Meta (Zeiss).
B7 Analysis of cell migration and spreading
Col/pdCol matrices were prepared on mica discs (Ø=10 mm) that had been glued onto the
glass bottom of a 34 mm Petri dish. Surfaces were carefully rinsed with cell culture
medium before 2 ml cell culture medium containing ~5x104 MC3T3-E1 cells were added
into the Petri dish. The Petri dish was mounted into a live cell chamber on top of an
inverted light microscope (Axiovert 200M, Zeiss). The system had been equilibrated to
37 °C and 5 % CO2. Phase contrast images at 10x magnification were recorded every
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30 sec over a total period of 90 min. Image sequences were viewed in Image J and the
percentage of spread cells was determined within the first hour after seeding.
Furthermore single cells were tracked using Image J (manual tracking plugin). From the
trajectories of single cells their mean migration speeds were calculated. At least five
different movies for each, Col and pdCol matrices, were analysed.
B8 FAK phosphorylation at tyr 397 in MC3T3-E1 cells on Col/pdCol
Col/pdCol matrices were prepared in 6-well dishes as described, washed twice
with PBS and once with alpha-MEM. Then ~2.5 x 105 MC3T3-E1 cells were seeded onto
the matrices. Cells were incubated for 45 and 90 min at 37 °C and 5 % CO2. Then cells
were lysed in 100 µl SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 2 % (w/v) SDS,
10 % glycerol, 50 mM DTT, 0.01 % (w/v) bromophenol blue) and incubated for 5 min at
95 °C. Cell lysates were analysed by western blot analysis. An antibody recognizing
phosphorylated tyr397 was used for detection (see D6).
B9 Washing assays
MC3T3-E1 cells were harvested with Accutase and transferred into CO2-
independent, serum-free medium. Cells were pre-incubated- when needed- with 10 mg/ml
blocking antibodies (D6) or RGD peptide (100 mM) for 30 min prior to experiments.
Then ~75000 MC3T3-E1 cells in 150 ml were seeded onto Col/pdCol coated thermanox
discs placed in 48well plates. After a 30 min-attachment period at 37 °C, loosely and
weakly attached cells were removed by carefully rinsing wells twice with 450 ml medium
using a 1 ml-pipette (Eppendorf).  Then 450 ml  PBS (with 0.5 mM Mg2+ and 1.8 mM
Ca2+) were added carefully. Wells were set upside down onto a layer of tissue paper
sheets to soak off all liquid. Wells were kept at –80 °C until numbers of attached cells
were quantified using the CyQuant Proliferations Assay Kit from Molecular Probes.
B10 Cell proliferation assay
Cell numbers were quantified after 7, 14, 21 and 28 days after seeding using the
CyQuant Cell Proliferation Assay Kit from Molecular Probes (Invitrogen). After medium
removal cells were rinsed with PBS and stored at -80 °C until analysis was performed.
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Then cells were lysed in cell lysis buffer provided by the manufacturer. Cell lysates were
appropriately diluted and 50 µl were transferred into a 96-well plate. Then 50 µl of 2x
concentrated CyQuant DNA binding dye were added. Fluorescence was detected at
530 nm using a plate reader (SpectraFluorPlus, Tecan, Crailsheim, Germany). A cell
suspension of known cell concentration was used as standard.
B11 Matrix mineralisation- Alizarin red stain
MC3T3-E1 cells were cultured for 28 and 35 and 42 days on Col and pdCol.
Osteogenic differentiation was induced after 1 day by replacing normal culture medium
by medium supplemented with osteo-inductive compounds (See C). Controls were
furtheron grown in normal cell culture medium. After the respective culture period,
medium was removed and cells were washed twice with PBS and fixed for 15 min in
10 % formaldehyde at RT. Then samples were washed carefully with dH2O and
incubated for 20 min with 2 % Alizarin red S solution (pH 4.1 - 4.3) under gentle
shaking. Thereafter, samples were rinsed three times with ddH2O water until no further
dye was released. Samples were dried and kept frozen at –20 °C until dye extraction.
Quantification of calcified matrix was performed following the protocol from Gregory et
al.*. Briefly, 200 µl of 10 % (v/v) acetic acid were added to each well and incubated for
30 min at RT on a rotary plate. Then the cell layer was scraped off and transferred in acid
solution to a 500 µl reaction tube. After vortexing for 30 sec, the reaction tubes were
heated at 85 °C for 10 min. Thereafter samples were cooled on ice and centrifuged at
16000g for 15 min. Then 125 µl of the supernatant were taken and neutralized with 50 µl
10 % (v/v) ammonium hydroxide. The pH of the supernatant was measured to ensure that
it ranged between 4.1 and 4.3. 150 µl of the samples were transferred into 96-well plates
and read at 405 nm using a plate reader.
                                                 
* Gregory, C.A., Gunn, W.G., Peister, A. & Prockop, D.J. An Alizarin red-based assay of
mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.
Anal Biochem 329, 77-84 (2004).
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B12 Flow Cytometry
A solution of PBS (PBS w/ Mg2+, Ca2+) containing 2 % BSA and 0.02 % Sodium-
azide was prepared and cooled on ice. Then cells were harvested using Accutase and
transferred into the prepared BSA solution. After washing once, a cell suspension of 106
cells/ml was prepared and kept on ice. 100 µl of cell suspension were incubated for each
sample in dublicate. Samples were incubated with primary antibodies (20 µg/ml) (D6) for
1 h. After washing twice with BSA-PBS cells were incubated with secondary antibodies
(10 µg/ml) (D6) for 45 min (if non-labelled primary antibodies had been used before).
Controls were solely incubated with fluorescently labelled secondary antibodies or
fluorescently labelled unspecific antibodies. Samples were washed three times with ice-
cold PBS (w/ Mg2+, Ca2+) and fixed in 4 % formalin (in PBS) for 20 min at RT. Finally
cells were washed with PBS and fluorescence staining of 20000 cells was analysed in a
flow cytometer (BD Biosciences).
B13 SDS-PAGE and western blot analysis
30 µl sample were loaded onto 8 % polyacrylamide (PA) gel, proteins were
separated for 60 to 90 min at 110 V. Proteins were thereafter transferred onto
nitrocellulose membranes (Schleicher&Schuell, Dassel, Germany). After blocking for
one hour in milk buffer (TBS-Tween 0.1 %, 5 % skim milk) membranes were incubated
overnight with primary antibodies. After washing, membranes were incubated with
secondary HRP-conjugated antibody (D6). After a final washing step in TBS (Tris-
buffered solution)-Tween (0.1 %) ECL (Biorad) was added and chemiluminescence was
detected on a photosensitive film (both from Amersham Bioscience). Loading controls
were performed with anti-b-tubulin or vinculin antibodies (D6) after stripping the
antibodies off the membrane.
B14. Reverse transcription and quantitative real-time PCR
(by the collaborator Fernando Fierro)
Quantitative real-time PCR was performed using TaqMan® Gene Expression Assays
(Applied Biosystems, Foster City, CA, USA); 1 µL cDNA synthesized from total RNA
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was used. Pre-designed primer sets for mouse itgb1 were purchased from Applied
Biosystems. Amplification conditions were: one initial cycle of 50 °C for 2 min plus
95 °C for 10 min followed by 40 cycles of 95 °C for 15 sec and 60 °C for 1 min. Itgb1
expression was normalized by comparison with the expression of the housekeeping gene
glyceraldehyde-3-phosphate-dehydrogenase (Applied Biosystems).
B15. Statistical analyses
All data were generated by at least three independent experiments. Non-Gaussian
distributed datasets were compared by a non-parametric two-sided significance test
(Mann-Whitney test) using Instat software. Significance of Gaussian distributed data sets
was tested by t-tests. Datasets were considered as significantly different if p-values were
smaller than 0.05.
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C. Cell culture
CHO cells. Chinese hamster ovary cells. CHO-WT and CHO-A2 (stably expressing
a2b1-integrin) cells were a kind gift from J. Heino. Cells were grown for continuous
passaging in alpha-MEM supplemented with 10 % FCS, 1 % L-glutamine, penicillin
(10000U/ml) and streptomycin sulfate (10000 mg/ml). Medium of CHO-A2 cells was
further supplemented with 0.4 µg/ml geneticin. 2-3 times a week, upon reaching
confluency, cells were detached from the tissue culture flasks by trypsin-EDTA (0.05 %)
and passaged at a ratio of 1:10 into a new culture flask.
Saos-2 cells. Human osteogenic sarcoma cells. Saos-WT and Saos-A2 cells were a kind
gift from J. Heino. Cells were grown for continuous passaging in DMEM supplemented
with 5 % FCS, 1% L-glutamine, penicillin (10000 U/ml) and streptomycin sulfate
(10000mg/ml). Medium of Saos-A2 cells was further supplemented with 0.2 µg/ml
geneticin. 2-3 times a week cells were passaged at a ratio of 1:10 .
M2-10B4. Mouse bone marrow derived stromal cells. M2-10B4 were purchased from
the American type culture collection (ATCC, Wesel, Germany) and cultured with RPMI
1640 supplemented with 10 % fetal calf serum (FCS). 2-3 times a week, cells were
passaged at a ratio of 1:10.
Preparation of M2-10B4 monolayers for SCFS. One day before AFM experiments,
~150000 M2-10B4 cells were seeded onto sterile glass coverslips within 6-well dishes to
obtain a cell layer of about 75 % confluency for experiments
32D cells. Mouse bone marrow cells (myeloid progenitors). 32D control cells were
retrovirally transfected with empty retroviral Mig vector (32D-V) or p210BCR/ABL (32D-
BCR/ABL). Cells were kindly provided by A. Neubauer (Marburg, Germany). 32D cells
were cultured in suspension using RPMI 1640 + 10 % FCS. 32D-V culture medium was
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supplemented with 1 U/ml recombinant mouse interleukin 3 (IL-3) (Strathmann Biotec,
Hamburg, Germany). 32D-BCR/ABL cells were growth factor independent.
MC3T3-E1. Mouse embryo calvaria cells. MC3T3-E1 cells were a kind gift from B.
Hoflack (Biotec, TU Dresden). Cells were grown for continuous passaging in alpha-
MEM supplemented with 10 % FCS, 1 % L-glutamine, penicillin (10000 U/ml) and
streptomycin sulfate (10000 mg/ml). 2-3 times a week cells were passaged (1:3).
4-weeks culture of cells on Col/pdCol matrices. MC3T3-E1 cells were seeded at a density
of ~3000 cells/cm2 onto Col/pdCol coated 13mm thermanox discs in cell culture medium.
The next day, medium was replaced by cell culture medium supplemented with
osteoinduction medium complements (10 mM b-glycerophosphate, 10 µM 1a,25-
dihydroxycholecalciferol (Vitamin D3), 50 µM ascorbic acid). Controls were grown in
cell culture medium lacking osteoinductive complements. Media were renewed three
times a week.
Recipes for cell culture media used in AFM-SCFS
CO2-independent medium (DMEM-Hepes) (Chapter 4)
For a total volume of 1l:
DMEM 10.1 g
NaHCO3 350 mg
HEPES 4.77 g
Penicillin/streptomycin (100x) 10 ml 
dH2O 990 ml
‡ adjust pH to 7.2
‡ sterile-filter medium and keep at 4°C
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CO2-independent medium w/o Mg
2+ and Ca2+
(equivilant to media formulation of DMEM-Hepes, but w/o Mg2+ and Ca2+)
For a total volume of 1L:
Hank´s balanced salt solution 100 ml
D-Glucose 3500 mg
MEM aminoacids solution  20 ml 
MEM vitamin solution 40 ml 
L-Serine 42 mg
L-Glutamine 584 mg
L-Glycine 30 mg 
NaHCO3 350 mg
Penicillin/Streptomycin 10 ml 
dH2O 830 ml 
‡ adjust to pH 7.2 using NaOH
‡ sterile-filter medium and keep at 4°C
Note:  All buffers and solutions are prepared using ultrapure deionized H2O (18.2 MΩ)
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D Materials
D1. Chemicals and media ingredients
1a,25-dihydroxycholecalciferol (vitamin D3) , Sigma
Accutase, PAA
Alizarin Red S, Sigma
Alpha-MEM, Gibco (Invitrogen, Karlsruhe, Germany).
Ascorbic acid, Sigma
b-glycerophosphate, Sigma
CO2-independent medium, Gibco
DMEM (1x, liquid), Gibco
DMEM (powder, 1000mg/l Glucose, w/Pyruvate, w/o NaHCO3), Gibco
FCS (fetal calf serum) (FBS), Gibco
Hank´s Balanced Salt Solution (10x HBSS, w/o Ca2+, Mg2+), Gibco
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ), Carl Roth GmbH
L-Glutamine, Gibco
L-Glycine, Sigma
L-Serine, Fluka
MEM vitamin solution (100x), Gibco
MEM amino acids solution (50x), Gibco
NaHCO3, Sigma
PBS, phosphate buffered saline containing Ca2+, Mg2+ , Biotec media kitchen
PBS, phosphate buffered saline without Ca2+, Mg2+, Biotec media kitchen
penicillin/streptomycin (100x), Gibco
RPMI 1640, Gibco
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tryspin-EDTA (0.5%), Gibco
trypsin inhibitor, Sigma
D2. Plastic equipment
6-well dishes, Nalgene Nunc
Steritop filter units (500 ml), Millipore
Sterile plastic pipettes, Greiner
Thermanox discs, Nalgene Nunc, Thermo Fisher Scientific, Waltham, USA
Tissue culture flasks, Nalgene Nunc
D3. AFM cantilevers
NP-O, Vecco probes, Plainview, USA
MLCT, Veeco probes
MSCT, Veeco probes
D4. ECM proteins
Bovine skin collagen type I (Purecol), Inamed Biomaterials (Fremont, USA).
Human plasma FN, Roche Pharma AG, (Basel, Switzerland).
D5. Proteins for cantilever functionalization
Bovine serum albumin, biotinamidocaproyl-labeled, Sigma
Streptavidin, Sigma
Concanavalin A, biotin conjugated, Sigma
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D6. Antibodies & blocking peptides
Integrin function-blocking antibodies
anti-b1 integrin (clone Ha2/5), BD Biosciences, New Jersey, USA
anti-b3 integrin (clone 2C9.G2), Biolegend, San Diego, USA
anti-aV integrin (Clone RMV-7), Biolegend
anti-a5b1 integrin (Clone BMB5), Millipore, Billerica, USA
Blocking peptides
Linear RGD peptide (GRGDSPK), Sigma
l229ox (CTRKKHDNAQC), Eurogentec Deutschland GmbH, Köln, Germany
Immunofluorescence
mouse monoclonal anti-collagen type I (clone COL-1), Sigma
rabbit polyclonal anti-collagen type I, Abcam, Cambridge, UK
Western Blots
Anti-FAK ptyr397, New England Biolabs GmbH, Frankfurt, Germany
Anti-human a2-integrin, Millipore
Anti-rat b1-integrin, BD Biosciences
Anti-hamster b1-integrin, kind gift from J. Heino, Turku, Finland
Anti-human vinculin, Sigma
FITC- conjugated anti-mouse IgG, Jackson Immunoresearch, West Grove, USA
TRITC/FITC- conjugated anti-rabbit IgG, Jackson Immunoresearch
Horseradish peroxidase (HRP)-conjugated anti-mouse/rabbit IgG, Amersham
Biosciences
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